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Abstract 
A convergent approach was applied to the synthesis of a range of Xanthomonas 
pigments and a number of selected analogues, with a view to understanding more 
about their photoprotective properties, and utilising the group’s iterative Heck-
Mizoroki/ iododeboronation cross-coupling methodology to access polyenyl 
intermediates. This involved the synthesis of a number of key arenyl building blocks. 
Three polyenyl building blocks were accessed via sequential Heck-Mizoroki and 
iododeboronation reactions, providing flexibility in the construction of the pigments 
and their analogues. Following some optimisation of final cross-coupling reactions, 
two truncated bacterial pigment analogues were successfully synthesised, with 
evidence of the synthesis of one of the natural product pigments also obtained. The 
key challenges in these syntheses lay in the considerable instability of many of the 
polyenyl intermediates (particularly the polyenyl iodides) and in the successful 
coupling onto the arenyl intermediates. 
Extensive NMR analysis, along with UV-Vis analysis provided insight into 
the photochemical behaviour of the truncated model compounds, and also 
corroborated the initial characterisation obtained by Andrewes et al. when they 
isolated xanthomonadin in 1976.  
Studies were also undertaken into novel methods of polyene synthesis, with 
vinyl iodide established as a potential Heck-Mizoroki coupling partner, providing 
access to a key dienyl boronate building block. This dienyl boronate was used to 
access a range of terminal dienes and trienes, providing a versatile route to such 
compounds. The group’s Heck-Mizoroki cross-coupling conditions were also re-
optimised to operate at room temperature, at low catalyst loadings, and on much 
shorter timescales than had been utilised previously.
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Introduction 
The term ‘polyene natural product’ encompasses a large group of compounds with a 
variety of interesting structures and properties. Of particular interest are those natural 
products which display biological activity. Whilst a large number of polyenes have 
been discovered, with over 200 polyenes in the polyene macrolide class alone,
1
 they 
still present a considerable challenge in terms of total synthesis.
2
 The construction of 
longer conjugated polyenes presents a number of obstacles in terms of 
stereoselectivity, reactivity and product stability. Those natural products containing 
all-trans polyene moieties tend to be more stable, whilst those containing all-cis 
olefins, or a mixture of cis and trans double bonds are much more prone to 
isomerisation and therefore present a greater challenge in terms of their synthesis.
3
  
Polyenes can be unstable to light and heat, and strongly acidic or basic 
conditions, often resulting in a need for mild reaction conditions.
4
 The traditional 
method of double bond formation has been achieved using ylide-based Wittig 
chemistry, with the Horner-Wadsworth Emmons (HWE) employing the mildest 
conditions.
5
 Reasonable levels of stereoselective control are well established within 
ylide chemistry. There is, though, a need to either separate or subject stereoisomers 
to isomerisation conditions. With the ever expanding scope of palladium cross 
coupling chemistry, it has become possible to assemble highly complex conjugated 
systems with high efficiency and stereoselectivity.
1,2
 In addition, olefin cross 
metathesis has been used more recently in polyene construction.
6 
An interesting question is whether transition metal-based strategies are 
beginning to take over as the method of choice for polyene construction. This review 
aims to provide an insight into some of the non-isoprenoid polyene structures 
discovered to date, and highlight attempts to complete their total synthesis. These 
non-isoprenoid polyene natural products will be discussed in classes determined by 
the length of the polyene moieties, with the total synthesis of at least one example in 
each class discussed in detail. Particular focus is given to the construction of the 
polyene chains within these natural products, and the strategies and synthetic 
methods which have been employed to make them. As the class of triene non-
isoprenoid natural products is quite large, reasonably simple to construct, and 
20 
 
provides enough scope for a review in its own right, this review will begin its focus 
from tetraene-containing natural products and longer. 
Tetraenes 
There are a large number of compounds containing the tetraene moiety. These 
have been isolated from a wide variety of natural sources and display a 
number of different types of biological activity. 
 
Macrocyclic tetraenes 
Polyene macrolide structures are often strongly associated with antifungal 
activity. There are a large number of tetraene polyene macrolides, produced by 
many different organisms, but often with very similar structures. Some 
important tetraene polyene macrolides are discussed below and all share 
common features. The macrocycles are bicyclic, with a larger ring of varied 
size and a six-membered cyclic ether. In addition, they also all possess an 
oxygen-linked cyclic six-membered ether substituent, the structure of which is 
highly conserved. Seven tetraene natural products share the same general 
structure. One difference, however, is the nature of the amine. Lucensomycin 
1, otherwise known as etruscomycin, is produced by S. lucensis
7 
and contains 
an epoxide. Arenomycin B 2 is produced by A. tumemacerans var. 
griseoarenicolor.
8 
The family of tetrins A-C have similar structures, with tetrin 
A 3 and B 4 produced by Streptomyces sp.
9,10
and tetrin C 5 produced by 
Streptomyces sp. GK9244.
11 
Tetromycin A 6 and B 7 are both produced by S. 
noursei var. jenensis.
12
 Similar structures to these tetraenes include pimaricin 
8, AB-400 9, rimodicin 10 and rimodicin B 11, C 12, CE-108 A 13, B 14 and 
C 15. Pimaricin 8, otherwise known as natamycin, is a polyene macrolide 
produced by S. natalensis, S. chattanoogensis, and S. gilveosporus and is used 
as a natural preservative in the food industry.
13
 It is also used as a treatment 
for fungal keratitis, as well as cutaneous, vaginal and intestinal cancer,
14
 and 
antimalarial activity.
15 
AB-400 9 is a closely related analogue, produced by 
Streptomyces sp. RGU5.3.
16 
Rimocidin 10 and rimocidin B 11 and C 12 are all 
produced by S. diastaticus, and rimocidin is also produced by S. 
rimosus.
17,18
CE-108 A 13, B 14 and C 15 are all produced by S. diastaticus 
var. 108.
19
 Larger macrocycles with similar structures include amphotericin A 
21 
 
16 and nystatin 17. Amphotericin A 16 is produced by S. nodosus.
20
 Nyastatin 
17 is produced by S. noursei and displays broad spectrum antifungal activity
21 
and possesses antimalarial activity.
15 
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Common to all of the macrocycles above are the all-E configuration of the 
polyene moieties. Other macrocyclic polyenes are viridenomycin 18 and the 
marinomycins A-C 19-21, whose total syntheses will be discussed in due 
course and whose structures are very different to those discussed above. 
 
Linear tetraenes 
There are a number of linear tetraene natural products and these include 
fumigillin 22 and lajollamycin 23. These structures share far fewer similarities 
than those discussed in the macrocyclic tetraenes section above. Fumigillin 22 
is produced by Aspergillus fumigans and displays amebicidal, anticancer, 
antiparasitic and antibacterial properties. It is also an angiogenesis inhibitor.
1,22 
Its structure contains an all E-tetraene and a highly functionalised cyclohexane 
ring, as well as two epoxide rings. Lajollamycin 23 is produced by 
Streptomyces nodosus and displays antimicrobial and antitumour activities.
23 
Its structure contains an E:E:Z:Z-tetraene, an amide linkage and a conjoined 
lactam and lactone. 
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Viridenomycin 
Viridenomycin 18 was first reported as a polyene natural product in 1975 by 
Hasegawa et al., who isolated it from S. viridochromogenes. This compound 
was shown to have activity against Trichomonas vaginalis and Gram-positive 
bacteria.
24 
In 1991, a compound was also reported to be isolated from S. 
gannmycicus and was shown to be identical to 18. The absolute 
stereochemistry of the compound was not determined, with only the relative 
stereochemistry of the cyclopentene core known and the relative 
stereochemistry between the core and benzylic stereocentre.
25 
This macrocycle 
also contains two tetraenes, one with an E:E:E:Z-configuration and the other 
being E:E:Z:Z. Additionally, the macrocycle contains a functionalised 
cyclopentene ring and is connected together by a lactam and enol ester. 
Shortly after, 18 was shown to have anticancer properties, prolonging the lives 
of mice affected by B16 melanoma and P388 leukaemia.
26
 Two groups have 
published work pertaining to the synthesis of the polyene portions of 
24 
 
viridenomycin 18. Kruger and Meyers attempted two routes,
27,28 
with their 
disconnection of the macrocycle giving three fragments 24-26 (Scheme 1). 
The intention was to install the lower (E:E:E:Z)-tetraene using a Julia 
olefination and the upper (E:E:Z:Z)-tetraene by a palladium catalysed cross 
coupling and subsequent alkyne reduction. Diene 30 was synthesised 
successfully using the Stork-Zhao Wittig homologation and then a Stille 
coupling. The aryl sulfonate was then successfully installed to give 31, ready 
for an olefination reaction to give the lower tetraene (Scheme 2). 
 
Scheme 1 Kruger and Meyers disconnection of 18 
 
 
 
 
 
 
 
 
 
Scheme 2 Synthesis of sulfonate 31 
 
 
 
 
 
 
 
 
 
 
 
 
 Attempts to build the tetraene using a Julia olefination proved unsuccessful 
in a closely related model system. This route was put on hold and another 
25 
 
investigated.
27 
The new route involved construction of the lower tetraene using 
either Wittig or Horner-Emmons chemistry. Another change was made in the 
formation of the upper tetraene, where the previously designed alkyne 
incorporation and reduction was causing concern. Instead, the intention was to 
undertake direct tetraene formation using a Stille coupling.   
 In order to make the upper tetraene, trienyl stannane 34 was required. This 
was made via a Still-Gennari-style phosphonate to afford cis-diene 33 with > 
20:1 E:Z ratio. Palladium catalysed cross coupling with distannylethylene gave 
the desired triene 34 (Scheme 3). Coupling of stannane 34 to give the upper 
tetraene was successful, giving the desired product 36 in quantitative yield 
(Scheme 4). Formation of the lower tetraene to yield the bis-tetraene 38 was 
then attempted and the bis-tetraene was obtained as a 1:1 mixture of alkene 
stereoisomers (Scheme 5). Unfortunately, attempts at deprotection and ring 
closure proved unsuccessful.
28
 
 
 
Scheme 3 Synthesis of triene 34 
 
 
 
 
 
Scheme 4 Synthesis of tetraene 36 
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Scheme 5 Synthesis of bis-tetraene 38 
 
 The Whiting group has focussed on Heck-Mizoroki (HM) methodology to 
build 18,
29 
with the proposed disconnection strategy for viridenomycin shown 
in Scheme 6. A model incorporating benzene rings as Z-alkene analogues was 
also used to identify suitable conditions for the synthesis of the polyene 
chains. In addition, the northern triene 47 was synthesised using the group’s 
iterative HM/iododeboronation cross-coupling methodology (Scheme 7).
 30,31 
Here, the stereochemistry of the resulting alkenyl iodides could be completely 
controlled via altering the order of addition for the iododeboronation reagents; 
addition of iodine monochloride first resulted in a Z geometry, whereas 
addition of sodium methoxide first resulted in an E geometry. 
 
 
Scheme 6 Proposed disconnection strategy for 18 
 
 
 
 
27 
 
Scheme 7 HM/iododeboronation methodology used in the synthesis of triene 
47 
 
Marinomycins A-C 
Marinomycins A-C 19-21 are three polyenic macrodiolides isolated by Fenical 
et al. in 2006 from the saline culture of a new group of marine actinomycetes, 
Mannispora strain CNQ-140. The marinomycins display antitumour and 
antibiotic activity. Fenical et al. showed that marinomycin A 19, the most 
abundant and active of the three natural products, was photochemically 
converted into an equilibrium mixture of marinomycins A 19, B 20 and C 21 
upon exposure to ambient light. As a result, the total synthesis of marinomycin 
A 19 would also constitute a total synthesis of the two others.
32
 
 The marinomycins are characterised by a highly complex 44-membered 
dimeric molecule, with a monomer consisting of a tetraene conjugated with an 
aromatic unit derived from 2-hydroxybenzoic acid and connected to a 
pentahydroxylated polyketide chain.
33 
The variation between the three 
different marinomycins lies in the stereochemistry of the two double bonds 
adjacent to the 2-hydroxybenzoic acid groups. 
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Three groups have either attempted or completed the total synthesis of 19. 
Nicolaou’s group was the first to synthesise 19 and undertake isomerisation 
studies to form 20 and 21.
34,35 
The retrosynthesis for 19 involved cleavage of 
the tetraene to give two monomeric counterparts. Two building blocks were 
synthesised, diene 48 and enyne 49, which could then be joined together by a 
palladium catalysed cross coupling. In this synthesis, the tetraenes were built 
using palladium chemistry, although ylide chemistry was used elsewhere in 
the synthesis for isolated double bonds. The aryl dienyl bromide 54 was easily 
made by converting aryl alkyne 50 to the vinyl boronate ester 51, followed by 
a Suzuki-Miyaura (SM) reaction with trimethylsilyl vinylbromide 52 and 
subsequent conversion to the desired bromide (Scheme 8). The aryl dienyl 
iodide was also made, but this compound underwent isomerisation to give the 
29 
 
undesired cis-isomer.
34,35
A Mitsunobu reaction between the carboxylic acid of 
aryl diene fragment 48 and the hydroxyl of enyne 49 was used to join the 
building blocks at one end. The first tetraene formation was then undertaken 
by conversion of the enyne triple bond to a vinyl boronate ester, and 
subsequent Suzuki coupling with the aryl dienyl bromide (Scheme 9). A 
further Mitsunobu, followed by another hydroboration/SM sequence was used 
to close the macrodiolide. The closure was difficult, requiring stoichiometric 
palladium and 300 equivalents of a thallium base (Scheme 10).
34,35 
Attempts 
were also made to improve the yield of the cyclisation, investigating the use of 
both HM and Stille couplings as methods of tetraene formation. Unfortunately, 
none of these routes were successful and the yield was not improved.  
 The ability to form marinomycins B 20 and C 21 from A 19 was also 
demonstrated by exposure to ambient light. Marinomycin A underwent 
photoinduced isomerisation, giving a ratio of roughly 1.1:1:1.5 (A:B:C 
respectively) after two hours, as analysed by HPLC.
 34,35 
 The other groups that attempted the synthesis of marinomycin chose to 
build the tetraene into a building block, rather than form it during a ring 
closure. Efforts of the Cossy group have yielded the monomeric counterpart of 
marinomycin A.
33,36
 The intention was to form a triene building block, with a 
palladium catalysed cross coupling envisioned to form the tetraene (Scheme 
11). Initially, an attempt was made to form the boronate ester variant of the 
triene 64. Unfortunately, stereoselectivity problems led to the concept of a 
tetraene-forming Suzuki coupling being abandoned for a Stille approach 
(Scheme 12). The new approach involved a Stille coupling followed by an 
olefination to give a trienic vinyl stannane 69 (Scheme 13). 
 
 
 
 
 
 
 
 
 
30 
 
Scheme 8 Synthesis of dienyl bromide 54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9 Construction of tetraene 56 
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Scheme 10 Completion of the synthesis of 19 
 
 
Scheme 11 Envisioned construction of tetraene 60 
 
 
 
 
 
 
 
 
 
 
 
 Triene 69 was then used to complete the monomer synthesis via a Stille 
coupling with a penta-alkoxylated alkenyl iodide 70 (Scheme 14). Difficulties 
32 
 
in deprotection prevented the completion of the total synthesis of marinomycin 
A 19 using this route.
33,36 
In the Evans group, the tetraene was again built 
before dimerization.
37 
 
Scheme 12 Attempted route towards 64 
 
 
 
 
 
 
 
 
 
 
 
Scheme 13 Synthesis of trienic vinyl stannane 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
Scheme 14 Stille coupling to form monomer 71 
 
 
Scheme 15 Synthesis of tetraene 74 
 
 
 
 
 
 
 
 
 
 
 
Pentaenes 
Macrocyclic pentaenes 
Like the tetraene polyene macrolides, there are a number of pentaene 
containing-compounds with closely related structures. TPU-0043 or chainin 
75, filipin III 76 and fungichromin 77 all possess similar structures, varying in 
the nature of the aliphatic side-chain and in one substituent on the macrocycle. 
TPU-0043 75 is an antifungal compound produced by Streptomyces sp. TP-
A0625 and Chainia minutisclerotica.
38,39,40 
Filipin III 76 is another antifungal 
produced by S. filipinensis.
41
 It has also been shown to have antimalarial 
activity.
15 
Fungichromin 77 was first isolated from S. padanus PMS-702 in 
1958
42 
and was also shown to be produced by S. griseus in 1980.
43 
A number 
of apparently different antifungals were isolated in the 1950s, 60s and 70s, all 
believed to have the same chemical structure as fungichromin. There were, 
34 
 
however, inconsistencies in the analytical data [HPLC, 
13
C NMR, circular 
dichroism (CD) and counter-current distribution (CCD)], which the groups 
reporting these compounds believed to be due to differing stereochemistry in 
each of the different compounds. The supposed new compounds discovered 
were named pentamycin, (isolated in 1958 from S. penticus)
44
 lagosin (isolated 
in 1964)
45
 and cogomycin (isolated in 1975).
46,47
 In 1982, it was shown that 
these compounds were in fact identical and that the previous inconsistencies in 
the analytical data were due to differing levels of impurities in the isolated 
samples. This report also listed S. cellulosae, S. roseoluteus and S. fradiae as 
the organisms producing fungichromin.
48  
 A compound with a similar structure, but a shorter polyol chain is aurenin 
78, an antifungal isolated from S. aureus
49 
and later from Actinomyces 
aureorectus.
50
 Other macrocyclic pentaenes include roflamycoin 79, RK-397 
80, roxaticin 81, mycoticins A 82 and B 83, marinisporolides A 84 and B 85, 
strevertenes A-G 86-92, eurocidin D 93, mirabilin 94 and lienomycin 95. 
Roflamycoin or flavomycoin 79 is an antifungal isolated from S. roseoflavus.
51 
RK-397 80 is another polyene macrolide isolated from a strain of soil 
bacteria.
52
 This compound, along with attempts made at its total synthesis, are 
discussed later (vide infra). Roxaticin 81 is an antifungal isolated from 
streptomycete X-14994.
53,54 
Mycoticins A 82 and B 83  are compounds with 
broad antimicrobial properties, isolated from Streptomyces ruber (ATCC 
#3348).
55,56 
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 Marinosporolides A 84 and B 85 are produced by Marinispora sp. and 
display antifungal activity against Candida fungi.
57 
Strevertenes A-G 86-92 
are a closely related class of polyene macrolides produced by 
Streptoverticillium sp. LL-30F848. They possess antifungal activity against 
phytopathogenic fungi.
58,59 
Eurocidin D 93 is produced by Streptoverticillium 
sp. and displays antifungal activity against T. vaginalis.
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Mirabilin 94 and lienomycin 95 have more distinct structures from those 
detailed above. Mirabilin possesses a 6-membered cyclic ether as part of its 
structure, along with a long side chain containing an amide moiety. Produced 
by Siliquariaspongia mirabilis, 94 displays antitumour activity.
60 
Lienomycin 
36 
 
is a larger macrocycle and possesses a shorter side-chain, containing a primary 
amine functionality. Isolated from Actinomyces diastatochromogenes var. 
lienomycini, lienomycin 95 possesses antifungal, antibacterial and antitumour 
activity.
61
 
 
Linear pentaenes 
Compounds whose pentaene fragments are not contained within a macrocyclic 
system include mycolactones A 96 and B 97, and spirangiens A 98 and B 99. 
Mycolactones A and B are produced by Mycobacterium ulcerans and 
Mycobacterium marinum. 96 and 97 are believed to be linked to the Buruli 
ulcer skin disease.
62 
Spirangiens A and B are produced by Sorangium 
cellulosum (strain So ce 90) and are discussed later (vide infra).
63 
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RK-397 
RK-397 80 was isolated from Streptomyces sp. in 1993 and displays antifungal 
activity. In 2009, it was shown to be active against human leukaemia cell lines 
K-562 and HL-60 at 50 and 25 μg/ mL, respectively.52 
 Five groups have reported efforts towards its total synthesis, but the efforts 
of the Loh group were towards the polyol chain and are not discussed here.
64
 
The first total synthesis of 80 was accomplished by Burova and MacDonald in 
2004.
65
 
This synthesis involved a combination of ylide and palladium chemistry to 
achieve the synthesis and incorporation of the polyene fragment, involving 
synthesis of a trienyl building block. This building block was all-trans-7-
(tributylstannyl)-2,4,6-heptatrien-1-ol 100 and was originally made in the de 
Lera group
66 
using Wittig chemistry and a diisobutylaluminium hydride 
(DIBAL) reduction starting from all-trans-5-(tributylstannyl)-2,4-pentadienal 
101 (Scheme 16). The polyol core 103 had already been synthesised, 
containing a primary alcohol moiety at one end and a vinyl iodide at the other. 
Esterification of the primary alcohol with diethylphosphonoacetic acid gave 
phosphonate ester 104 ready for HWE-type ring closure. 
 
Scheme 16 Synthesis of all-trans-7-(tributylstannyl)-2,4,6-heptatrien-1-ol 100 
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Scheme 17 MacDonald synthesis of 80 
  
 The trienyl building block 100 was then installed into the polyol core using 
a Stille coupling between the tributylstannyl group on the trienyl fragment and 
the vinyl iodide group on the polyene core. Oxidation of the primary alcohol 
of the resulting tetraene 105 to the corresponding aldehyde and then Horner-
Emmons macrocyclisation under Masamune-Roush
67
 conditions gave the 
tetraacetonide derivative of the natural product 106. Deprotection furnished 
RK-397 80 (Scheme 17).
65
 Denmark and co-workers published a total 
synthesis shortly after MacDonald, in 2005.
68 
Here, the polyene fragment was 
fully installed before macrocyclisation was attempted, palladium chemistry 
was used to build the key tetraenyl intermediate 107 and ylide chemistry to 
incorporate the polyene into the rest of the molecule. Synthesis of 107 
involved sequential palladium-catalysed cross coupling of 1,4-bis-silyl-1,3-
butadiene compound 108, first with 3-iodo-2-propenol THP ether 109 and then 
with ethyl (E)-3-iodoprenoate 110. These reactions proceeded with high yields 
but poor diastereoselectivity, with mixtures of olefins being obtained. 
39 
 
Deprotection and isomerisation to give the all-(E)-tetraenoate using iodine, 
then conversion to the phosphonate ester gave the desired building block 107 
(Scheme 18). This was installed using standard HWE chemistry, then ring 
closure and deprotection gave RK-397 80.
68 
 In 2007, Sammakia et al. reported a total synthesis of RK-387 80
69
 using a 
trienyl aldehyde 113 which was installed onto the polyol core 114 by olefin-
cross metathesis with Grubb’s first generation catalyst. HWE yielded the 
pentaenyl moiety, followed by saponification, Yamaguchi macrolactonisation 
and global deprotection to yield 80 (Scheme 19). O’Doherty et al. reported a 
total synthesis of RK-397 80 in 2008. The polyene core, however, was 
installed using the procedure developed in the Denmark group.
68,70 
 
Spirangien A and B 
The spirangiens A 98 and B 99 were isolated from Sorangium cellulosum 
(strain So ce 90) in 2005 by Niggemann et al.
63 
Aside from their antifungal 
properties, these compounds have been investigated for either treatment or 
prevention of IL-8 or IL-6 mediated disorders.
71,72 
The spirangiens are linear 
polyene natural products, with the polyene moiety having a 
(4Z,6E,8Z,10E,12Z)-configuration. Three groups have completed the total 
synthesis of 98 and 99, but only Paterson reported a synthesis of the polyene 
fragment;
73
 both Rizzacasa and Ley reported formal total syntheses, but 
utilised the Paterson methodology.
74,75 
The total synthesis of spirangens A and 
B was accomplished by the Paterson group in 2008. A bis-stannylated triene 
119 was obtained as the (1E,3Z,5E)-isomer via a (Z)-selective Julia 
olefination. A Stille coupling furnished the tetraenyl methyl ester 121, with a 
second Stille coupling forming the pentaene and completing the synthesis of 
the methyl ester of spirangien A 123 (Scheme 20).
73 
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Scheme 18 Synthesis of tetraene 107 
 
 
 
 
 
 
 
 
 
Scheme 19 Sammakia synthesis of 80 
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Scheme 20 Paterson route to the synthesis of 123 
 
Hexaenes 
Cyclic hexaenes  
Perhaps the most well-known of the cyclic hexaenes are the polyene 
macrolides dermostatin A 124 and B 125, isolated from S. virdigreseus 
Thirum.
76 
Their biological activity and synthesis are discussed later (vide 
infra). 
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Linear hexaenes  
The linear hexaenes include the mediomycins A 126 and B 127, clethramycin 
128 and etnangien 129. The mediomycins and clethramycin are similar in 
structure. They are all produced by S. mediocidicus ATCC23936 and display a 
broad spectrum of antifungal activity.
77 
Etnangien 129 has a different 
structure, with an unsaturated lactone as part of the compound, isolated from 
Sorangium cellulosum.
78 
Its synthesis is discussed later (vide infra). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dermostatin A and B 
The dermostatins A 124 and B 125 were first isolated from S. virdigreseus 
Thirum. in 1962.
76
 These compounds display potent antifungal activity against 
a number of human pathogens.
79,80 
They have also been used clinically as a 
treatment for deep vein mycoses,
79
 and display anti-proliferative activity 
against human immunodeficiency virus (HIV) in H9 cells.
81 
Initially, the 
43 
 
dermastatins were thought to be pentene compounds, but their structures were 
further elucidated and found to contain a hexaene moiety.
82,83
 Two groups 
have completed the total synthesis of dermostatin A 124. The Rychnovsky 
group completed a total synthesis of 124 in 2001. This synthesis was 
analogous to Burova and McDonald’s synthesis of RK-397 80, utilising the 
tetraene analogue of all-trans-7-(tributylstannyl)-2,4,6-heptatrien-1-ol 100 as 
reported by de Lera et al.,
66
 and installing using the same method. The 
tetraenyl alcohol 130 was attached to the polyol 131 fragment using a Stille 
coupling. The primary alcohol of the resulting pentaene 132 was then oxidised 
to give the corresponding aldehyde and the ring closure achieved using the 
same Horner-Emmons macrocyclisation under Masamune-Roush conditions 
(Scheme 21).
84,85
 
 
Scheme 21 Rychnovsky synthesis of 124 
  
 In 2011, the Sammakia group reported a total synthesis, analogous to their 
synthesis of RK-397 80, using ruthenium cross metathesis for incorporation of 
the polyene into the polyol core.
69,86 
Model studies were undertaken to 
establish the best polyenyl substrate to undertake the olefin cross metathesis 
with, finding that the same trienyl aldehyde 113 as used in the synthesis of 
RK-397 was by far the most reactive, and better than the tetraenyl analogue. 
44 
 
Application of the first generation Grubbs catalyst gave the desired triene 135 
in an 82% yield as a 4:1 mixture of olefin isomers distal to the aldehyde. HWE 
with phosphonate ester 136 gave the desired hexaenoate 137 which could be 
isolated in a geometrically pure form. Hydrolysis, Yamaguchi cyclisation and 
global deprotection gave dermostatin A 124 (Scheme 22).
69,86 
 
Scheme 22 Sammakia synthesis of 124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Etnangien 
Etnangien 129 was isolated from Sorangium cellulosum and found to be active 
against a range of Gram-positive bacteria.
78
 It was also found to inhibit 
retroviral RNA and DNA polymerases.
87
 Etnangien 129 was also reported to 
45 
 
have an unstable structure, presumed to be due to the polyene chain. It has 
only been synthesised by the Menche group,
87,88
 which also established the 
absolute stereochemistry in the process of completing the total synthesis. The 
synthetic route involved a mixture of ylide and palladium chemistry. The 
hexaene chain was synthesised from two trienyl building blocks 142 and 148. 
Ylide chemistry was used to create diene 140, then a series of steps were used 
to form the macrocycle. Selective removal of the primary TBS group and 
allylic oxidation were followed by a Takai reaction to install the E-vinyl 
iodide 142 (Scheme 23). Homologation of alkene 143 by olefin cross-
metathesis using the Grubbs (II) catalyst gave the required enal 145. HWE 
chemistry furnished the required trienyl stannane 147 and 
tetrabutylammonium fluoride (TBAF) deprotection gave building block 148. 
The side-chain was coupled to the trienyl iodide using a Stille coupling 
(Scheme 24). 
87,88
 
 
Scheme 23 Synthesis of iodide 142 
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Scheme 24 Completion of the synthesis of 129 
 
 
Heptaenes 
Cyclic heptaenes 
One of the most commonly known and widely used polyene natural products 
is a member of the heptaene polyene macrolide class of compounds, 
amphotericin B 150 and its derivatives 151-153, which are discussed later 
(vide infra). The polyene macrolide candidin 154 has a similar structure to 
amphotericin B, possessing an extra carbonyl moiety on the polyol fragment. 
It is an antifungal agent produced by S. viridoflavus, and has also been 
patented as a treatment for mammalian tumours.
89,90 
Another very closely 
related structure is mycoheptin 155, produced by Streptoverticillium 
mycoheptinicum, which displays antifungal activity and is used in the therapy 
47 
 
of coccidioidomycosis, histoplasmosis, cryptococcosis, chromodermycosis, 
blastomycosis, aspergillosis, sporotrichosis, and candidiasis.
91,92  
 
Another class of compounds with very similar structures, all containing a 
side-chain with a para-amino phenyl ketone group, are hamycin 156, levorin 
A2 157, partricin A and B 158-159 and 67-121 A and B 160-161. Perimycin A 
162, DJ-400 B1 and B2 163-164, FR-008 165 and trichomycin A 166 are also 
similar. Hamycin 156 is produced by S. pimprina and displays antimicrobial 
activity against a number of forms of candidiasis and deep-seated mycoses.
93 
Levorin A2 157, or candicidin D, is produced by A. levoris and S. griseus 
ATCC 3570. 
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 This compound is an antifungal and possesses the ability to inhibit the 
growth of adenoma prostate.
94,95 
Partricin A and B 158-159 are produced by S. 
aureofaciens and possess high antifungal activity, particularly against Candida 
albicans, and antiprotozoal activity.
96 
67-121 A and B 160-161 are produced 
by Actinoplanes caeruleus and are antifungals.
97,98 
Perimycin A 162, otherwise 
known as fungimycin, NC-1968 and aminomycin, is an antifungal produced 
by S. coelicolor var. aminophilus.
99
 DJ-400 B1 and B2 163-164 is produced by 
S. Surinam and displays antifungal activity.
100,101 
FR-008 165 is also an 
antifungal produced by S. griseus.
102 
Trichomycin A 166 is produced by S. 
hachijoensis and is used as a potent clinical drug for the treatment of vaginal 
infections.
103
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Linear heptaenes 
Two interesting linear heptaene structures are peridinin 167 and fucoxanthin 
168, which contain an allene moiety. Peridinin 167 is produced by Gonyaulax 
polyedra and is believed to possess activity against atherosclerosis, 
rheumatoid arthritis and cancer. In particular, this compound is believed to 
reduce membrane permeability to reactive oxygen species.
104,105 
Fucoxanthin 
is discussed later (vide infra). 
Amphotericin B 
Amphotericin B 150 and its derivatives 151-153 have a wide range of 
biological applications. First reported in 1955, amphotericin B is an antifungal 
antibiotic produced by S. nodosus.
106 
It was tested as early as in 1957 for 
activity against Candida albicans,
107
 and has since been shown to have a 
number of other biological applications, including activity against deep-seated 
mycotic infections,
108 
activity against intercranial fungal masses,
109
 activity 
against visceral leishmaniasis,
110
 potential as a treatment for prion infection 
treatment,
111
 as a malaria treatment in humans and animals,
15 
activity against 
HSV I, HSV II and hepatitis B,
8
 and as a treatment for severe mucocutaneous 
candidal infections in the mouth.
112 
 Despite being such an important compound, only the Nicolaou group has 
completed the total synthesis of amphotericin B 150.
113,114 
The Negishi group 
has also completed a synthesis of the polyenyl fragment. Completed in 1987, 
the Nicoloau synthesis used ylide chemistry to build up the polyene fragment. 
This was achieved via a series of HWE reactions using dienyl phosphonate 
ester 170 as a key building block. Ring closure was also accomplished using a 
HWE reaction (Scheme 25).
113,114 
 The Negishi synthesis of the polyene fragment 176 was published in 2013 
and utilised HWE, alkyne hydrozirconation, palladium-catalysed Negishi 
coupling, and HM coupling chemistry.
115 
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Scheme 25 Nicolaou synthesis of 150 
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The first building block made was a trienyl phosphonate ester 182. The first 
step involved a hydrozirconation of metallated propargyl alcohol 177, 
iodinolysis, in situ metallation and then Negishi alkenylation. The next step 
involved hydrozirconation of the metallated enyne 179 and then another 
Negishi alkenylation to yield trienyl alcohol 181, which was then converted to 
the phosphonate ester 182 (Scheme 26). A HM reaction was then used to form 
dienyl ester 184, which was then reduced and used in a HWE reaction with 
trienyl phosphonate ester 182 to complete the hexaene fragment 176 (Scheme 
27).
115
 
 
Fucoxanthin 
Fucoxanthin 168 is an allenic compound found in brown algae. Its isolation, 
along with a number of other brown pigments, was reported in the early 
1900s.
116–118 
Fucoxanthin 168 is a pigment associated with a range of 
biological activities,
119,120 
including potential as a treatment for diabetes and 
obesity,
121
 as an anti-inflammatory agent,
122
 in neutrophil modulation,
123
 in 
inhibition of cancer metastasis,
124
 and the ability to protect against UV-B 
induced cell damage.
125
 
 The synthesis of 168 was first completed by the Ito group in 1994. 
Construction of the polyene fragment was achieved solely by ylide chemistry, 
but was hampered by poor selectivity and low yields. This can be seen in the 
synthesis of building blocks 192 and 195, where diastereomeric ratios of 1:1 or 
less were achieved (Scheme 28).
126,127
 
 Another synthesis was completed by the Katsumara group in 2012.
128
 
Again, de Lera group chemistry was used in the construction of a key building 
block.
66
 A modified version of the de Lera procedure was used to create 
trienyl iodide 199, which was then coupled with an alkyne to install the 
epoxycyclohexane group. This was then converted to allenyl building block 
203 (Scheme 29). 
129,130,131,132 
 A second benzothiazolylsulfone building block 208 was synthesised and the 
two building blocks coupled using a Julia olefination which gave a mixture of 
isomers at the connected olefin, predominantly Z. Deprotection and oxidation 
of 207 yielded fucoxanthin 168 (Scheme 30).
128,129,130,131,132 
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Scheme 26 Synthesis of phosphonate ester 182 
 
 
 
 
 
 
 
 
 
Scheme 27 Synthesis of hexaene 176 
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Scheme 28 Ito synthesis of 168 
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Scheme 29 Synthesis of building block 203 
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Scheme 30 Completion of the Katsumara synthesis of 168 
 
 
Octaenes and above 
Those natural products possessing a polyene chain of eight or more conjugated 
double bonds are dominated by linear structures. To the best of our 
knowledge, no polyene macrolide structures containing an octaene polyene 
fragment have been elucidated, nor have any structures for polyene 
macrocycles containing more than eight conjugated double bonds. Two of 
these linear polyenes are xanthomonadin 208 and granadaene 209. 
Xanthomonadin 208 is an octaene bacterial pigment isolated from 
Xanthomonas juglandis. Its structure was elucidated in 1976
133
 and was later 
shown to protect against photodamage.
134
 It was also isolated from 
56 
 
Xanthomonas oryzae pv. oryzae in 1997.
135 
Granadaene 209 is a dodecaene red 
pigment characteristic of Streptococcus agalactiae, isolated in 2006.
136,137 
 
 
 
 
 
 
 
Correlation between polyene chemical structure and biological 
activity 
There has been surprisingly little reported in the literature about the correlation 
between polyene chemical structure and biological activity. Some work has 
been done to compare the activity of various polyene macrolides. In a review 
published by Hamilton-Miller in 1973, it was stated that the biological activity 
of the polyene macrolides increases with the number of conjugated double 
bonds.
100
 Several natural product tetraene macrolides, namely pimaricin 8, 
AB-400 9, rimocidins A-C 10-12 and CE-108s A-C 13-15, were compared 
with the heptaene macrolide amphotericin B 150 to assess their biological 
activities on Trypanosoma cruzi. These tetraene compounds were found to be 
less effective, but also less toxic.
19
 Kotler-Brajtburg et al. attempted to 
correlate the chemical structures of polyenes and their biological properties by 
investigating their ability to cause K
+
 leakage and cell death.
138 
The work 
hypothesised that the polyene macrolides could be categorised into two 
functionally different groups.  Amongst the polyenes in group I was the 
tetraene pimaricin 8, pentaenes (chainin 75 and filipin 76) and the hexaene 
(dermostatin A 124), while group II included the heptaenes (amphotericin B 
150, amphotericin B methyl ester 151, N-acetylamphotericin B 152, hamycin 
154 and candicidin 156) and one tetraene, nyastatin 17. Group I antibiotics 
caused potassium ion leakage and cell death or hemolysis at the same 
57 
 
concentrations of added polyene, while group II caused considerable 
potassium ion leakage at low concentrations and cell death or hemolysis at 
high concentrations.
138
 
 
 
 
 
 
 
 
 Work undertaken by Akiyama et al. supported the above theory. Polyene 
antibiotics were classified according to their synergistic effect on fungi into 
two groups: a non-heptaene group including pimaricin 8 and filipin 76, and a 
heptaene group including amphotericin B 150.
139 
 A study into the difference between the linear polyenes and the macrocyclic 
polyenes does not seem to have been undertaken. It appears that in general, the 
longer chain linear polyenes possess a more diverse range of biological 
activities, additional to antimicrobial properties, for example fucoxanthin 168, 
xanthomonadin 208 and granadaene 209, all of which have polyene chains of 
seven double bonds or greater. As discussed in previous sections (vide supra), 
these compounds have properties such as antioxidant and anti-inflammatory 
activities and an ability to inhibit cancer metastasis.  
 The link between polyene structure and cancer activity in particular is 
interesting. Seemingly small changes in structure can impart a significant 
increase in biological activity. An example of this is the difference in 
biological activity between RK-397 80 and the mycoticins A and B 82 and 83. 
RK-397 displays anti-leukaemic activity, whereas the mycoticins only possess 
antimicrobial activity. The structures are exceptionally similar, differing only 
in the stereochemistry of the polyol chain and in the absence of a methyl group 
in the RK-397 structure.  
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Conclusion  
The polyene natural products include a wide variety of different structures 
with a range of biological activities. Total syntheses of a number of interesting 
compounds have been accomplished using a mixture of ylide chemistry, 
palladium cross coupling and cross-metathesis. Whilst ylide chemistry was 
used effectively in a number of total syntheses, there are a number of 
examples where poor stereoselectivity was a clear issue, for example in the 
1994 synthesis of fucoxanthin 168. Palladium chemistry, on the other hand, 
has given consistently better stereoselectivity in the total syntheses reported. 
The examples where olefin cross-metathesis was used highlight its potential as 
an efficient and selective method of polyene synthesis. Despite all the research 
that has been undertaken in this area of polyene natural product synthesis, 
there is not yet a standout method for the highly stereoselective formation of 
polyene chains that has completely general application in synthesis, though 
some methods have clear advantages over others. 
 In addition, relatively little is understood about the correlation between 
chemical structure and biological activity as a general phenomenon. 
Establishment of the structural features which contribute to the activity of the 
polyene natural products is necessary for a better understanding of this 
interesting class of compounds. 
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Section 1    
Synthesis of polyene natural products 
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Section 1.1 Synthesis of Xanthomonas pigments- introduction 
and proposed targets 
 
Section 1.1.1 Xanthomonas pigments 
Members of the genus Xanthomonas are the cause of a number of plant diseases e.g. 
Xanthomonas oryzae pv. oryzae, rice blight; Xanthomonas campestris pv. 
campestris, black rot of crucifers. These bacteria form characteristic yellow colonies 
due to the yellow, membrane-bound pigments they produce.
135,140–150 
Andrewes and Starr pioneered the investigations into these yellow pigments, first 
proposing arylated, polyenic, halogenated structures in 1973.
151 
Andrewes then 
reported the total synthesis of one of the proposed structures later in that year, 
although the characteristics of this compound did not match any of the isolated 
pigments.
152
 The first of these pigments, isobutyl xanthomonadin 208, was 
successfully isolated and characterised from Xanthomonas juglandis strain XJ103 in 
1976, then the micro- and Raman resonance spectroscopy characteristics obtained by 
Sharma et al. in 2012.
133,153 
 
Their initial investigations in 1973 suggested four different pigments.
151
 In 1977, 
this work was extended further, with the pigments of a range of different 
Xanthomonas species isolated as the isobutyl esters and analysed.
154 
The two most 
common pigments were found to be xanthomonadin 208 and the putative 
monobrominated analogue 210. Starr later went on to try to establish the biological 
function of 208 in 1982, providing the first evidence that the pigment may protect 
bacteria from photodamage.
155 
 
 
 
62 
 
 
 
 
 
Starr observed the Xanthomonas pigments’ similarity to the carotenoids and 
postulated that their biological role may be to protect the bacteria from 
photodamage. Xanthomonadin 208 was tested and shown to protect Xanthomonas 
juglandis strain XJ103 from photodamage, but whether or not the pigment protected 
the bacterium from oxygen-related killing was not determined.
155 
The Sonti group 
showed that 208 does indeed display antioxidant properties in Xanthomonas oryzae 
pv. oryzae in 1997.
135 
In particular, they showed that it protects membrane lipids 
from peroxidation. The Poplawsky group has pioneered much of the investigation 
into the mechanism of bacterial survival for the Xanthomonas genus.
 135,140–150  
In 
2000, they investigated the role of 208 in Xanthomonas campestris pv. campestris. 
They concluded that it is unlikely that the xanthomonadin pigments offer protection 
against direct UV damage and that they were more likely to offer protection when a 
photosensitiser was present. They also showed that a diffusible factor is needed for 
xanthomonadin production via quorum sensing. In addition, they showed that the 
pigB transcriptional unit was vital for bacterial survival.
 141,146
 
The group’s research has gone into greater detail about the mechanisms 
behind xanthomonadin production, identifying the diffusible factor as 3-
hydroxybenzoic acid and also implicating 4-hydroxybenzoic acid in the pathogenesis 
of Xanthomonas oryzae pv. oryzae.
150 
The group also proposed that a novel type II 
63 
 
polyketide synthase pathway is responsible for xanthomonadin synthesis, a 
hypothesis that has been supported by other groups.
4,20,21 
A number of other pigments have been identified or proposed in the 
literature, and some are detailed below.
155,158,159
 A common feature amongst the non-
brominated analogues below is that they all possess a phenolic OH. Studies of these 
pigments have provided an insight into the synthesis of the xanthomonadins, in 
particular the installation of the bromines on the scaffold. The pigment 213 made by 
Lysobacter enzymogenes is unbrominated and the bacterium does not possess a 
halogenase enzyme, suggesting that the bromine functionalities may be incorporated 
into the xanthomonadins by halogenases.
158 
 
Starr proposed that the main pigment produced by Xanthomonas populi 220 
is in fact a nonbrominated aryl heptaene, not fitting with the traditionally accepted 
64 
 
halogenated octaene model associated with the xanthomonadins. Mass spectrometric 
analysis of this pigment gave a molecular weight of 376, which was consistent with 
the formula C25H28O3. No structure was given but a proposed compound fitting these 
data is shown below. 
 
 
 
Section 1.1.2 Characterisation of Xanthomonas pigments 
Xanthomonadin 208 is the only pigment to have been extensively characterised, with 
mass spectrometric, 40 MHz 
1
H NMR, IR, X-ray crystallographic and UV-Vis data 
obtained by Andrewes and Starr when it was first isolated in 1976.
133 
The X-ray 
crystallographic data was reported to be of poor quality.
 
Other pigments have been 
characterised by mass spectrometry, and the UV-Vis properties of mixtures of 
pigments have been measured, but none of the other pigments have been fully 
isolated and characterised. 
Section 1.1.3 Summary 
Xanthomonas pigments have garnered interest amongst the scientific community due 
to their contribution to the survival of a number of prolific agricultural diseases. It 
has been proposed that these pigments are non-carotenoid, polyenyl structures, with 
one pigment, xanthomonadin 208, successfully isolated. Structures for other 
pigments have been proposed in the literature, with the most common pigments 
postulated to be octaenes. These pigments are believed to be membrane-bound, 
protecting membrane lipids from peroxidation, but the exact conditions under which 
these pigments protect the bacterium from photodamage are not known; there is 
some evidence to suggest that the pigments only offer protection in the presence of a 
leaf-made photosensitiser compound. Similar compounds are produced by other 
bacteria, with a considerable about of variation in the structures of these polyenes, 
raising questions about exactly which functionalities are required for 
photoprotection. 
65 
 
Section 1.1.4 Previous work done within the group 
The original retrosynthesis of methyl xanthomonadin 208 involved utilising the 
group’s iterative cross-coupling methodology to build two tetraenes and then join 
them together using a Suzuki-Miyaura cross-coupling (Scheme 31).
160–167
 
Scheme 31 Original retrosynthesis of xanthomonadin 208 
 
 
 
 
 
 
 
Progress had already been made towards the synthesis of xanthomonadin 208 
on starting this project, with a route towards aryl intermediate 228 determined 
(Scheme 32).
168
 The deprotection step in the route was poor yielding at 36%, 
yielding the aryl in an overall 23% yield, with an average of 75% per step. In 
addition, the group’s iterative cross-coupling methodology had been used to access 
trienyl iodide 230,
169
 and the methodology further applied to give pentaenyl boronate 
on a small scale, in an overall 3% yield (Scheme 33).
170 
In all of these routes there 
was obvious room for development, in particular for the iterative cross-coupling 
methodology, where the low yields obtained would make accessing the heptaene 
difficult. 
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Scheme 32 Previously established route towards aryl 228 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 33 Previous applications of the iterative cross–coupling methodology. 
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Section 1.1.5 Project aims and objectives 
The only target within the group at this time had been xanthomonadin 208 itself. 
Following consideration of the literature on commencing this project, a number of 
key questions were identified: 
1) Do the compounds proposed in the literature offer protection for bacteria 
against photodamage? 
2) What is the mechanism of this protection? 
3) What structural moieties are required to impart this protection? 
4) What is the function of the polyenic bromine in xanthomonadin 208? 
5) Are these pigments lipid-bound? 
In response to this, the project was expanded to include 6 target compounds in 
total, where compounds 208 and 210 were the natural products, xanthomonadin and 
the proposed monobrominated xanthomonadin not previously targeted in the group. 
The alkyne moiety in analogue 232 was chosen not only in the hope that it will 
impart some stability to the compound, but also to investigate the effect of the non-
natural group on the activity of the pigment. The shorter chain analogues 233-235 
were chosen in order to investigate the required polyene chain length for 
photoprotective activity, as well as providing good models for development of the 
iterative cross coupling methodology. The shortest polyene chain identified in the 
literature search was a hexaene, and therefore a pentaene was chosen to see if this 
could still impart any photoprotective activity. 
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In order to synthesise these compounds in the most efficient way possible, it 
was envisaged that a polyenyl intermediate would be used to couple with different 
aryl building blocks.   
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Section 1.2 Synthesis of Xanthomonas pigments- construction 
of key aryl building blocks and selection of cross coupling 
reactions  
Section 1.2.1 Synthesis of a range of aryl building blocks 
In the design of key aryl building blocks, flexibility was the primary focus, as the 
final cross-coupling to connect the polyenyl chain and aryl had not been identified 
for the pigments and their analogues. One of the coupling partners would have to be 
an iodide and the key consideration would be one of stability. Attention was first 
turned to improving the route to brominated boronate ester 228, where use of TBAF 
in the deprotection of trimethylsilane 225 gave a large increase in the yield of the 
deprotection step (Scheme 34). 
Scheme 34 Improved route to brominated boronate ester 228 
 
The most challenging step in this synthesis proved to be the reliable 
formation of boronic acid 227.  It was found that all samples of boronic acid 227 
contained between 10 and 20 per cent of a side product. This product gave 
characteristic signals in the 
1
H NMR spectrum, i.e. two doublets at 5.80 and 6.12 
ppm (Figure 1). These corresponded to the proton signals of unsubstituted geminal 
alkene 236 (Equation 1). Initially it was thought that this product was formed due to 
protodeboronation by excess base, but it was later shown that addition of more base 
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to the reaction mixture did not affect the proportion of unsubstituted alkene. It is now 
believed that formation of this product was due to reaction with hydrogen bromide 
present in the boron tribromide reagent. It was eventually found that this could be 
minimised, although not eliminated, by using fresh boron tribromide. Boronic acid 
227 was found to be unstable over time, and so was taken straight through to the 
ester formation. 
 
 
 
 
 
Figure 1 1H NMR spectrum of boronic acid 227, showing the characteristic peaks of 
side product 236 
Attention was then turned to the conversion of the pinacolate ester to an 
iodide, to provide another coupling partner for the final cross-coupling. 
Iododeboronation methodology had been previously applied to boronate ester 228, 
but with limited success.
170
 A literature procedure was found which could effect the 
Terminal alkene protons 
O 
Br 
Br 
236 
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conversion of boronic acids to halides using N-halidesuccinimides at room 
temperature in acetonitrile.
171 
Initially, this was attempted using N-iodosuccinimide 
(NIS) 237 on pinacol ester 228 (Equation 2), due to concerns over the stability of 
boronic acid 227. None of the desired iodide was isolated, but the 
1
H NMR spectrum 
of the product obtained from the column showed a singlet at 3.14 ppm, 
corresponding to the alkyne hydrogen for compound 226, formed by an elimination 
reaction. 
 
Due to the fact that this reaction used acetonitrile as the solvent, the same 
solvent used for the HM couplings, formation of the iodide was attempted again. 
Instead of subjecting the reaction mixture to work up, the product was transferred 
directly into a Heck-Mizoroki (HM) coupling to see if the iodide was forming in situ 
(Scheme 35). After stirring for one day, no polyene-like peaks were observed in the 
1
H NMR spectrum and so it was concluded that the iodide had not been formed.  
Scheme 35 Attempted one-pot formation of iodide 238 and HM coupling. 
 
 
 
 
 
The mechanism for the iodide-forming reaction given in the literature 
reference first involves coordination of an NIS carbonyl to the boron, forming a 
boronate anion. This is then able to leave and the bond between the carbon and boron 
used to form a new bond with the electropositive iodine atom in a concerted step 
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(Scheme 36).
171 
The formation of alkyne product 226 indicated successful 
coordination, but unsuccessful substitution of the boronate anion for an iodine. Two 
possible mechanisms are given below. The first is an E1cb-like loss of the boronate to 
give an alkenyl anion, followed by loss of the bromide and triple bond formation. 
The second is a more concerted, pseudo E1cb-like loss of both groups in the same 
step (Scheme 37). The conclusion made was that the steric hinderance of the 
boronate ester had prevented successful iodine substitution. As a result, the same 
reaction was attempted on styrenyl boronic acid 227, giving styrenyl iodide 238 in a 
78% yield as a white solid (Equation 3).  Iodide 238 proved to be quite stable, 
perhaps surprisingly so given the dihalogenated alkene and the continual observation 
within the group that alkenyl iodides can be very unstable, and could be stored 
successfully for months at -18 °C under argon and in the dark. 
Scheme 36 Mechanism proposed in the literature for conversion of a boronic acid 
moiety to an iodine atom with NIS
171 
 
 
 
 
Scheme 37 Proposed mechanisms for elimination of pinacol boronate ester group 
and bromide ion to give alkyne 226 
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An attempt was made to make iodide 238 directly from alkyne 226 in a one-
pot procedure via dibromoboron intermediate 239, circumventing the isolation of the 
unstable boronic acid 227. Unfortunately, a 50:50 mixture of boronic acid 227 and 
geminal by-product product 236 was obtained (Scheme 38). 
Scheme 38 Attempted one-pot formation of styrenyl iodide 238, resulting in 
formation of boronic acid 227 and geminal by-product compound 236 
 
For the monobrominated analogues of xanthomonadin, the de-brominated 
analogue of pinacolate ester 228, compound 240 was required. It was envisaged that 
this could be easily synthesised by hydroboration of alkyne 226. Copper-catalysed 
borylation of 226 was attempted using copper chloride, xantphos, sodium tert-
butoxide and 4,4,5,5-tetramethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-
dioxaborolane in THF and methanol (Equation 4). Gratifyingly, this approach was 
successful and, with some optimisation of the purification conditions, styrenyl 
pinacolate ester 240 was isolated in a 79% yield. 
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As a result, three key building blocks could be accessed in a highly efficient 
manner, with both pinacolate esters accessed via either a bromoboration or 
hydroboration protocol from key alkynyl building block 226 (Scheme 39). 
Scheme 39 Current route to key aryl intermediates 226, 228 and 240 
 
Section 1.2.2 Selection of cross-coupling reactions to form 
Xanthomonas pigment and their analogues 
With a range of potential building blocks successfully obtained, potential cross-
coupling reactions were evaluated. At this stage it was envisioned that HM coupling 
onto styrenyl iodide 238 would be the route to building an aryl polyenyl building 
block, and that SM couplings onto boronates 228 and 240 would also be useful. For 
the alkynyl target analogues, a Sonogashira coupling onto terminal alkyne 226 was 
required. Hence, work was undertaken on establishing the reactivity of the above 
mentioned building blocks to the desired cross-coupling reactions. 
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Section 1.2.2.1 HM couplings 
A HM coupling was attempted on styrenyl iodide 238 (Equation 5), using the 
standard HM conditions developed within the group and detailed in the Introduction 
for the partial synthesis of viridenomycin. After stirring for 24 hours, the 
1
H NMR 
spectrum showed a number of compounds, which were difficult to identify. It was 
not easy to tell if the desired diene had been made. The crude mixture was subjected 
to work up and silica gel chromatography in an attempt to identify the products. 
  
The sample of iodide 238 used to attempt this reaction contained 17% of the 
unsubstituted geminal impurity 236. The products isolated from the column included 
33% 236, 29% unreacted styrenyl iodide 238 and 10% alkyne 226. This 
corresponded to an increase in the impurity 236, suggesting that it was a side-product 
in this attempted HM coupling.  Formation of 236 and 226 could be attributed to 
protodehalogenation and elimination reactions on the palladium, respectively. The 
isolation of these compounds indicates that oxidative addition of styrenyl iodide 238 
was occurring, but that there was a problem with catalyst turnover after this point. 
This is not unexpected due to the hindered nature of the styrenyl iodide, with a 
bromine atom on the α-carbon, the large pentanediol ester on the vinyl boronate 
acceptor 42 and the steric bulk of the tri-(o-tolyl)phosphine ligand. It may be that the 
palladium intermediate is too crowded for effective ligand exchange and migratory 
insertion.  
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It was found that drying of boronic acid 227 on the high vacuum line 
overnight resulted in considerable decomposition of the product, and increased 
proportions of the unwanted geminal by-product 236 (Scheme 40). The geminal  
by-product 236 was isolated from the mixture in a 13% yield and a HM coupling 
attempted on it. A potential alkene signal was observed at δ 5.58 ppm with an 
integral of 17% with respect to that of the geminal species 236, but no other signals 
corresponding to the other alkenyl or aryl peaks could be easily identified from the 
complex signals observed (Scheme 40). 
Scheme 40 Formation of geminal by-product 236 from alkyne 226 and its attempted 
HM coupling 
 
 
 
 
 
 
Section 1.2.2.1 Initial SM couplings 
Suzuki-Miyaura (SM) coupling of all of the brominated aryl intermediates 
was investigated, with boronic acid 227 investigated first, using Pd(PPh3)4 and THF. 
A range of bases were tried, but unfortunately in all of these cases, no product was 
observed (Table 1, Equation 6). In the cases of potassium acetate and sodium 
hydroxide, complete decomposition of boronic acid 227 was seen with no obvious 
product formed. With sodium methoxide and barium hydroxide, conversion of 
boronic acid 227 to geminal by-product product 236 and alkyne 226 was observed in 
differing amounts (sodium methoxide gave 16% alkyne, whereas barium hydroxide 
gave 28%). With the carbonate bases, decomposition of boronic acid 227 was 
observed, along with some conversion to geminal by-product 236. Additionally, at 
this temperature, loss of all of the THF from the reaction mixture was observed over 
the 3 days. 
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Table 1 Table showing the effect of base on the attempted SM coupling of boronic 
acid 227 
 
Entry Base Effect on boronic acid 227 after 3 day stir 
1 KOAc Decomposition 
2 NaOH Decomposition 
3 NaOMe Conversion to geminal by-product 236, 16% alkyne 226 
4 Ba(OH)2 Conversion to geminal by-product 236, 28% alkyne 226 
5 Cs2CO3 
Decomposition and some conversion to geminal by-
product 236 
6 Na2CO3 
Decomposition and some conversion to geminal by-
product 236 
 
The reasons for this pattern of reactivity are unclear. Geminal by-product 
product 236 is likely a product of protodeboronation, whereas alkyne 226 is likely 
formed by elimination of the boronic acid and bromine atom. Both of these can 
occur due to base, and both could result from complexation with palladium (for 
proposed mechanisms, see Scheme 41). In all cases, the first step could be the 
quaternisation of the boron by the alkoxide ion of the base. The following step could 
be either elimination of the boron-‘ate’ anion and bromide ion or abstraction of a 
proton, presumably from another boronic acid group present in solution to effect 
protodeboronation. This can either take place straightaway, or following 
transmetallation onto the palladium. 
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Instead of attempting to achieve some level of reactivity on this unstable 
intermediate, focus turned to potential SM couplings on the more stable pinacolate 
ester 228 and styrenyl iodide 238. 
Scheme 41 Proposed mechanisms for the different routes by which boronic acid 227 
can undergo elimination and protodeboronation 
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In a similar manner to the SM screen undertaken for boronic acid 227, 
conditions for the potential SM coupling of iodide 238 were investigated. The same 
bases were used for this screen as were for the screen on boronic acid 227, with the 
addition of silver(I) oxide (Table 2, Entry 7)., in the hope that it would help prevent 
elimination of the alkenyl iodides in the cross-coupling reactions.
 
Pd(PPh3)4 was 
used as the catalyst, as before, but the solvent was changed to 1,2-dimethoxyethane 
(DME) in order to circumvent issues with solvent loss. The results of this screen 
show quite a profound effect of base on the stability of iodide 238 (Table 2, 
Equation 7).  
Table 2 Table showing the effect of base on the attempted SM coupling of styrenyl 
iodide 238 
 
Entry Base Effect on iodide 238 after 3 day stir 
1 KOAc Iodide intact, no alkyne 226 formation 
2 NaOH Only alkyne 226 present 
3 NaOMe 73% alkyne 226 present 
4 Ba(OH)2 8% alkyne 226 present 
5 Cs2CO3 Only alkyne 226 present 
6 Na2CO3 7% alkyne 226 present 
7 Ag2O 
Complete decomposition of iodide, no alkyne 226 
formation 
 
In all cases, no SM product 244 was seen, and the only identifiable product 
was alkyne 226, presumably formed by an E1-type elimination, post-oxidative 
addition of the iodide onto the palladium (Scheme 42) via complex 245. No 
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protodehalogenation to give geminal by-product 236 was observed for any of the 
reactions, indicating that this E1-type elimination is very facile. The level of 
elimination varied between bases, with only potassium acetate leaving iodide 238 
intact. In the cases of sodium hydroxide and cesium carbonate (Table 2, Entries 2 
and 5), complete conversion to alkyne 226 was seen. Sodium methoxide effected a 
73% conversion of iodide 238 to alkyne 226 (Table 2, Entry 3), where barium 
hydroxide and sodium carbonate resulted in minimal alkyne formation (Table 2, 
Entries 4 and 6). Silver(I) oxide (Table 2, Entry 7), although employed in an 
attempt to counteract any elimination, resulted in complete decomposition of iodide 
238, with no obvious identifiable product.  
Scheme 42 Proposed mechanism for elimination of iodide 238 to give alkyne 226 
  
 
 
 
There was no obvious pattern in the results (Table 2) relating to either 
alkoxide nature or cation size. Indeed, both strong and weak bases, as well as large 
and small cations were able to effect the complete conversion of iodide 238 to alkyne 
226. This is clearly seen in the contrast between sodium hydroxide and barium 
hydroxide, and cesium carbonate and sodium carbonate (Table 2, Entries 2,4,5 and 
6). The nature of the alkoxide ion can influence the rate of ligand exchange post 
oxidative addition, in a successful cycle enabling better transmetallation of the 
acceptor onto the palladium species. In that case, it would be suspected that a more 
nucleophilic alkoxide would facilitate the regeneration of the palladium(0) complex, 
and therefore speed up the rate of reductive elimination. Both hydroxide and 
carbonate, were observed to effect complete conversion of the iodide 238. It was 
observed that complete conversion occurred when a strong base was paired with a 
small cation (sodium hydroxide, Table 2, Entry 2) and when a weaker base was 
paired with a large cation (cesium carbonate, Table 2, Entry 5). Nevertheless, it 
would be expected with such hindered systems that a strong base paired with large 
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cation would facilitate the coupling, as has previously been detailed in the 
literature.
172
 
A model system was therefore investigated in the hope of finding conditions 
to successfully couple onto the iodide analogue (Table 3, Equation 8). It was found 
that the combination of Pd(OAc)2 with potassium acetate gave no conversion at all 
(Table 3, Entry 2), with the other conditions giving good conversions (Table 3, 
Entries 1, 3 and 4).  
Table 3 Table showing the conditions attempted to optimise SM coupling onto 
model iodide 246 
 
 
Entry Catalyst Base Conversion/ % 
1 Pd(PPh3)4 Ba(OH)2 67 
2 Pd(OAc)2 KOAc 0 
3 Pd(PPh3)4 t-BuOK 81 
4 Pd(PPh3)2Cl2 Cs2CO3 77 
 
Despite Entry 3 giving the highest conversion, concerns over the ability of 
potassium tert-butoxide to potentially facilitate elimination of iodide 238 led to the 
conditions in Entry 4 being chosen to attempt SM coupling onto 238. 
 
 
 
 
Unfortunately these conditions were not met with any success, with 
elimination of the iodide and 5% of the desired product observed (Equation 9). 
Buchwald’s G2 XPhos precatalyst was tested, both using aqueous and anhydrous 
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conditions (Scheme 43). No elimination was observed, but no coupling was 
observed either. 
Scheme 43 Attempted SM coupling onto iodide 238, using XPhos G2 precatalyst 
and both aqueous and anhydrous conditions 
 
 
 
 
 
Section 1.2.2.2 Other cross-couplings 
Following the unsuccessful attempts at SM couplings onto boronic acid 227 and 
iodide 238, and HM couplings onto iodide 238 (see Equations 5, 6, 7 and 9), other 
types of cross coupling were considered. Both Stille and Sonogashira couplings were 
considered, as the conditions used for these are commonly milder than those 
generally used in SM and HM couplings.  
The Stille coupling was attempted on iodide 238 with vinyl stannane 248 
(Equation 10). Conditions without a base were deliberately employed in the hope of 
avoiding the elimination of iodide 238 before it could react. Initially the reaction was 
undertaken at room temperature, and 
1
H NMR analysis after 16 hours was 
inconclusive, not displaying the expected multiplicity for the desired product 244. 
 
TLC analysis was also inconclusive, so the temperature was increased to  
50 
o
C and the reaction stirred for a further 2 days to see the effect. At this point, a 
series of smaller signals were observed with the expected multiplicity for 244, 
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showing approximately 25% conversion. An attempt was made to isolate this 
compound by silica gel chromatography, but it was isolated as a mixture together 
with unreacted iodide 238, alkyne 226 and tin by-products in an approximate 17% 
yield. The presence of compound 244 was confirmed by accurate mass spectrometry. 
With the successful isolation of a cross coupling product (albeit not pure), 
attempts were made to optimise this reaction to obtain a higher conversion (Table 4, 
Equation 11). Addition of 1.2 equivalents of LiCl was attempted, in the hope that 
this would promote the reaction (Table 4, Entry 2). After stirring at 50 
o
C for 24 
hours, only 7% product was observed, and the iodide 238 had converted to the 
alkyne. The proportion of catalyst was increased to 20 mol% and the reaction 
undertaken in the microwave at 105 
o
C (Table 4, Entry 3). Conversion to the alkyne 
was again seen. A copper catalysed coupling was attempted using copper(I) 
thiocarboxylate, a procedure which could be undertaken at 0 
o
C, in the hope this this 
would preserve iodide 238 (Table 4, Entry 4). Unfortunately, no reaction between 
iodide 238 and stannane 248 was observed, even after allowing the reaction mixture 
to warm to room temperature. The reaction was then stirred at 50 
o
C overnight. After 
this, full consumption of the vinyl stannane was seen, but the 
1
H NMR did not show 
any peaks corresponding to product 244. Stirring the reaction mixture with no 
additives at 50 °C resulted in no conversion, only giving the undesired elimination 
and homocoupling products 226 and 249 (Table 4, Entry 5). 
It was also found that stirring the tin acceptor with the catalyst in an 
‘activation’ period before adding the iodide resulted in some improvement (Table 4, 
Entry 6). On larger scale, however, the successful coupling could not be repeated 
(Table 4, Entry 8). The preactivation period was, however, much shorter (3 hours vs 
overnight). Addition of silver(I) oxide also improved the conversion further (Table 
4, Entry 9), giving the best conversion of 50%. This benefit was only observed 
when a prestir was used in the procedure, giving no conversion without this step 
(Table 4, Entry 7). Success in this coupling appeared to be a fine balance between 
the heat required to facilitate the desired Stille coupling and the temperature at which 
the competitive elimination takes place. 
 
 
84 
 
Table 4 Table showing the conditions attempted to effect Stille coupling onto 
styrenyl iodide 238 
 
Entry Conditions Result 
1 rt, o/n, then 50 °C <10%, then 25% conversion 
2 LiCl addn, 50 °C 7%, Elimination of iodide 
3 20 mol% cat., microwave 105 °C Elimination of iodide 
4 CuOTc, NMP, 0 °C No reaction 
5 50 °C 
Elimination of iodide and 
butadiene formation 
6 
o/n rt, no iodide, then warm to 50 °C 
and add iodide 
34% conversion 
7 50 °C, Ag2O as additive 
No product formation, minimal 
butadiene 
8 
o/n rt, no iodide, then warm to 50 °C 
and add iodide (10x scale) 
Solely elimination and 
butadiene formation 
9 
o/n rt, no iodide, then warm to 50 °C 
and add iodide (10x scale), Ag2O as 
additive 
~50% conversion, butadiene 
formation, small amount of 
iodide elimination 
 
In light of these promising results (Table 4), a new polyenyl building block 
incorporating a stannane and boronate ester at each end was considered (see Section 
1.3), but synthesis of this building block consistently proved challenging and 
attention turned away from the Stille as a potential cross-coupling. 
A Sonogashira coupling was attempted on styrenyl iodide 238 (Equation 
12). After stirring for three days at room temperature, consumption of the iodide was 
seen, along with a change in shift for the singlet proton on the brominated alkene. 
The reaction was worked up and subjected to silica gel chromatography in the hope 
of isolating this product. A mixture of compounds was obtained, but the Sonogashira 
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product 251 was identified by mass spectrometry and and seen to be the major 
component in the mixture by 
1
H NMR, opening up the potential to deprotect the 
alkyne and complete the polyene chain, reducing down the alkyne to the desired 
alkene. Notably, in this coupling, no elimination product was observed. 
Unfortunately, the isolated yield in this reaction was disappointingly low. 
 
 
 
 
A Sonogashira coupling was attempted on alkyne 226 to establish whether it 
would be reactive to coupling (Equation 13). This was successful, giving the 
resulting product 252 in an 89% yield. 
 
Following the success of this reaction (Equation 13), an attempt was made to 
form the brominated alkene 244. It seemed prudent to avoid the use of HBr in 
aqueous solution due to the ester and alkene, so this reaction was attempted by 
generating HBr in situ using ethanol and acetyl bromide (Equation 14), in the hope 
of accessing 244. Unfortunately, no reaction at the alkyne was observed. 
 
 
 
Section 1.2.2.3 Revisiting the SM couplings 
Attention was turned back to the SM cross coupling, focussing now on the 
seemingly more stable brominated pinacol ester 228. Initally this was unsuccessful, 
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as was coupling onto the non-brominated styrenyl pinacol ester 240. It was noted 
that the boronate esters were not decomposing during the course of the reaction, but 
the alkenyl/ polyenyl iodide coupling partners employed were decomposing. To that 
end, coupling onto both the pinacolate analogues was attempted using silver(I) oxide 
as the base in an attempt to prevent elimination. The desired SM product could be 
identified in both of the crude products by accurate mass. It became apparent that the 
temperature being used in the cross-coupling could well be a cause of the 
decomposition of the iodides and so lower temperature SM conditions needed to be 
identified if at all possible. Previous SMs were revisited, and new conditions were 
tested for the SM between monobrominated pinacol ester 240 and iodoacrylate 229, 
in order to try to optimise this cross-coupling (Table 5, Equation 15). Isolation of 
diene 253 proved difficult in the past due to the diene’s tendency to polymerise, so 
the crude mixtures were not subjected to chromatography. 
1
H NMR data could be 
attributed to the desired diene and this, in combination with the accurate mass 
analysis previously obtained, provided evidence that the desired diene was being 
formed. The aryl and alkenyl sections of the 
1
H NMR data were very complex, but 
the characteristic doublet at δ 5.96 ppm for the diene was easily identifiable, as was 
the characteristic doublet for pinacolate ester 240. 
The SM did tolerate lower temperatures, but benefitted from an increase in 
catalyst in order to improve the reaction rate (Table 5, Entries 2 and 3). Doubling 
the Pd(PPh3)4 loading from 5 to 10 mol % at 40 
o
C increased the conversion from 69 
to 92%.  
Equivalent conversion was also seen at 30 
o
C (Table 5, Entry 4), but 
dropping to room temperature resulted in a drop in yield to 78% (Table 5, Entry 5). 
However, room temperature coupling using in situ generated Pd(PPh3)4  from 
Pd(OAc)2 and PPh3, along with Ag2CO3 as the base and MeCN as the solvent gave 
an increased yield comparable with those seen at 30 and 40 
o
C (Table 5, Entry 6). 
A minor side-product 254 was observed, with 
1H NMR signals at δ 6.12 (1H, 
d, J=18.3 Hz), 6.55-6.60 (1H, m) and 7.90 (1H, dd, J=12.4, 7.8 Hz) inter alia. This 
side product was not isolated. When tBuOK was used as the base, this side-product 
was observed as the major product, suggesting that the unwanted product could be an 
elimination product. 
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Table 5 Conditions screen for the Suzuki-Miyaura coupling of styrenyl Bpin 240 with iodoacrylate 229 
 
Entry Catalyst Catalyst loading/ mol% Base Eq. base Temperature / 
o
C Solvent 
Product conversion 
after 24 h/ % 
1 Pd(PPh3)2Cl2 5 Ag2O 1.2 60 DME 35
a
 
2 Pd(PPh3)4 5 Ag2O 1.2 40 DME 69 
3 Pd(PPh3)4 10 Ag2O 1.2 40 DME 92 
4 Pd(PPh3)4 10 Ag2O 1.2 30 DME 90 
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Entry Catalyst Catalyst loading/ mol% Base Eq. base Temperature / 
o
C Solvent 
Product conversion 
after 24 h/ % 
5 Pd(PPh3)4 10 Ag2O 1.2 rt DME 78 
6 
Pd(OAc)2/ 
PPh3 (3 eq.) 
10 Ag2CO3 2 rt MeCN 89 
7 Pd(PPh3)4 10 
t
BuOK 2 40 DME 42
b,c
 
a
 Multiple side-products observed. 
b
 Major product was the minor side-product observed in all other reactions. 
c
 Conversion after 14.5 h
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Following the success of this screen, a similar optimisation was attempted 
with brominated styrenyl Bpin 228 (Table 6, Equation 16). In this case, the 
1
H 
NMR spectra were much more difficult to analyse, with multiple alkenyl products 
observed. For some of the cleaner spectra, it was observed that 
1
H NMR for the 
presumed dienyl product was lacking a proton signal (Figure 2).  
 
Figure 2 
1
H NMR spectrum of undesired product 252 formed by subjecting 
brominated styrenyl Bpin 228 and iodoacrylate 229 to SM conditions, showing that 
not enough proton signals are present. 
The product was isolated from one of the reaction mixtures and found to be 
alkynyl dienyl analogue 252, rather than the desired brominated alkene 241 (Figure 
2). Mass spectrometry of the crude reaction mixture in Entry 4 showed that the mass 
ions for both the desired brominated diene 241 and the alkynyl analogue 252 were 
present. As was the case for the monobrominated diene 253, identification of the 
brominated diene 241 was difficult due to the complexity of the spectra. Again, 
1
H 
NMR peaks could be attributed to the desired diene, with a characteristic alkenyl 
signal at δ 6.12 ppm, which could be used to approximate the conversion in the 
cross-couplings. These NMR data were corroborated by accurated mass analysis of a 
O 
Br 
O 
O 
undesired  product  252 
* 
* 
* 
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crude reaction mixture, providing confidence that the desired brominated diene had 
been formed. A number of different conditions were attempted in the hope of 
obtaining the desired alkenyl product 241 (Table 6, Equation 16). Another non-
isolated side-product 255 was formed in some cases (indicated by a doublet observed 
in the 
1
H NMR spectrum at δ 8.24, J=12.6 Hz), along with the brominated diene 241 
and the undesired (presumed) Sonogashira product 252. Desired product 241 was 
seen when 5 mol% of either Pd(PPh3)4 or Pd(OAc)2 was used at 60 
o
C (Table 6, 
Entries 4 and 5). Use of Pd(PPh3)2Cl2 at 60 
o
C with Ag2O gave a moderate amount 
of brominated diene 241, but changing the base to Cs2CO3 gave exclusively the 
alkynyl dienyl product 252 (Table 6, Entries 1 and 3). The one attempt to perform 
this coupling at 40 
o
C lead exclusively to alkynyl dienyl product 252 (Table 6, 
Entry 2), giving rise to concerns as to whether a low-temperature SM would be 
possible. 
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Table 6 Attempted Suzuki-Miyaura couplings onto brominated styrenyl pinacolate 
ester 228 
 
Entry Catalyst 
Catalyst 
loading/ 
mol% 
Base 
Temperature/ 
o
C 
Conversion after  
24 h/ % 
     
241 252 255 
1 Pd(PPh3)2Cl2 5 Cs2CO3 60 0 43 0 
2 Pd(PPh3)4 10 Ag2O 40 0 72 0
a
 
3 Pd(PPh3)2Cl2 5 Ag2O 60 38 62 0 
4 Pd(PPh3)4 5 Ag2O 60 37 61 2 
5 Pd(OAc)2 5 Ag2O 60 0 48 52 
6 Pd(dppf)Cl2 5 Ag2O 60 34 66 0 
a
 Conversion after 14.5 h 
In order to shed some light on why this coupling was proving so 
unsuccessful, the two starting materials 228 and 229 were exposed to the reaction 
conditions separately (Scheme 44). They were first exposed to the silver base, and 
then to Pd(PPh3)4 after stirring overnight at 40 
°
C. Iodoacrylate 229 was stable to 
both additions, but brominated styrenyl Bpin 228 was deboronated immediately to 
give the geminal by-product compound 236 on addition of base. 
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Scheme 44 Effect of SM reaction conditions on brominated styrenyl Bpin 228 and 
iodoacrylate 229 separately 
 
Whilst ideal Suzuki-Miyaura conditions had not been identified, enough 
progress had been made to select a Suzuki-Miyaura coupling for both mono- and di-
brominated xanthomonadins and their truncated analogues, and a Sonogashira 
coupling for preparation of the alkynyl analogues. 
Section 1.2.3 Summary 
A number of different aryl building blocks 226, 228, 238 and 240 were made and 
evaluated as partners for key cross-coupling reactions to complete the synthesis of 
the target pigment molecules. The brominated styrenyl building blocks 228 and 238 
suffered from a tendency to undergo undesired side reactions under cross-coupling 
conditions, particularly elimination and protode-boron/halogen-ation. After 
investigating a number of different couplings, it was decided that the most promising 
cross-coupling was the SM coupling, where the brominated styrenyl pinacol 
boronate ester 228 seemed to be the most amenable to optimisation. The 
debrominated styrenyl pinacol boronate ester 240 was much more amenable to cross-
coupling, where SM conditions were more readily optimised, and fewer side-
products were observed. 
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Section 1.3 Synthesis of Xanthomonas pigments - synthesis of 
polyene chains using the Heck-Mizoroki/iododeboronation 
iterative cross coupling methodology 
As was  discussed in Section 1.1, some progress had been made towards the 
construction of the all trans-heptaene moiety of xanthomonadin via the iterative 
Heck-Mizoroki (HM)/ iododeboronation (IDB) methodology previously developed 
within the group, with the synthesis of (2E,4E,6E)-7-iodo-hepta-2,4,6-trienoic acid 
methyl ester 230, via iodoacrylate 229, and its subsequent conversion to pentaenyl 
boronate 231 on a small scale.
169,170
 In order to access the all-trans heptaene, the 
methodology required considerable optimization. In addition, there was no indication 
of how stable the longer chain analogues would be. 
Work was undertaken to improve the efficiency of the routes already 
determined to key iodoacrylate building block 229. The original synthesis of 229 
involved sodium iodide addition to methyl propiolate 256 to form the (Z)-analogue 
43, followed by an isomerization reaction using hydrogen iodide to give the desired 
(2E)-3-iodoprop-2-enoate 229 (Scheme 45) in a 70% yield over the two steps.
169 
Because the (Z)-analogue was not to be required during the synthesis of 
xanthomonadin 208, an alternative route which did not require an isomerisation 
reaction seemed desirable to avoid the need to purify a mixture of isomers. As a 
result, an alternative pathway to 229 was investigated (Scheme 46). This route 
involved the addition of hydroiodic acid across the alkyne bond of propiolic acid 
257, and then the subsequent methylation of the acid 258 to give 229. This route was 
successful, affording 229 in a higher overall yield than the previous route (86% cf. 
70% with previous method). The geometry of the double bond was confirmed by 
performing X-ray crystallography on a sample of the crude (E)-3-iodoprenoic acid 
258 (Figure 3). Iodoacrylate 229 was found to be stable for over a year if kept at 4 
°C, in the dark and under argon. 
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Scheme 45 Original route for synthesis of 229
169 
 
 
 
Scheme 46 New route for synthesis of 229 
 
 
 
 
 
 
 
Section 1.3.1 Propagation of polyene chains from iodoacrylate 1, using 
HM/IDB ICC methodology 
Due to the photosensitivity of the polyenes, and particularly the polyenyl iodides, all 
reactions, work ups and purifications were performed in the dark. Iodoacrylate 229 
was subjected to the previously developed HM conditions to afford dienyl boronate 
259 (Scheme 47); 100% conversion of iodoacrylate 229 was observed, with 
approximately 10% of this being converted to the Suzuki-Miyaura (SM) product, but 
only 78% was recovered after silica gel chromatography. A range of different eluent 
systems was tried, but streaking of the boronate compound was consistently 
observed, and this was presumed to be the cause of the lower mass recovery on 
purification. Dienyl boronate 259 was cleanly converted to dienyl iodide 260 using 
an IDB approach, adding sodium methoxide before the iodine monochloride to 
preserve the trans geometry. Silica gel chromatography of iodide 260 was performed 
Figure 3 Crystal structure confirming the (E)-geometry of the double bond of (E)-3-
iodoprenoic acid 258 
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using eluents cooled to 0 °C, with the separation being much better than for dienyl 
boronate 259, and with no streaking.  This was then converted to trienyl boronate 
261 via another HM coupling. Purification of the trienyl boronate was particularly 
troublesome, proving to be very low yielding despite 100% conversion being 
observed in the coupling reaction itself (Scheme 47). 
Scheme 47 Initially obtained yields for synthesis of trienyl boronate 261 
 
In order to try and minimise the loss of yield during the polyene synthesis, 
telescoping the crude dienyl boronate 259 into the IDB step directly was attempted, 
using only a filtration through a short Celite/silica plug to remove silver and 
palladium residues. This was attempted on a month-old sample of crude dienyl 
boronate 259, giving a 56% yield of clean dienyl iodide 260 over the two steps 
(Equation 17). Complete conversion of the dienyl boronate intermediate 259 to 
iodide was observed, indicating that nothing present in the crude HM product was 
interfering with the desired iododeboronation. 
 
Whilst the yield was not as high for the two steps (Equation 17) as had been 
obtained by doing the steps discreetly (Scheme 47), it seemed that telescoping the 
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polyenyl boronates through into the IDB step was a viable course of action. The 
stability of the polyenyl iodides (particularly those longer chain iodides) was still a 
cause of concern and therefore an HM/IDB ICC cycle where all intermediates were 
telescoped through without the need for silica gel chromatography would be 
preferable. Dienyl iodide 260 was therefore subjected to HM coupling conditions to 
give crude trienyl boronate 261, which was then telescoped into the IDB step to give 
crude trienyl iodide 230. This was then telescoped into the next HM coupling, to 
give crude tetraenyl boronate 262 (Scheme 48). 
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Scheme 48 Attempted synthesis of xanthomonadin 208 by sequential telescoped 
HM/IDB steps 
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It was noted that the 
1
H NMR spectrum for tetraenyl boronate 262 looked 
remarkably clean, with the main impurites being residual borate from the IDB and a 
build-up of phosphine ligand (Figure 4).  
 
Figure 4 
1
H NMR spectrum for crude tetraenyl boronate 262 
Crude tetraenyl boronate 262 was consequently telescoped through further 
IDB/HM sequences to yield tetraenyl iodide 263, pentaenyl boronate 231 (a small 
amount of this was isolated to confirm presence of product as at this stage in the 
route there was a considerable amount of borate present), pentaenyl iodide 264, 
hexaenyl boronate 265 (presence confirmed by MS) and hexaenyl iodide 266 
(Scheme 48). It was noted that there was a distinct colour change as the double 
bonds were added, even though the excess iodine species in the crude mixture added 
brown colour. The colour became more and more vivid with each addition changing 
from brown in the shorter chain polyenes to neon orange-dark neon yellow in the 
longer chain polyenes. This is consistent with the increased conjugation of the longer 
polyene chains. 
It became much more difficult to calculate the correct amount of reagents for 
the IDB step as the polyene chain became longer, due to large amounts of borate 
present, as well as accumulating amounts of ligand. Excess vinyl boronate 42 left in 
* * 
* 
* phosphine ligand signals 
* integration of peak too large 
due to excess boron species 
 
Ha 
Ha 
Hb 
Hb 
Excess vinyl boronate 
Hc 
Hc 
Hd 
Hd 
He 
He 
Hf 
Hf 
Other polyene protons 
262 
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the crude polyenyl boronates could be removed by using the right amount of ICl and 
NaOMe, such that the vinyl boronate 42 was converted to vinyl iodide 269, which 
was then removed in vacuo. Iodides were not fully characterised, due to their 
inherent instability. Instead, successful synthesis of the subsequent polyenyl species 
was used to confirm presence of desired iodide. 
It was found that, as predicted, the solubility of the polyenyl iodides in 
MeCN decreased with increasing chain length, presumably due to the increasing 
hydrophobicity of the growing chain. From pentaenyl iodide 264 onwards, it was 
necessary to perform HM couplings in a 3:1 mixture of MeCN:tetrahydrofuran 
(THF), dissolving the iodide in THF before adding it to the MeCN (Scheme 48).  
From the hexaenyl iodide onwards, the 
1
H NMR was far too complex to identify 
peaks corresponding to product. The final HM/IDB ICC cycle was performed in an 
attempt to make heptaenyl iodide 268. However, no real change in the 
1
H NMR from 
the hexaenyl derivatives was observed and the large amount of borate present made 
it next to impossible to determine if the desired iodide 268 was present. The crude 
iodide was taken on into an attempted SM coupling with boronic acid 227, but 
unfortunately the boronic acid decomposed to the alkyne 226 under SM conditions 
and xanthomonadin 208 was not formed (Scheme 48). It was suspected that the 
heptaene was in fact not made, due to a possible over calculation of the amount of 
ICl for IDB and therefore decomposition of the polyene. 
Nevertheless, the principle of telescoping the products through multiple 
HM/IDB ICC cycles was proven. Synthesis of the polyene chain was recommenced, 
with more attention paid to when purification was necessary. It was found that 
drying the crude boronates on under high vacuum removed excess vinyl boronate 42 
and other borate species, giving a much cleaner product. Trienyl boronate 261 was 
exceptionally clean (Figure 5a), as was tetraenyl boronate 262 (Figure 5b). 
However, tetraenyl boronate 262 started to show a build-up of phosphine ligand and 
small amounts of borate. Using this method, tetraenyl boronate 262 was produced 
from iodoacrylate 229 in an estimated 26% yield over the five steps. This was a 
considerable improvement, where previously the three steps involving columns from 
iodoacrylate 229 to trienyl boronate 261 were accomplished in only a 14% yield. 
There was still a considerable loss of yield observed, which was attributed to the 
iododeboronation steps. 
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Figure 5 
1
H NMR spectrum for a) crude trienyl boronate 261 and b) crude tetraenyl 
boronate 262 (see Figure 4 for assigments) 
Upon repeating this sequence of reactions, the overall yield to tetraenyl 
boronate 262 improved to 47% over the 5 steps (Scheme 49).  
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Scheme 49 Improved yields for the HM/IDB ICC methodology, yielding tetraenyl 
boronate 262 
 
Throughout the different attempts to apply the HM/IDB ICC methodology, it 
was observed that the stability of the polyenes reduce considerably with increasing 
chain length. It also appeared that chains with an odd number of alkenes were much 
less stable than those with an even number of chains. 
It was found that tetraenyl iodide 263 could be purified by silica gel 
chromatography. A considerable amount of yield was lost upon purification, with the 
overall yield from the starting acrylate being 20% (76% per step). However, this 
intermediate proved remarkably stable and could be stored successfully for up to 8 
weeks at -18 °C, in the dark, under argon. As a result, it was chosen as a likely 
building block for the construction of the different polyene-containing target 
molecules. 
Section 1.3.2 Propagation from the aryl end using the HM/IDB ICC 
methodology 
As discussed in Section 1.2, it was envisaged that the xanthomonadins would be 
completed with a final Suzuki-Miyaura coupling between polyenyl intermediates. 
The lack of reactivity of the brominated styrenyl iodide 238 to HM coupling meant 
that a the ester polyenyl intermediate would have to be a heptaene, but the reactivity 
of the de-brominated styrenyl pinacol boronate 240 towards the HM/IDB ICC 
methodology was yet to be established. 
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De-brominated styrenyl pinacol boronate 240 was subjected to IDB and HM 
steps in an attempted to make the aryl dienyl boronate 270 (Scheme 50). This was 
successful, with the product characterised by 
1
H NMR and accurate mass. The dienyl 
boronate was then taken through two more HM/IDB cycles to give the aryl tetraenyl 
boronate 272, with the boronate characterised after each cycle by accurate mass to 
make sure it was there. In all cases, complete conversion was observed. The overall 
estimated yield was very low, only 5% over the 6 steps, but this was attributed to the 
small scale these reactions were performed on, where temperature control was very 
difficult in the IDB steps. 
Scheme 50 Initial investigations into the reactivity of aryl boronate 240 towards 
HM/IDB ICC methodology 
 
This sequence was attempted again, with boronates subjected to silica gel 
chromatography to observe their stability upon purification (Scheme 51). The 
polyenyl iodides were not subjected to any purification after work up. The boronates 
proved to be stable to silica gel chromatography and purifying them improved the 
iododeboronation step as it was easier to calculate the right amount of ICl to add. It 
had been previously assumed that all intermediates would become brown on 
iododeboronation, but in this sequence addition of precisely the right amount of ICl 
allowed this brown colour to be removed on work up, regardless of how many steps 
in the sequence had been performed. Streaking of the polyenyl boronates was still 
observed during silica gel chromatography, but even with columns, the overall yield 
was improved from 5% to 9%, increasing to an average of 67% per step. The yields 
did appear to drop off as the length of the polyene chain increased, with this trend 
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particularly obvious in the HM steps (Scheme 51). It was noted that, whilst the 
polyenyl boronates appeared more stable and easier to handle than the ester polyenyl 
boronates in Section 1.3.1, the polyenyl iodides were considerably less stable that 
those in Section 1.3.1. Aryl trienyl iodide 275 proved to be unstable even at room 
temperature in the dark, where the colour changed from bright yellow to murky 
brown within two hours. 
Scheme 51 Improved yields for the construction of aryl tetraenyl boronate 272 
 
 
Section 1.3.3 Application of the HM/IDB ICC methodology to give a 
trienyl building block 
With the recurring trend of decreasing stability with increasing polyene chain length, 
it seemed appropriate to adopt a more convergent approach to the construction of 
pigment molecules. Terminal trienyl iodide 279 was proposed as a possible building 
block for synthesis of both Xanthomonas pigments, with the yields obtained for the 
construction of the building block and its proposed use in the synthesis of 
xanthomonadin 208 shown in Scheme 52. 
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Scheme 52 Route to terminal trienyl building block 279, and its proposed use in the 
synthesis of xanthomonadin 208 
 
The sequence commenced with the formation of terminal dienyl boronate 
276, using vinyl iodide 269 as a HM donor. The optimisation of these conditions is 
discussed in Section 2.1.
173
 During optimisation of this methodology, it was found 
that any unreacted vinyl boronate could not be separated from dienyl boronate 276 
by silica gel chromatography and this, combined with concerns over stability of the 
terminal polyene, meant that chromatography was not attempted as a means of 
purification. The dienyl boronate was also shown to be highly susceptible to 
polymerisation (see Section 2.1), so distillation was not viewed as a viable 
purification method either. Unfortunately, the high volatility of all intermediates 
meant that crude products could not be purified using vacuum. It was found that 
dienyl boronate 276 could be successfully iododeboronated to give dienyl iodide 
277. Dienyl iodide 277 was successfully converted to trienyl boronate 278 via 
another HM coupling, obtained as a mixture with excess vinyl boronate 42. Trienyl 
boronate 278 was then subjected to IDB conditions to give trienyl iodide 279 in an 
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11% yield over the 4 steps, giving an average of 57% per step (Scheme 52) which, 
given the volatility of the compounds, was considered an acceptable yield. 
Section 1.3.4 Attempted construction of a bismetallated building block 
Similar to the reasoning behind the construction of terminal trienyl iodide 279 in 
Section 1.3.3, and in light of the promising results obtained for attempted Stille 
couplings onto the brominated styrenyl iodide, a trienyl stannane building block was 
targeted to help with convergent construction of the pigment molecules. 
Trienyl distannane building block 281 was originally envisaged to complete 
the synthesis, but concerns over potential selectivity issues led to bismetallated 
building block 282 being considered. 
 
 
 
This building block had been synthesised in the Menche group, and 
successfully used in the synthesis of polyene natural product analogues.
174,175
 
Alcohol 285 had been made in the Goldring group starting from iodoacrylate 229.
176 
This provided an excellent opportunity to use this building block twice. The route 
towards bismetallated triene 282 is detailed in Scheme 53.  
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Scheme 53 Route towards the synthesis of bismetallated building block 282
174–176 
 
Initial yields for this route were disappointing, with the volatility of the 
intermediates presenting a real challenge on work up and purification. Despite 100% 
conversion for the Sonogashira coupling to give alkyne 283, a poor initial yield of 
38% was obtained after silica gel chromatography. Unprotected alcohol 285 was 
particularly volatile, and a 44% isolated yield was obtained for this step. With some 
optimisation, the yields of all steps were improved to become more in line with the 
literature yields, and improved in the case of the DIBAL reduction to alcohol 284 
(Scheme 54).
174–176 
However, the final Takai oxidation proved consistently 
problematic, with the crude mixture showing the desired triene, but showing a 
changed 
1
H NMR spectrum on attempts to purify it. The product obtained from 
purification was subjected on a number of occasions to Stille conditions, but no 
coupling was observed, indicating that the desired stannane had not been formed. 
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Scheme 54 Progress made towards the synthesis of bismetallated building block 282 
 
At this point Suzuki-Miyaura cross-coupling started to show more promise as 
a potential option for the final cross-coupling and so this building block was 
abandoned, since it was taking too long to optimise. 
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Section 1.3.5 Temperature studies and reoptimisation of the HM 
methodology 
It was mentioned in Section 1.2 that reoptimisation of the SM conditions to operate 
at a lower temperature was required, due to the tendency for the temperatures used to 
cause decomposition of the polyenyl iodides used. It seemed appropriate, therefore, 
to investigate the currently used temperatures in the HM/IDB methodology for their 
effect on the polyenyl iodides. Given the considerable drop off in yields past the 
tetraene, tetraenyl iodide 263 was chosen. Tetraenyl iodide 263 was dissolved in 
degassed d3-MeCN. An initial 
1
H NMR was run and then the NMR tube was held in 
the dark at the required temperature for 2 hours. Another NMR was then run and the 
spectra compared (Table 7). 
Table 7 Table showing the effect of heat on tetraenyl iodide 263, comparing the 
relative integral of a signal possibly corresponding to a decomposition product with 
a signal corresponding to tetraenyl iodide 263 
 
Entry 
Temperature/ 
o
C 
Relative integral 
of signal at 9.65 
ppm- initial 
Colour change 
over 2 hours 
Relative integral 
of signal at 9.65 
ppm after 2 hours 
1 rt 0.01 none 0.03 
2 30 0.01 none 0.04 
3 40 0.01 none 0.10 
4 50 0.02 none 0.11 
5 60 0.02 
Yellow-pink-dark 
brown 
0.16, plus d at 
9.72 (0.08), plus t 
at 9.20 (0.43) 
 
It was observed that, during the course of heating, a particular dd at 9.65 
increased in intensity. This was present in very small amounts in the initial spectra.  
The proportion by which this increased became larger as the temperature increased, 
increasing by small amounts at room temperature and 30 °C, but becoming more 
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significant above this. Upon heating to 60 
o
C a large change was noticed, with 
multiple new peaks appearing. This indicated that there was a possibility that some 
of the unexplained loss of product through the ICC sequence could be due to 
decomposition of iodide intermediates in HM reaction conditions, particularly for the 
longer chain iodides. 
In response to this, a temperature screen was undertaken, to establish whether 
the HM coupling could be performed at lower temperatures (Table 8, Equation 18). 
The reaction was highly tolerant of lower temperatures, achieving 100% conversion 
at all temperatures, and requiring no increase in catalyst loading. 
Table 8 Temperature screen for the HM coupling of iodoacrylate 229 and vinyl 
boronate 42, showing HM vs competing SM ratios. 
 
Entry 
Catalyst loading/ 
mol% 
Temperature / 
o
C 
Conversion 
after 24 h/ % 
HM: SM 
ratio 
1 5 50 100 
90:10 to 
97:3 
2 5 40 100 87:13 
3 10 40 100 80:20 
4 5 30 100 87:13 
5 10 30 100 85:15 
6 5 rt 100 72:28 
7 10 rt 100 68:32 
 
It was observed that in the room temperature reactions a considerable amount 
of SM product was being formed, hence all 
1
H NMRs were analysed to see how 
much was being formed. Some SM product was formed in the original conditions 
(Table 8, Entry 1). Decreasing the temperature to 40 and 30 °C had a minimal 
impact (Table 8, Entries 2 and 4), but operating the HM coupling at room 
temperature resulted in a deterioration of the HM:SM ratio. It was decided that 30 °C 
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could be a viable operating temperature for the HM coupling, and so was trialled in 
the synthesis of two of the polyenyl intermediates. 
The synthesis of tetraenyl iodide 263 was attempted first. As suggested by 
the temperature screen, the quantity of SM side product did seem higher throughout 
route, but was at a tolerable level and so the route was continued. None of the 
polyenes required an increase in catalyst loading, nor an increased reaction time to 
achieve completion, with intermediates proving to be easily coupled at this lower 
temperature. It was immediately noted that the reaction mixtures were much paler in 
colour throughout the synthesis, and crude mass recovery was good all the way 
through. Unfortunately, due to the increased amount of crude tetraenyl iodide 263, 
purification became problematic. Chromatography took several hours, and required 
two attempts, resulting in the loss of a huge amount of material. Material that was 
obtained has decomposed considerably. However, the yield even with the problems 
in purification was comparable to the route performed at 50 
o
C, with an estimated 
yield at the tetraenyl boronate 13 stage of 49%, working out at average 87% per step 
(Scheme 55). 
Scheme 55 ICC methodology to access tetraenyl iodide 263, with HMs performed at 
30 
°
C 
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The lower temperature methodology was then applied to the synthesis of aryl 
tetraenyl boronate 272, with intermediates again proving to be reactive at lower 
temperatures (Scheme 56). In this case, the benefit was much more obvious, with the 
overall yield doubling for this route. This is not surprising, given the instability of 
the iodides that had been observed previously. 
Scheme 56 ICC methodology to access aryl tetraenyl boronate 272, with HMs 
performed at 30 
°
C 
 
This methodology was further optimised to operate at room temperature, with 
these results discussed in Section 2.1. 
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Section 1.3.6 Summary 
The group’s stereoselective ICC methodology was applied to the synthesis of a 
number of polyene building blocks. The methodology required reoptimisation to 
reflect the increased instability observed with increasing chain length. Issues with 
stability above the tetraene length led to only two key tetraenyl building blocks 263 
and 272 being selected for further use, along with a terminal trienyl iodide 279.  
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Section 1.4 Synthesis of Xanthomonas pigments - new 
retrosynthetic routes to access mono- and di-brominated 
xanthomonadin, along with truncated analogues 
Section 1.4.1 Attempts to access xanthomonadin via a heptaenyl iodide 
Initial attempts to make xanthomonadin 208 focussed on application of the HM/IDB 
methodology to the synthesis of key heptaenyl iodide (see Section 1.3). The final 
SM was attempted on 268 in an attempt to make xanthomonadin 208 (Scheme 57). 
Unfortunately, the reaction to make boronic acid 227 was problematic due to a lot of 
HBr present in the BBr3 used and so most of crude 227 was in fact the undesired 
geminal product. Some boronic acid was present, therefore this was coupled with 
268. The mixture was subjected to silica gel chromatography and all spots isolated, 
but no trace of desired natural product 208 was found.  The crude 
1
H NMR showed 
loss of all peaks corresponding to a longer chain polyene, and also loss of the 
boronic acid peaks. Some alkyne was observed, indicating that decomposition of 
both the polyenyl and aryl intermediates had taken place.  The loss of the boronic 
acid was unsurprising, due to the instability it had previously shown on storage. 
Scheme 57 Attempted synthesis of xanthomonadin 208 by sequential telescoped 
HM/iododeboronation  
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In response to this, another attempt was made at forming xanthomonadin 208 
(Scheme 58), with a focus on acquiring a purer sample of the heptaenyl iodide to 
use, but also using the more stable pinacol boronate ester aryl building block 228. As 
previously observed (Section 1.3.1), mass recovery during the HM/IDB sequence 
was good until formation of the pentaene. The pentaenyl boronate was in fact 
isolated during this sequence to see if cleaning up the crude polyene would help with 
the latter stages of chain extension. Unfortunately, drop offs in mass recovery 
became progressively worse with each subsequent step. An attempted coupling 
between the crude heptaenyl iodide 268 and brominated styrenyl Bpin 228 was 
performed, but xanthomonadin 208 could not be identified from the crude mixture 
by mass spectrometry. The crude 
1
H NMR showed no clear peaks corresponding to 
either of the starting materials, suggesting that yet again they had not survived the 
reaction conditions. 
Scheme 58 Attempted synthesis of xanthomonadin 208 using brominated boronate 
ester 228 
 
 
These attempts highlighted the issues with the final SM cross-coupling 
conditions and were a cause of the investigations undertaken in Section 1.2.  They 
also led to the strong suspicion that the stability of the heptaenyl iodide was a real 
issue in the final cross-coupling reaction. It was apparent that a different approach 
needed to be adopted towards the synthesis of these pigment molecules, particularly 
avoiding the use of such unstable polyenyl iodides. 
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Section 1.4.2 Redesigning the retrosynthetic route 
After the initial attempts to access xanthomonadin, it became obvious that the 
previously envisaged route, where different aryl building blocks were all reacted 
with one heptaenyl intermediate to give the desired octaenes, was unlikely to be 
successful. It seemed prudent to develop a ‘toolbox’ of polyenyl building blocks in 
order to impart some flexibility into the way the pigments were accessed, with the 
synthesis of these discussed in detail in Section 1.3. The key focus was on the 
construction of building blocks that could be connected via palladium cross-
coupling. Terminal trienyl iodide 279 was proposed as a possible building block, 
with the potential to act as a donor in a range of palladium cross-coupling reactions 
at the iodide moiety and then as a HM acceptor at the terminal alkene (Scheme 59). 
A SM coupling was attempted between the iodide and aryl pinacol boronate ester, in 
the hope that it would be more stable than heptaenyl iodide 268 to the conditions 
(Scheme 59, Equation 19).  
 
TLC analysis of the reaction mixture showed a number of highly conjugated 
species. The crude 
1H NMR looked promising, with two key peaks at δ 5.22 (1H, dd, 
J=7.8, 2.5 Hz) and 5.33 (1H, d, J=15.1 Hz). These fitted the pattern observed for 
previous compounds of the cis and trans terminal alkenyl protons, giving some 
confidence that a coupling had taken place. Other peaks seemed consistent with a 
conjugated terminal arylated tetraene, with signals observed at δ 3.96 (s 
corresponding to aryl methoxy group) and multiplets at δ 6.40, 6.73, 6.95, 7.10 and 
7.52. Furthermore, the signals observed were consistent with those we had seen 
previously in other related compounds, where inter chain alkenyl signals typically 
come together in a large multiplet at δ 6.40 ppm, and the aryl signals typically come 
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at ~ δ 7 ppm and between δ 7.4 and 7.5 ppm. The mixture of conjugated polyenyl 
species proved difficult to separate by silica chromatography, with considerable 
decomposition of the presumed product observed. Accurate mass analysis did 
identify the desired brominated aryl tetraene, giving confidence in the previously 
identified NMR data. Initially it was thought that the isolated solid contained a 
mixture of the desired brominated tetraene and a large amount of the 
protodeboronated aryl, but later analysis of the mass spectrum also showed alkynyl 
species 291. This mixture was then subjected to HM conditions with tetraenyl iodide 
263 in an attempt to make xanthomonadin 208. The crude 
1
H NMR showed polyenyl 
peaks that could correspond to the natural product, at an approximate 7% yield. The 
mass spectrum did not clearly show the molecular ion for xanthomonadin 208, but it 
did show the fragment ions found by Andrewes et al. when they isolated 
xanthomonadin 208 were visible (501 and 473 for loss of methoxy and 
carbomethoxy fragments, Figure 6).
1 
A potential mass ion for alkynyl pigment 
analogue 232 was observed with low abundance. 
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Scheme 59 Attempted synthesis of xanthomonadin 208 via terminal trienyl iodide 
279 
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Figure 6 ASAP MS chromatogram showing fragment ions comparable to those 
found by Andrewes et al. for xanthomonadin 208 (501 and 473 for loss of methoxy 
and carbomethoxy fragments)  
The crude reaction mixture was subjected to silica gel chromatography in the 
hope of isolating xanthomonadin 208. Unfortunately, the compound giving rise to 
this mass could not be isolated cleanly, so whether or not the HM reaction was 
successful was inconclusive. 
Terminal trienyl iodide 269 was also coupled with monobrominated styrenyl 
Bpin 240 to give terminal aryl tetraene 292. This compound was susceptible to 
polymerisation and degraded before the final HM could be attempted (Equation 20). 
The desired tetraene was, however, characterised by accurate mass, and also 
displayed two key signals in the crude 
1
H NMR spectrum that were indicative of a 
terminal alkenyl species; δ 5.13 (1H, d, J=8.4 Hz), 5.26 (1H, dd, J=16.7, 1.6 Hz). 
 
In light of the above reactions, where the heptaenyl iodide was proving 
challenging to access and the HM to close up the two tetraenes did not seem facile, 
focus turned away from xanthomonadin 208 to the synthesis of debrominated 
xanthomonadin 210 and the truncated analogues. Here the heptaene seemed not to be 
required, as the aryl boronate ester had proven amenable to the HM/IDB 
methodology and the tetraene 272 had been successfully made (see Section 1.3). 
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Section 1.4.3 Sonogashira couplings to give alkynyl analogues 
Having already successfully performed a Sonogashira coupling onto the alkyne 
building block 226 (see Section 1.2), another Sonogashira coupling was attempted 
using tetraenyl iodide 263 (Equations 21 and 22). This reaction proved extremely 
facile. Silica gel chromatography again proved difficult, with a number of fractions 
discarded for the sake of purity. Nevertheless, desired truncated analogue 235 was 
synthesised in a 56% yield as a bright yellow solid.  
 
With the success of this reaction, it was considered that xanthomonadin 
might be accessible via the alkyne analogue 232. An attempt was also made to add 
HBr across alkyne 235, with a view to giving truncated xanthomonadin analogue 
233. This was done using HBr in AcOH (33% by weight). Accurate mass did show 
presence of desired product, but the 
1
H NMR was extremely complex. Given the 
difficultly that had already been experienced in separating the crude mixtures of 
polyenyl compounds, this was not considered to be a viable route. 
Crystals of alkynyl dienyl analogue 252 were successfully obtained and 
analysed by X-ray crystallography. The structure showed a degree of planarity 
between the alkyne and the aryl, seeming also to extend through to the alkene, but 
with the ester group lying out of the plane (Figure 7a). The molecules packed by 
alternating orientations, with the alternating aryl and ester groups interacting with 
each other, hydrogen bonds forming between the ester and the aryl bromine atom. A 
further interaction was presumed between the aryl methoxy group and the ester 
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carbonyl oxygen (Figure 7b-d).  The molecules alternately stack together, held 
together by π-π stacking interactions and weak hydrogen bonds.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
c 
b 
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Figure 7 Pictures obtained from X-ray crystallography on analogue 252 
d 
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Section 1.4.4 Returning to SM couplings 
An initial attempt was made to form monobrominated pentaenyl analogue 234, using 
the best conditions to come out of the first screens undertaken to optimise the key 
SM couplings (Equation 23). Unfortunately, no peaks that could be ascribed to 
product were observed by 
1
H NMR during the course of the reaction. On closer 
analysis, it was observed that the polyene was decomposing in the reaction mixture. 
Simultaneously to the optimisation of the required SM conditions, the 
coupling reaction to produce analogue 234 was attempted again, this time using 
silver(I) oxide as the base in an attempt to minimise degradation of the polyene 
(Equation 24). A number of polyenyl products were formed, most of which could 
not be separated in order to identify them, but desired compound 234 was isolated.  
During the purification process, compound 234 could be seen as one clear, 
fluorescent spot on TLC, but as will be discussed in Section 1.5, the NMR spectra 
were rather complicated.  
 
Synthesis of pentaenyl xanthomonadin analogue 233 was also attempted 
using the Pd(PPh3)4/silver(I) oxide conditions (Equation 25). NMR and accurate 
mass analysis was performed on the purified product, where a lot of mass loss was 
due to poor separation. Mass spectrometry clearly identified the desired compound, 
which looked exceptionally clean with only two major mass ions, one being the 
desired product and an m/z corresponding to [M-HBr]. Originally this ion was 
thought to have originated during the mass experiment, but it was later realised that 
this was in fact due to the alkynyl product, formed during the attempted SM itself in 
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an approximate 2:1 ratio of alkyne to desired pentaene. Again, the mixture obtained 
ran as one fluorescent spot on TLC. 
 
A series of NMR experiments were used to evaluate the nature of these 
mixtures, showing that there was likely a mix of some isomers and some other 
polyenyl products (see Section 1.5 for this discussion). The potential to make these 
analogues was demonstrated, however, and the need for a new purification system 
was highlighted. 
As detailed in Section 1.3, styrenyl boronate 240 was successfully converted 
to aryl tetraenyl boronate 272 through repeated HM/IDB ICC cycles, telescoping 
each intermediate through and performing the final cross coupling on the crude 
tetraene (Scheme 60). 
Scheme 60 Initial synthesis of aryl tetraenyl boronate 272 
 
Aryl tetraenyl boronate 272 and tetraenyl iodide 263 were subjected to the 
SM conditions used to make pentaenyl analogue 234 in an attempt to make 
monobrominated xanthomonadin 210 (Equation 26). The 
1
H NMR spectrum after 
stirring overnight showed consumption of boronate and iodide, giving rise to new 
polyenyl peaks, particularly a large complex multiplet at around δ 6.31. Mass 
analysis of the crude mixture showed a weak signal in the ASAP corresponding to 
[M-2H] at 450.084, for which the exact mass is 450.083, along with the 
81
Br isotope 
at 452.082 (Figure 8). 
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The crude mixture was subjected to silica gel chromatography in an attempt 
to isolate the compound 210. One of the isolated spots was very impure, but 
contained a series of peaks which integrated to give the correct number of protons, 
including a complex multiplet at δ 6.24-6.47 containing the vast majority of the 
polyene protons, as well as the signals for the two methoxy groups and the 
characteristic low and high shifted multiplets for the more distal polyene protons 
(Figure 10). This fraction also showed a mass ion in the ASAP for [M-H] at 451.093 
(exact mass 451.092) and at 453.094 for the 
81
Br isotope (Figure 9).  
 
 
 
 
Figure 8 ASAP mass spectrum of the crude residue from the attempted formation of 
debrominated xanthomonadin 210 
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Figure 10 
1
H NMR spectrum showing the presence of monobrominated 
xanthomonadin 210 
A yield for the reaction could not be accurately estimated from the 
1
H NMR 
spectrum due to lack of purity, but this, combined with the mass spectrum, provided 
the first real evidence for the presence of monobrominated xanthomonadin. There 
were clearly, however, still problems with the SM conditions which needed to be 
remedied if more than trace amounts of the natural product were to be detected.  It 
was assumed that the high temperatures were causing at least some degradation of 
the tetraenyl iodide, but whether either the tetraenyl boronate or indeed the product 
itself was decomposing was still unknown. 
In order to shed some light on the reason for such low reactivity, the 
synthesis of aryl tetraenyl boronate 272 was attempted again, this time performing 
silica gel chromatography on each of the boronate intermediates, but still leaving the 
iodides crude (Scheme 61). The boronate intermediates proved stable to silica gel 
chromatography, and their purification resulted in improved iododeboronation. 
Despite this, the boronates were still prone to streaking, and yield was still lost. Even 
with columns, the overall yield was improved from 5% to 9%, increasing to an 
average of 67% per step. 
210 
* 
* 
* 
* * * 
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Scheme 61 Improved yields to aryl tetraenyl boronate 272 
 
It was noted that the yields appeared to drop off as the length of the polyene 
chain increased. Aryl trienyl iodide 274 appeared unstable even at room temperature 
in the dark, where the colour changed from bright yellow to murky brown within two 
hours. The final SM was attempted again on a larger scale than done previously 
(Equation 27). 
 
 
 
 
 
 
 
This was the first time that ‘clean’ building blocks had been used in this final 
SM coupling. Following on from the suspicion that the temperature in this reaction 
was too high for natural product 210, the reaction was closely monitored for 
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consumption of starting material. It was noted that the reaction mixture turned dark 
brown almost instantly on heating. After 2 hours it appeared that tetraenyl iodide 263 
had all been consumed. The crude ASAP spectrum showed a peak at the correct 
mass, but the sample was too weak in intensity to obtain accurate mass. 
1
H NMR analysis of the crude reaction mixture did not show quantifiable 
amounts of MB xanthomonadin 210. It did, however, show complete consumption of 
tetraenyl iodide 263, with a large amount of unreacted aryl tetraenyl boronate 272. It 
seemed at this point that the heat was causing decomposition of the iodide and, as a 
result, reoptimisation of the final SM coupling (and HM couplings) was undertaken 
as detailed in Sections 1.2 and 1.3. Alongside this, a small amount of aryl tetraenyl 
boronate 272 was recovered from the crude reaction mixture and this was put into a 
test reaction at a lower temperature of 40 
o
C overnight (Equation 28). 
1
H NMR 
analysis showed peaks in the same places as observed previously, when low 
resolution mass spectrometry indicated potential formation of the natural product. 
The TLC of the crude reaction mixture was complicated; several spots were 
observed, with more than one spot both showing activity under long wave UV and 
also having a yellow colour. 
The original isolation of xanthomonadin 208 involved its precipitation from 
chloroform with petroleum ether, and it was decided to attempt this method of 
purification from the crude reaction mixture.
151
 In addition, purification of pigment 
mixtures was undertaken using benzene as the eluent for silica gel chromatography. 
TLC performed on the crude mixture showed a greatly improved separation, better 
than had been seen before with any other solvent system. Precipitation from CDCl3 
with 40-60 °C petroleum ether at 0
 
°C gave a red solid which only gave two spots 
under UV, one very bright under long wave UV and colourless, and another less 
strong, but bright yellow. 
1
H NMR analysis of this solid showed that the vast 
majority of this solid was Pd(PPh3)4, but a small proportion was a highly conjugated 
polyenyl product, with was confirmed by accurate mass to be monobrominated 
xanthomonadin. The yield was estimated to be extremely low, at around 2%. 
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The synthesis of aryl tetraenyl boronate 272 was scaled up and a much larger 
scale cross coupling was attempted to access monobrominated xanthomonadin 210. 
Unfortunately no obvious reactivity was seen, with both iodide 263 and boronate 272 
remaining untouched in the reaction mixture. Heating to 50 
o
C resulted in the 
expected decomposition of some of the tetraenyl iodide 263, but again no obvious 
increase in reactivity. Addition of more catalyst did not result in any increased 
reactivity either. 
What tetraenyl boronate 272 could be salvaged was recovered by 
chromatography and two small scale reactions put on in an attempt to increase the 
proportion of natural product formed, one using the same conditions as before and 
one using the same conditions, but with a 3:1 ratio of DME to water. An increased 
peak at δ 5.1 ppm was seen in the 1H NMR spectrum for the reaction containing 
water, but nothing could be easily concluded from the reactions. 
Pentaenyl analogue 234 was synthesised in a 42% yield, at a lower 
temperature of 40 
o
C (Equation 29). Reactivity was better than this, going to 
completion, but yield was sacrificed in trying to obtain purer product. 
 
A SM reaction was also attempted using the room temperature conditions 
identified in Section 1.2, using palladium(II) acetate, triphenyl phosphine and 
silver(I) carbonate in acetonitrile (Equation 30). This reaction also went to 
completion, with pure product being obtained after silica gel chromatography with 
benzene (81% estimated yield from 
1
H NMR). 
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In light of this, the synthesis of monobrominated xanthomonadin 210 was 
attempted again, using the same room temperature conditions. Peaks corresponding 
to product 210 could be observed in the 
1
H NMR spectrum. Neutral alumina was 
selected for column chromatography following TLC trials on the crude mixture. A 
mixture of polyenyl products was obtained, amongst which a bright orange spot was 
observed under long wave UV. This appeared most easily separated by silica gel 
chromatography on TLC, so purification was attempted again. Unfortunately, the 
desired product could not be isolated from the column, suggesting that it had 
decomposed during purification. 
Scheme 62 below shows the routes used in an attempt to synthesise the 
mono- and di-brominated xanthomonadins. It would appear that the biggest obstacle 
to the synthesis of these natural products lies in their purification. 2D TLC analysis 
indicates decomposition of the polyene over time. 
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Scheme 62 Current routes to a) MB xanthomonadin 210 and b) xanthomonadin 208 
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Section 1.4.5 Summary 
Two truncated pigment analogues 234 and 235 have been successfully isolated, with 
the truncated pentaenyl xanthomonadin analogue 233 also made, but proving 
difficult to separate from the alkyne 235, formed during the final SM coupling. 
Several attempts have been made to synthesise both xanthomonadin 208 and 
debrominated xanthomonadin 210, with accurate mass spectrometry indicating 
successful formation of debrominated xanthomonadin 210. Unfortunately, the 
octaenes have proven extremely unstable and their successful isolation has been 
elusive. 
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Section 1.5 Synthesis of Xanthomonas pigments- spectroscopic 
properties 
Section 1.5.1 NMR observations and studies 
Following on from the synthesis of various polyenyl analogues and intermediates, 
the next challenge lay in their spectroscopic analysis. In their isolation of the 
Xanthomonas pigments, Andrewes et al. obtained mass spectrometry, some infrared 
and some UV-Vis analysis, but high resolution 
1
H NMR data was not available, nor 
any 
13
C data (see Figure 11 for the only NMR data reported). There were also no 
NMR spectra available for any of the pigments isolated.
133,151,154
 X-ray 
crystallography data was reported to be poor. As a result, there was not a great deal 
of spectroscopic data to use as a benchmark. 
 
Figure 11 
1
H NMR data as reported by Andrewes et al. for isobutyl xanthomonadin 
208
133
. Reprinted from Tetrahedron Letters, volume 17, Andrewes et al., Structure of 
xanthomonadin I, a novel dibrominated aryl-polyene pigment produced by the 
bacterium Xanthomonas juglandis, 4023-4024, 1976, with permission from Elsevier 
Nevertheless, the 
1
H NMR peaks reported by Andrewes et al. provided a 
good indication of the types of shifts likely to be present for our polyenyl 
compounds.
133
 Some NMR spectra were available for a series of hexaenyl pigments 
analogous to the xanthomonadins, reported by Fischbach et al., but again 
13
C NMR 
spectra were not given.
159
 These spectra did, however, confirm what we had begun to 
observe for our own compounds; that the NMR data was very complex for these 
polyenyl structures.  
Dehydro-tetraen-yne xanthomonadin 235 had been successfully made in a 
56% yield previously (Equation 31), but good 
13
C NMR data had not been acquired, 
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so assignment of 
1
H NMR signals had not been possible. The NMR sample was left 
exposed to normal light and was not degassed, to see what the effect would be 
(Figure 12). It was observed that the solution changed from bright yellow to bright 
orange and over time it was also noted that a new set of signals was visible in the 
1
H 
NMR spectrum after 1 week, at around 6% intensity. This ratio seemed essentially 
unchanged after 2 weeks. There were other signals that overlapped with those of the 
original alkynyl compound 235, but some were separate and identifiable. These new 
signals had lower coupling constants than some of those of the desired dehydro-
tetraen-yne xanthomonadin 235, suggesting isomerisation of at least one of the 
alkenes in the structure. The data is tabulated in Table 9, showing the new 
identifiable signals and their coupling constants. 
 
 
Figure 12 
1
H NMR spectra showing the change in dehydro tetraen-yne 
xanthomonadin 235 over a period of 2 weeks.  
T= 0 weeks 
T= 1 week 
T= 2 weeks 
235 
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Table 9 
1
H NMR signals and coupling constants for dehydro-tetraen-yne 
xanthomonadin 235 and minor compound 293 
Pentaenyl analogue 235 
Minor component 293 (~5%), new 
identifiable signals 
Entry δH J/ Hz  δH J/ Hz 
1 - -  5.72 (1H, d) 11.2 
2 - -  5.74-5.79 (1H, m) - 
3 5.91 (2H, dd) 15.3, 6.1  - - 
4 - -  6.21 (1H, t) 11.5 
5 6.29-6.54 (3H, m) -  - - 
6 6.60 (1H, dd) 14.8, 10.5  - - 
7 6.75 (1H, dd) 15.4, 10.4  - - 
8 6.89-6.99 (2H, m) -  - - 
9 7.28-7.39 (1H, m) -  - - 
10 7.49 (1H, dd) 11.4, 8.3  - - 
11 - -  7.78 (1H, d) 12.4 
12 - -  7.82 (1H, d) 12.0 
 
In order to shed more light on which bonds might be isomerising, another 
sample was made in order to obtain 
13
C NMR and 2D NMR data, so that the carbons 
and protons in the molecule could be assigned. The 
1
H NMR spectrum possessed a 
number of complex multiplets, so the coupling constants for all of the protons could 
not be easily determined. The signals have, however, been assigned below. This 
information, combined with that in Table 9 above, suggests that the bond 
isomerising is most likely to be the one adjacent to the ester, or that adjacent to the 
alkyne. 
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Synthesis of pentaenyl xanthomonadin 233 was attempted using the 
Pd(PPh3)4/ silver(I) oxide conditions previously determined (Equation 32). NMR 
and accurate mass analysis was performed on the purified product. Mass 
spectrometry clearly identified the desired compound, which looked exceptionally 
clean with only two major mass ions (one for the dibrominated pentaene 233, and 
one for the loss of bromine). 
 
However, the NMR data was more complicated (Figure 13). The sample 
contained two major products; the desired pentaenyl xanthomonadin 233 (27%) and 
dehydro-tetraen-yne xanthomonadin 235 (69%), accounting for the two mass ion 
peaks observed.  The 
1
H NMR spectrum also showed signals similar to those found 
for dehydro-tetraen-yne xanthomonadin 235 after a week of exposure to light (4%) 
(Figure 13a). There were several singlets in the regions corresponding to the methyl 
ester and aryl methoxy groups, suggesting the presence of a number of compounds 
possessing these groups. The 
13
C NMR spectrum showed a large number of signals, 
forming clusters at different shifts (Figure 13b). The HSQC looked fairly simple, 
but again the HMBC was complicated, showing that a number of different 
compounds were present, despite being one spot on TLC and having a clean mass 
spectrum (Figure 13c and d). At this point it was not clear whether this complexity 
arose from impurities in the sample, or from isomers of the natural product analogue, 
as the clustering of methyl peaks in the 
1
H NMR spectrum and of the signals in the 
13
C NMR spectrum indicated that a number of the compounds were similar. DOSY 
NMR analysis was undertaken to try to correlate the signals with a diffusion 
coefficient (Figure 13e).  
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O 
Br 
O 
O Br 
233 
* * 
* 
* 
* * * 
*
 signals corresponding to 233 
b) Clustering of peaks in the 
13
C NMR spectrum 
a) 
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c) Complex HMBC spectrum 
d) Less complex HSQC spectrum 
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Figure 13a) 
1
H NMR, b) 
13
C NMR, c) HMBC 2D NMR, d) HSQC 2D NMR and e) 
DOSY NMR spectra for dibrominated pentaenyl analogue 233 
The DOSY NMR spectrum showed that the majority of alkenyl signals 
formed a cluster at a similar diffusion coefficient, which was consistent with the 
mass spectrum in suggesting that many of the different signals corresponded to 
compounds of a high level of structural similarity. There were also, a number of 
signals that did not correlate with this diffusion coefficient, indicating that some of 
the polyenyl species present were not isomers of the desired natural product 
analogue. The 
1
H NMR data is shown in Table 9, showing that the signals for the 
most identifiable minor component(s) differed in a similar way to those of dehydro-
tetraen-yne xanthomonadin 235, with the most shifted signals displaying cis-type J 
couplings of the order of 8-10.5 Hz. 
 
 
e) DOSY spectrum 
Majority of 
signals at 
similar Dc 
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Table 10 
1
H NMR signals and coupling constants for pentaenyl analogue 233 and 
minor compound(s) 
Pentaenyl xanthomonadin 233 
Minor component(s) (~4% total mixture, 
15% compared to pentaenyl xanthomonadin 
233), new identifiable signals 
Entry δH J/ Hz  δH J/ Hz 
1 - -  5.74 (1H, d) 10.5 
2 5.91 (2H, dd) 
15.4, 
10.4 
 - - 
3 - -  6.04 (1H, dd) 15.5, 10.0 
4 6.35-6.50 (3H, m) -  - - 
5 6.56-6.67 (2H, m) -  - - 
6 6.70-6.77 (1H, m) -  - - 
7 6.87-6.98 (2H, m) -  - - 
8 7.03-7.15 (1H, m) -  - - 
9 - -  7.40 (1H, dd) 8.1, 1.9 
10 7.44-7.51 (1H, dd) -  - - 
11 - -  7.64 (1H, d) 8.1 
 
The same thing was observed for debrominated pentaenyl xanthomonadin 
234, where the compound was also one spot on TLC, displayed a clean mass 
spectrum and yet had complex NMR spectra (Figure 14, Equation 33). 
Unfortunately, the multiplets for this compound were not as well resolved, so it was 
harder to make a comparison. Some less easy to identify peaks are omitted from the 
table, but it is still possible to see cis alkenyl couplings in similar places as observed 
for dibrominated pentaenyl analogue 233, again of the order of 8-10.5 Hz (Table 
11). 
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Figure 14a) 
1
H NMR and b) 
13
C NMR spectra for debrominated pentaenyl 
xanthomonadin 234 
 
 
 
a) 
b) Clustering of peaks in the 
13
C NMR spectrum 
O 
Br 
O 
O 
234 * signals corresponding to 234 
* 
* 
* 
* 
* 
* 
* 
* 
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Table 11 
1
H NMR signals and coupling constants for debrominated pentaenyl 
xanthomonadin 234 and minor compound(s) 
Debrominated pentaenyl xanthomonadin 234 
Minor component(s) (~11%), new 
identifiable signals 
Entry δH J/ Hz  δH J/ Hz 
1 - -  5.74 (1H, d) 10.5 
2 5.97-5.97 (2H, m) 
15.4, 
10.4 
 - - 
3 6.35-6.53 (3H, m) -  - - 
4 6.63 (1H, dd) 
11.8, 
2.7 
 - - 
5 6.87-6.94 (4H, m) -  - - 
6 7.29-7.35 (1H, m) -  - - 
7 7.44-7.51 (2H, m) -  - - 
8 - -  7.64 (1H, d) 8.1 
9 - -  7.74 (1H, d) 7.9 
 
The lack of stability for debrominated pentaenyl xanthomonadin 234 was of 
particular note. When illuminated by long wave UV, a spot on TLC corresponding to 
product shone bright orange, being clearly visible and fluorescent. This spot visibly 
faded, to the point of no longer being visible after around 15 minutes on the TLC 
plates. 
The new signals for both the mono- and dibrominated pentaenes showed a 
good deal of similarity and, if the shifts for the pentaenes are analogous to those of 
the alkynyl derivative, suggesting that the bond isomerising in the most identifiable 
minor component could be the one next to the ester. 
Whilst these NMR studies provided evidence that many of the complex 
signals observed corresponded to isomers, it could be seen from the DOSY NMR in 
particular that there were indeed some signals corresponding to polyenes of a 
different molecular weight, indicating that the current purification conditions were 
not effectively separating mixtures of polyenes. This proved a key discovery, and led 
to the use of benzene as a column chromatography solvent (see Section 1.4). 
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Polyenyl intermediates also displayed complex NMR spectra. The 
1
H NMR 
spectrum for tetraenyl iodide 263 after column chromatography showed a number of 
peaks in the area corresponding to the methyl ester, as were observed for the natural 
product analogues. In this case, there were two distinct spots visible on the TLC, 
both visible in the long wave UV. One spot was, however, blue whilst another was 
white. Previously, extensive NMR analysis was not undertaken due to the presumed 
instability of the compound at room temperature. In light of the NMR studies 
undertaken on the natural products, it was decided to run a number of NMR 
experiments to study the compound’s behaviour over time. 1H NMR experiments 
were run in between the longer 2D and 
13
C experiments to observe any changes in 
the signals over these few hours (Figure 15a). An increasing level of complexity 
was visible over time, with some signals increasing and others changing in 
multiplicity. In Section 1.3, a study was performed on tetraenyl iodide 263 to 
ascertain the effect of temperature on its stability. The peaks observed due to 
decomposition were different to those observed to be increasing or changing in this 
case. It was not possible to quantify all of the peaks due to the complexity of the 
spectrum, but two signals were observed to be clearly increasing at δ 6.64 and 6.80 
ppm. The integrations of these were compared to the integration of a peak 
corresponding to tetraenyl iodide 263 that did not change over time (Table 12). In 
the space of a few hours, the relative integration of these peaks quadrupled, 
eventually being observed at an equivalent integration to the tetraenyl iodide itself. 
The 
13
C NMR also showed clustering, as was observed before for the truncated 
pentaenyl analogues (Figure 15a). 2D HSQC and HMBC experiments were done to 
try to correlate the clusters with specific proton signals. This showed that they are 
indeed clusters corresponding to individual multiplets. DOSY analysis was not 
undertaken for this sample, so these signals were not correlated to a particular 
diffusion coefficient. 
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Table 12 Table showing the change in selected signals for a possible isomer of 
tetraenyl iodide 263 over a period of a few hours through 
1
H NMR spectra run at 
intervals 
Entry 
Relative 
1
H NMR integral to 
δ 6.29 ppm (m @ 6.64 ppm) 
Relative 
1
H NMR integral to 
δ 6.29 ppm (m @ 6.80 ppm) 
1 0.25 0.29 
2 0.23 0.28 
3 0.58 0.56 
4 1.00 0.99 
5 1.01 1.01 
6 0.99 0.99 
 
 
a) 
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Figure 15a) Stacked 
1
H NMR spectra for tetraenyl iodide 263, showing change over 
time and b) 
13
C NMR spectrum for tetraenyl iodide 263 
After storing all three pentaenyl natural product analogues 233-235 for two 
months, 
1
H NMR spectra were compared (Figure16-Figure 18). The compounds 
were stored in the dark, under argon, and at -18 
o
C.  
 
 
 
 
 
 
 
 
 
b) 
263 
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Figure 16 
1
H NMR spectra for dehydro-tetraen-yne xanthomonadin 235, indicating 
stability over 2 months 
 
T=0 
T= 2 months 
O 
Br 
O 
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Figure 17 
1
H NMR spectra for dibrominated pentaenyl analogue 233, indicating 
stability over 2 months 
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Figure 18 
1
H NMR spectrum for debrominated pentaenyl xanthomonadin 234, 
indicating stability over 2 months 
 
T= 2 months 
T=0 
O 
Br 
O 
O 
234 
149 
 
Debrominated pentaenyl xanthomonadin 234 appeared to be the least stable, 
with the most changes visible on comparison of the spectra. There were some small 
differences between the spectra for brominated analogue 233, but this analogue did 
appear to be more stable than 234, suggesting an explanation for dibrominated 
xanthomonadin being the most observed pigment in Xanthomonas bacteria. The 
resolution was poor for the 
1
H NMR spectrum obtained for dehydro tetraen-yne 
xanthomonadin 235 after two months, but it can be seen that the two spectra are very 
similar (Figure 16).  
Debrominated pentaenyl xanthomonadin 234 was re-isolated as a bright 
yellow solid that clearly fluoresced under normal lighting, using new conditions for 
column chromatography. Using benzene as an eluent proved highly successful, with 
debrominated pentaenyl xanthomonadin 234 observed as a single spot that shone 
brine orange under long wave UV. Dehydro tetraen-yne xanthomonadin 235 slowly 
turned from custard yellow to orange over time at room temperature (particularly if 
dissolved and then concentrated again in vacuo), but no colour change was observed 
for debrominated pentaenyl xanthomonadin 234.  
The behaviour of debrominated pentaenyl xanthomonadin 234 in solution 
was investigated in the same way as for tetraenyl iodide 263, with 
1
H NMR spectra 
run periodically in between 2D experiments overnight. No change in the sample was 
observed in this time, as shown by Figure 19 and Table 13. 
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Figure 19 Stacked 
1
H NMR spectra for debrominated pentaenyl xanthomonadin 
234, showing stability overnight. 
Table 13 Table showing the change in selected signals for a possible isomer of 
debrominated pentaenyl xanthomonadin 234 over a period of a few hours through 
1
H 
NMR spectra run at intervals 
Entry 
Relative 
1
H NMR integral to 
δ 5.88 ppm (m @ 7.51 ppm) 
1 0.26 
2 0.30 
3 0.26 
4 0.27 
5 0.26 
 
It was immediately noticeable that all of the NMR spectra were much less 
complex than those obtained previously for debrominated pentaenyl xanthomonadin 
234 (Figure 20, c.f. Figure 14). The HMBC still displayed considerable complexity, 
and smaller peaks corresponding to a potential isomer were visible in the 
1
H NMR. 
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Figure 20a) HSQC 2D NMR b) HMBC 2D NMR and c) 
13
C NMR spectra for a 
sample of debrominated pentaenyl xanthomonadin 234, isolated using benzene 
Unfortunately, not enough sample was obtained to ascertain the stability of 
compound 234 over a longer period, as was investigated for dehydro-tetraen-yne 
xanthomonadin 235 (Figure 12).  However, these data indicated that benzene was a 
much more effective solvent for purification of these pigment analogues, as well as 
showing that there is still a considerable degree of complexity for the pure 
compounds. 
Section 1.5.2 UV-Vis and fluorescence data  
Andrewes et al. reported both UV-Vis data for mixtures of pigments that they 
initially isolated from Xanthomonas bacteria, and also data from their isolated 
sample of isobutyl xanthomonadin 208, with the the values for isobutyl 
xanthomonadin 208 given in Table 14.
151
 No fluorescence data was reported. 
  
 
 
c) 
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UV-Vis and fluorescence data was obtained for both dehydro tetraen-yne 
xanthomonadin 235 and the debrominated pentaenyl xanthomonadin 234, and their 
UV-Vis values compared to that of isobutyl xanthomonadin 208 (Table 14). The 
shapes of the UV-Vis curves were comparable to those reported by Andrewes et al., 
as shown in Figure 21.
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Figure 21 UV-Vis spectra obtained for dehydro tetraen-yne xanthomonadin 235 and 
debrominated pentaenyl xanthomonadin 234 
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Table 14 UV-Vis and fluorescence data for isobutyl xanthomonadin 208, along with 
dehydro-tetraen-yne xanthomonadin 235 and debrominated pentaenyl 
xanthomonadin 234 
a
Data reported by Andrewes et al.
151  
b
This work 
The UV-Vis absorption maxima for the two truncated analogues were lower 
than those of isobutyl xanthomonadin, appearing to be consistent with lower 
conjugation. Debrominated pentaenyl xanthomonadin 234 showed a noticeable red 
shift when compared to dehydro-tetraen-yne xanthomonadin 235, again seeming to 
be consistent with the increased conjugation of the pentaene.  Debrominated 
pentaenyl xanthomonadin 234 also showed an increased Stokes-shift when compared 
to dehydro-tetraen-yne xanthomonadin 235. In order to establish the trend in UV-Vis 
absorption maxima more definitively, the expected λmax values for dehydro tetraen-
yne xanthomonadin 235 and debrominated pentaenyl xanthomonadin 234 were 
calculated using the polyene specific Fieser-Kuhn rules,
177
 following Equation 34, 
with the results shown in Table 15. The expected λmax value for xanthomonadin was 
also calculated. 
 
Compound 
UV-Vis 
absorption/ nm 
Emission/ nm 
 
453, 482
a 
- 
 
370, 391
b 
440, 468, 494
b 
 
397, 417
b 
498,527, 566, 
594
b 
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𝜆𝑚𝑎𝑥 = 114 + 5𝑀 + 𝑛(48.0 − 1.7𝑛) − 16.5𝑅𝑒𝑛𝑑𝑜 − 10𝑅𝑒𝑥𝑜           (𝟑𝟒) 
Where n = the number of conjugated double bonds 
           M = the number of alkyl or alkyl-like substituents 
           Rendo = the number of rings with endocyclic double bonds 
           Rexo = the number of rings with exocyclic double bonds 
The solvent was also corrected for, subtracting 7 nm for diethyl ether and 1 nm for 
chloroform, to allow for a direct comparison.
177
 
Table 15 Calculated and observed values of λmax, for isobutyl xanthomonadin, 
dehydro-tetraen-yne xanthomonadin 235 and debrominated pentaenyl 
xanthomonadin 234 
 
 It can be seen in Table 15 that the calculated λmax values for dehydro tetraen-
yne xanthomonadin 235 and debrominated pentaenyl xanthomonadin 234 correspond 
almost identically to the highest energy λmax observed for each of these two 
molecules, providing further evidence of the successful construction of these 
polyenes. They also corroborate the 
1
H NMR data, due to the presence of a lower 
energy λmax that could be explained by a cis-trans isomerisation of one of the alkenes 
in the structures.  It would be expected that the cis isomer would also display a lower 
Compound 𝜆𝑚𝑎𝑥
𝑐𝑎𝑙𝑐 / nm 𝜆𝑚𝑎𝑥
𝑜𝑏𝑠 / nm 
 
459.2 453 (chloroform)
151
 
 
392.2 391 (diethyl ether) 
 
417.3 417 (chloroform) 
156 
 
absorption coefficient, which is not observed here. It could well be the case that 
majority of molecules in solution during the UV-Vis experiments are in fact the cis 
isomerised molecules. The calculated λmax value for isobutyl xanthomonadin 
corresponds with the lower energy λmax value observed by Andrewes and Starr,
151
 
though with a larger discrepancy between the values of 6.2 nm. Molecular distortion 
is known to have an effect on the value of λmax.
177
 The crystal structure obtained for 
brominated styrenyl Bpin does show a considerable distortion of the mo1ecule due 
to the alkenyl bromine atom, removing the planarity.  
Calculation of the expected λmax value for dehydro tetraen-yne 
xanthomonadin 235 gave an interesting insight into the contribution of the alkyne 
group to the overall photochemical behaviour of the molecule. Within the group, we 
have previously assumed that an alkyne moiety will contribute directly to the λmax 
value for a given compound, increasing the value in a similar way to a conjugated 
double bond. However, treating the alkyne as a conjugated double bond and allowing 
it to be accounted for in the value of n (see Equation 34), gave a value of 411.3 nm 
for diethyl ether, which is higher than the observed value. Assuming that the alkyne 
does not contribute at all, and treating the arene and tetraene ester as separate 
functionalities on the molecule would mean that the highest number of conjugated 
double bonds is 5, which gives a value of 314.5 nm for λmax; a value that is far too 
low. Making the assumption that the alkyne does not contribute directly to λmax, but 
does allow the conjugation to continue throughout the molecule, gives the much 
more accurate value seen in Table 15.  
Section 1.5.3 Summary 
There was limited spectroscopic data in the literature for xanthomonadin 208, with 
particularly poor NMR data available. There was also little reported on the behaviour 
of isolated Xanthomonas pigments. A series of NMR experiments provided evidence 
of another isomer formed by cis-trans isomerisation, with assignment of the NMR 
signals providing some insight into which alkene along the polyene structure might 
the one isomerising. The 
1
H NMR signals also correlate well with those reported for 
isobutyl xanthomonadin 208 by Andrewes et al., with the characteristic peaks at δ ~ 
5.9 and 6.8 ppm observed, along with the remainder of the polyenyl signals occuring 
between δ 6.3 and 7 ppm.133  
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In addition UV-Vis data has shown good correlation both with the data 
measured by Andrewes et al. for a mixture of xanthomonadin 208 and debrominated 
xanthomonadin 210, but also with the calculated values for their principal λmax 
according to the Fieser-Kuhn rules.
151,177
 A second λmax at a lower wavelength 
provides evidence of a cis-trans isomerisation. In addition, some insight into the 
contribution of an alkyne functional group to the photochemical behaviour of a 
molecule has been gained.  
These data collectively provide sound evidence that the data obtained by 
Andrewes et al. is accurate, that the compounds made are in fact conjugated pigment 
natural product analogues, and that they form one major isomer via cis-trans 
isomerisation.
133,151
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Section 2    
Novel methods of polyene synthesis 
 
 
 
 
 
 
  
160 
 
 
  
161 
 
Section 2.1 Use of vinyl iodide as a Heck-Mizoroki coupling partner 
Whilst there are strategies by which polyenes can be synthesised,
178–182
 new, robust 
and reliable protocols, which deliver both high yields and stereocontrol are still 
required. Terminal, unsubstituted polyenes have been accessed by hydrazone 
formation, elimination and metal-mediated couplings,
183–189
 however, such methods 
are limited by substrate scope and stereoselectivity. The current methodology used 
within the group to effect formation of polyenes utilises an iterative 
HM/iododeboronation sequence, with vinylboronic acid pentanediol ester 42 as the 
alkene donor (Scheme 63).
30,31,160–162,164–166
 Such methodology is topical in the 
literature, with variations on both the type of palladium reaction and on the 
functional group converted to yield the vinyl iodide being reported.
190
  
Scheme 63 HM/iododeboronation methodology used within the group. 
 
 
 
 
 
 
 
 A method to facilitate the elongation of a polyene chain in one step using a 
palladium catalyst seems not to have been described. It was considered that if the 
reactivity was in effect switched round, with the growing polyene chain used as the 
alkene donor and the alkene acceptor being simply vinyl iodide 269, then polyene 
homologation in this manner could be achieved (Equation 35). In addition, the need 
to isolate an unstable vinyl iodide compound would be removed.  
 
 
 The use of vinyl iodide as a Heck-Mizoroki coupling partner seems to have 
162 
 
been overlooked, with only one use of it disclosed in the literature by Heck, where 
the reaction between vinyl iodide and methyl acrylate using 1 mol% Pd(OAc)2, 2 
mol% PPh3 and Et3N at 100 C resulted in a Diels-Alder product instead of the 
desired diene.
191
 Due to the possiblility of extensive applications of these types of 
polyene boronate species, the initial reactions undertaken to establish the success of 
vinyl iodide 269 as a HM coupling partner were performed using vinyl boronate 
ester 42.  
Section 2.1.1 Optimisation of Heck-Mizoroki coupling to form 2-[(1E)-
buta-1,3-dien-1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane 
The first attempt at diene formation used 50 mol% of palladium(II) acetate with no 
ligand or base and three equivalents of boronate 42 with respect to vinyl iodide 269, 
using acetonitrile as the solvent (Equation 36). After 2 days 2-[(1E)-buta-1,3-dien-
1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane 276 was isolated in a 78% yield with 
approximately 90% purity, giving an approximate 68% yield.  
 
 
 
 Diene 276 formation was attempted again, using 5 mol% of palladium(II) 
acetate and 1.3 equivalents of boronate 42. All other conditions remained the same 
as the previous reaction (Equation 37). A low crude mass recovery of 73% was 
obtained after work up, with less than 5% product formation evident from the crude 
1
H NMR. These conditions were also used in an attempt to form the triene from a 
sample of diene 276 already isolated. No signals that could be ascribed to product 
could be observed in the 
1
H NMR spectrum. 
 
 
 
 This result raised the question as to how the reaction is progressing, be it 
stoichiometrically or catalytically. In order to investigate the possibility of obtaining 
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a successful catalytic reaction, it was decided to screen for appropriate ligands and 
bases, in the hope that a combination could be found that could yield a satisfactory 
yield of diene 276, especially at low catalyst loadings. A slightly higher, though still 
catalytic, loading of 10 mol% palladium(II) acetate was chosen, along with generic 
conditions of 1.3 equivalents boronate 42, 1.2 equivalents base and 1 equivalent 
bidentate ligand or 2 equivalents monodentate ligand with respect to catalyst. Two 
bases were chosen i.e silver acetate (this base was currently used within the group to 
achieve HM couplings) and triethylamine (an example of a standard amine base). 
The three ligands chosen were triphenylphosphine, tri(o-tolyl)phosphine (these 
ligands were currently used within the group) and the bidentate 1,1’-
bis(diphenylphosphino)ferrocene (dppf). Naphthalene (0.1 equivalents) with respect 
to vinyl iodide 269 was also added as an internal reference to allow calculation of 
conversion from 1H NMR spectra. The reactions were stirred vigorously at 50 °C for 
3 days and investigated by 
1
H NMR (Table 16, Equation 38). 
 The best conditions were clearly identifiable as those involving silver(I) acetate 
as the base (Table 16, Entries 5-8), with the highest conversion of 52% seen where 
tri(o-tolyl)phosphine was used as the ligand (Table 16, Entry 7). Use of 
triethylamine (Table 16, Entries 9-12) yielded no product, and minimal product 
formation occurred where there was no base (Table 16, Entries 1-4). Use of the 
dppf ligand (Table 16, Entries 4 and 8) seemed to result in lower product 
conversions. Further analysis of the spectra revealed that the starting materials were 
not being exclusively converted to product. It seemed that a large amount of the 
vinyl iodide 5 was being consumed in another side-reaction in addition to the desired 
HM coupling. This is evident from the crude 
1
H NMR spectrum of Entry 7, where 
complete vinyl iodide consumption had occurred despite only 52% conversion to 
diene 276 (Figure 22).  
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Table 16 Determining optimal reaction conditions for formation of diene 276 
 
Entry Base Ligand Approx. conversion/ % 
1 - - 4 
2 - PPh3 2 
3 - P(o-tol)3 1 
4 - dppf <1 
5 AgOAc - 42 
6 AgOAc PPh3 30
a 
7 AgOAc P(o-tol)3 52 
8 AgOAc dppf 20
a 
9 Et3N - - 
10 Et3N PPh3 - 
11 Et3N P(o-tol)3 -
b 
12 Et3N dppf -
c 
a 
Complex 
1
H NMR spectra may have rendered these estimates less accurate due to 
overlapping peaks. 
b 1
H NMR too complex to accurately estimate product conversion. 
c 1
H NMR highly complex, but no product signals present. 
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Figure 22 Crude 
1
H NMR spectrum (Table 16, Entry 7) highlighting the 
consumption of vinyl iodide 269. Vinyl iodide gives signals of a doublet of doublets 
at δ 6.22 ppm and a multiplet between δ 6.43 and 6.58 ppm. 
 Our attention was then turned to the optimization of the conditions identified 
above. In order to determine whether or not the reaction was stalling, the reaction 
was repeated and monitored by gas chromatography (GC) to analyse its progression, 
with the results summarised in Figure 23. This indicated that the reaction initially 
progresses rapidly and then stalls. Addition of one further equivalent vinyl iodide at 
22 hours, along with a further 5 mol% palladium(II) acetate addition at 27 hours did 
not seem to make much difference to the reaction, which continued to progress 
slowly. 
 
 
Absence of vinyl 
iodide peaks 
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Figure 23 Graph showing diene 276:vinyl boronate 42  ratio over time. 
 The lower ratios at 22 and 28.5 hours suggest that the reaction almost reached 
completion, but these appear to be anomalous as the final ratio of 0.39 agrees with 
the crude 
1
H HMR obtained after 30.5 hours. When combined with the crude 
1
H 
HMR data, the GC data suggest that the reaction stalled at between 60 and 70% 
completion, with addition of further catalyst and vinyl iodide having no effect. A 
number of theories to explain why the reaction tended to stall were investigated (e.g. 
loss of vinyl iodide, catalyst turnover, base equivalents etc.). The loss of vinyl iodide 
269 during the course of the reaction needed to be addressed, although Figure 22 
shows that addition of vinyl iodide at 22 hours did not increase product formation. 
Vinyl iodide 269 was stirred at room temperature with silver(I) acetate for several 
days to ascertain whether it was reacting with the base, but no reaction was observed. 
In order to establish whether or not vinyl iodide 269 was capable of undergoing a 
HM coupling with itself, a HM coupling using the 5 mol% Pd(OAc)2, 10 mol% P(o-
tol)3, 1.2 equivalents AgOAc and only vinyl iodide 269 was set up. Crude 
1
H NMR 
analysis showed small peaks, which had been previously observed for the previous 
HM couplings, but not with a larger integral to those previously observed. The 
doublets of doublets at δ 4.50, 4.80 and 7.17 were identified as vinyl acetate. The 
vinyl iodide remained largely untouched and no dienyl signals were observed 
(Figure 24). 
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Figure 24 Crude 
1
H NMR spectrum, showing the unreactivity of vinyl iodide 269 
towards itself under HM conditions. 
 It was later noted that the suba seal placed into the top of the Schlenk flask 
expanded considerably during the course of these reactions, suggesting that the cause 
of vinyl iodide disappearance was its absorption by this seal.  
 A number of screens were undertaken in an attempt to optimise the reaction to 
form diene 276. The optimal ratio of vinyl boronate 42 to vinyl iodide 269 was 
investigated (Table 17). Use of 1.2 equivalents of 42 resulted in a significant 
increase in conversion (Table 17, Entry 4) from 43 to 69%. The reaction, however, 
did not go to completion. Purification of diene 276 to this point had proven difficult, 
with complete removal of the vinyl boronate starting material 42 and ligand having 
not been achieved. Furthermore, diene 276 proved susceptible to polymerization on 
silica. This resulted in a considerable loss of yield in cases where extra care had to be 
taken in an attempt to remove as many of the unwanted compounds from diene 276 
as possible. Vinyl boronate 42 proved by far the most difficult to remove, being 
extremely similar in polarity, and thus optimizing the reaction conditions to give 
100% consumption of vinyl boronate seemed essential. This meant that conditions 
needed to be found that achieved 100% conversion, with a 1:1 ratio of vinyl boronate 
42 to vinyl iodide 269. 
Vinyl iodide signals 
Absence of dienyl peaks 
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Table 17 Determining optimal starting material ratios for formation of diene 276 
 
Entry Equivalents 42 added wrt vinyl iodide 269 Approx. conversion / % 
1 0.8 44 
2 1 43 
3 1.1 50 
4 1.2 69 
Product formation monitored by 
1
H NMR. Ratios estimated using integrals from 
crude 
1
H NMR spectra. 
 A catalyst screen was then undertaken (Table 18, Equation 40). None of the 
catalysts investigated resulted in an increased yield. It was noted that palladium(II) 
chloride and palladium(II) bromide gave comparable yields, and also resulted in less 
vinyl acetate formation as determined by 
1
H NMR (Table 18, Entries 5 and 6). 
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Table 18 Results of catalyst screen for the reaction of iodide 269 and boronate 42 
 
 
Entry Catalyst used Conversion to 276 after 17 h/ % 
1 Pd(OAc)2 55 
2 Pd(dba)2 35 
3 Pd(dppf)Cl2 47 
4 Pd(PPh3)2Cl2 25 
5 PdCl2 50 
6 PdBr2 50 
7 PdI2 40 
Product formation monitored by GC, using naphthalene as internal standard. 
 The effect of base loading on the rate of reaction was then investigated (Table 
19, Equation 41). The relationship between base loading and both the mmol 
concentrations of vinyl boronate 42 and desired diene 276 is shown in Figure 25. It 
shows that an increase in base concentration resulted in an increase in diene 
formation, beginning to plateau out after 1.5 equivalents of silver(I) acetate. 
Formation of diene 276 reached a peak at 1.8 equivalents of base. The concentration 
of vinyl boronate 42 showed a dramatic drop at this loading. This result was 
corroborated by the crude 
1
H NMR spectrum, but was presumed to be due to an error 
in vinyl boronate addition. The HM reaction mixtures were not clear solutions, but a 
grey suspension due to the poor solubility of silver(I) acetate in acetonitrile. Previous 
work done in this group suggested that competitive HI elimination from olefinic 
iodides could be a competing issue in palladium cross-coupling reactions with 
alkenyl and polyenyl iodides.
192
 Being highly iodophilic, the silver cation is 
presumed to strip the palladium complex of chelated iodine, helping cycle turnover 
and therefore facilitating cross-coupling before elimination can take place. This 
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suggests that the improvement in reactivity could be due to either an increase in 
accessibility to either the silver, or the acetate, or both.  In order to establish whether 
the increase in diene formation was due to an increase in silver cations or due to an 
increase in acetate anions, a HM coupling was undertaken using 1 equivalent of 
silver(I) acetate and 0.8 equivalents of a more organic-soluble acetate source, 
tetrabutylammonium acetate. The crude 
1
H NMR after 17 hours indicates the 
presence of numerous compounds, but not diene 276. It was therefore concluded that 
the increase in reaction as observed in the base loading screen (Table 19, Figure 25) 
was due to the increase in accessible silver cation concentration as opposed to 
acetate anion concentration. 
Table 19 The effect of base loading on the reaction between 42 and 269 
 
Entry 
Equivalents base 
used 
Diene 276 concentration 
after 24 h/ mmol 
Vinyl boronate 42 
concentration after 24 h/ 
mmol 
1 1 0.268 0.496 
2 1.2 0.336 0.298 
3 1.5 0.458 0.309 
4 1.8 0.513 0.096 
5 2 0.510 0.252 
Product formation monitored by GC, using naphthalene as internal standard. 
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A number of different dilutions were tried to see if this would have an effect on 
the amount of silver accessible for reaction. None of these had any measurable effect 
on product formation. The reaction was attempted at reflux and under these 
conditions, the reaction still stalled, only at a faster rate. It was eventually found that 
undertaking the reaction in a round bottom flask gave a dramatically increased 
completion of 85% after 24 hours. This is a result that was repeated consistently and 
is presumed to be due to the more vigorous stirring that could be achieved when 
using a round bottomed flask. Diene 276 has since been isolated in yields of up to 
73%, which has been assessed as an adequate yield to progress on with despite the 
need for further optimisation. To mitigate the tendency of 276 to polymerise on 
purification, ca. 3 ppm of 2,6-di-tert-butyl-4-methyl phenol (BHT) was employed in 
eluents. Also, prolonged air exposure of the dienes resulted in polymerisation, hence, 
storage under argon at approx. 4 °C was required with 20 ppm BHT. 
Section 2.1.2 Expanding substrate scope 
Vinyl iodide 269 was also investigated as an HM coupling partner for a number of 
other alkenyl substrates (Table 20, Equation 42).
173
 It was originally believed that 
electron deficient alkenes would react most effectively based on the assumption that 
Figure 25  Graph showing the effect of base loading on the mmol concentration of vinyl 
boronate 42 and diene 276 
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this HM coupling was progressing via an electron-rich Michael-type palladium 
intermediate (Scheme 64).
193
 This mechanism involves addition of the electrons 
from the bond formed between the alkene donor and palladium to the alkene 
acceptor, with the end result being a migratory insertion of the donor onto the 
acceptor. Palladium activation of the alkene acceptor can play a part in this process if 
there are electron withdrawing groups coordinated to the palladium at this part, but 
the best reactivity will be observed with an electron deficient terminal alkene on the 
acceptor. It would therefore be expected that the acrylates 296-299 (Table 20, 
Entries 1-4) would be the most reactive due to their good Michael acceptor 
capability and that the highly electron-rich vinyl acetate 304 (Table 20, Entry 9) 
would react poorly. 
Scheme 64 A catalytic cycle for the HM coupling, where progression of the cycle 
involves Michael-type addition onto the acceptor alkene. 
 
 Initially, alkenes 296-299, and 300-304 were all tested and, surprisingly, all 
were unreactive towards HM coupling with vinyl iodide. The most reactive was 
methyl acrylate 296 (Table 20, Entry 1), the crude 
1
H NMR of which after 36 hours 
showed an extremely poor conversion of 3%. This reaction was repeated at reflux 
and an increased, but still very poor conversion of 7% was achieved. Methyl vinyl 
ketone 297 (Table 20, Entry 2) was the only other alkene to give any visible 
product by 
1
H NMR, just identifiable at 1% conversion. It appeared that neutral and 
electron rich alkenes were completely unreactive to HM coupling with vinyl iodide 
269. It was hypothesised that the poor reactivity of these alkenes with respect to the 
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successful vinyl boronate 42 was due to their lack of steric bulk. It seemed possible 
that the bulk of ester 42 was resulting in a more crowded and therefore less stable 
palladium species, aiding expulsion of the desired dienyl product and helping 
catalyst turnover. 
Table 20 Yields obtained for HM coupling of a range of different alkenes with vinyl 
iodide 269 
 
Entry Alkene Yield/ % 
1 
 
3, 7
a 
2 
 
1
 
3 
 
0 
4 
 
9 
5 
 
0 
6 
 
0 
7 
 
0 
8 
 
0 
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Entry Alkene Yield/ % 
9 
 
0 
10 
 
73
b 
11 
 
72
b 
12 
 
0 
13 
 
0 
Product formation monitored by 
1
H NMR. 
a
Reaction done at reflux. 
b
Isolated 
yield. 
 To this end, tert-butyl acrylate 299 was used (Table 20, Entry 4). The increase 
in steric bulk did give a small increase in diene formation, at 9%, but not a large 
enough conversion to establish increased steric bulk as a criterion for successful 
reaction. Vinylboronic acid pinacol ester 305 (Table 20, Entry 11) was also 
reactive, giving the diene in an isolated yield of 72% on the first attempt. Attempts to 
achieve further homologation with diene 276 were also unsuccessful (Table 20, 
Entry 12). Silyl-enol ether 306 (Table 20, Entry 13) also proved unreactive. The 
reason for the peculiar reactivity of these substrates is unclear. One theory is that the 
vinyl boronate interacts with a palladium intermediate in such a way as to make the 
coupling favourable. Two possible forms 307 and 308 for this interaction have been 
envisaged, depending on the form of the boronate in solution. As previously 
discussed, the amount of free acetate present in solution remains unclear, and it is not 
known whether the boronate will be present as a three-valent species, or as the four-
coordinate boronate anion formed by coordination of a free acetate to the boron. In 
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reality, both species will most likely be present. The first possible interaction could 
be between the empty p-orbital on the three-valent boron and the d-orbitals on the 
electron rich palladium intermediate, either bringing the alkene closer to the 
palladium for successful alkene coordination or stabilising the alkene-coordinated 
intermediate to allow for successful carbometallation (structure 307). The second 
possible interaction is a more formal coordination of the acetate on the four-valent 
boronate anion, forming a stabilising chelate ring (structure 308). Both of these 
interactions could also result in a lengthening of the palladium-iodide bond, making 
it easier for a silver cation to strip it from the palladium and regenerate the active 
palladium(0) catalyst. 
 
 If an interaction such as this is the cause for the increased reactivity of the 
vinyl boronates to HM coupling with vinyl iodide 269, it might offer an explanation 
for the lack of reactivity of diene 276 to further homologation. It is true that the 
terminal alkene of the diene is likely to be less reactive due to its increased distance 
from the electronic influence of the boronate ester group. However, the complete 
lack of reactivity of diene 269 suggests that another contributing factor may also be 
implicated. The structure 307 requires overlap with the palladium d-orbitals. It may 
be in the case of diene 276 that the boron is now too far away from the palladium 
centre and the orbital overlap is not good enough to create an interaction. The 
interaction depicted in structure 308 involves chelate ring formation, and here the 
negative effect of diene 276 could be one of coordination ring size. Structure 308 
shows a seven-membered chelate, whereas the chelate formed by diene 276 would 
be a less favourable 9-membered chelate. If structure 307 is possible, then one might 
expect a vinyl silane to react well in a HM coupling with vinyl iodide. This is 
because silicon has an empty d-orbital and, in fact, the better matched symmetry 
between the palladium and silicon orbitals may result in a higher reactivity for vinyl 
silanes with respect to vinyl boronate species. 
 In light of this, a range of new vinyl substrates were chosen to investigate their 
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reactivity with vinyl iodide 269 in a HM coupling (Table 21, Equation 43). A range 
of vinyl silanes and siloxanes were chosen to see if these could also form a 
favourable interaction during the carbometallation step (Table 21, Entries 6, 7 and 
11).  Vinyl stannane 248 was also chosen, as it also had the potential to form a 
favourable interaction (Table 21, Entry 10). Phosphonate ester 311, sulfone 312 and 
vinyl BMIDA 314 were also chosen as substrates that should not be able to form an 
additional interaction (Table 21, Entries 8, 9 and 12). Initially, these couplings were 
attempted using one equivalent of acceptor with respect to vinyl iodide, as was used 
for the couplings detailed in Table 20. Vinyl silanes 309 and 310 did show an 
increased level of reactivity when compared to Michael acceptors 296, 297 and 299, 
though these conversions were only modest when compared to the vinyl boronates 
42 and 305 (17% and 24% for silanes 309 and 310, respectively, Table 21, Entries 6 
and 7). This is perhaps not surprising due to the more diffuse nature of the silicon d-
orbitals, possibly resulting in a less strong chelation with the palladium complex. 
Vinyl (triphenyl) silane 313 was investigated as a substrate, as it was thought that the 
aromatic phenyl groups would be able to stabilise the chelated ‘siliconate’ anion. 
However, no reactivity was seen (Table 21, Entry 11). This was attributed to the 
large steric bulk of the triphenyl silyl group destabilising the chelate ring. 
 As expected, vinyl phosphonate 311 and vinyl sulfone 312 displayed very poor 
reactivity, with less than 5% diene observed for both (Table 21, Entries 8 and 9). 
Interestingly, vinyl boronic acid MIDA ester 314 displayed no reactivity (Table 21, 
Entry 12). The MIDA ester has all four coordinating sites fully occupied and 
therefore would not be capable of forming the supposed chelation to facilitate the 
reaction. This lack of reactivity supports the theory that the effect of the boronate 
ester and silyl groups is one of chelational assistance. 
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Table 21 Reactivity of new vinyl acceptors and effect of acceptor loading on 
reaction conversion. 
 
Entry Acceptor (Conversion) [Isolated yield]/ %  
  
1 equivalent 
acceptor 
1.2 
equivalents 
acceptor 
2 equivalents 
acceptor 
3x scale (2 
equivalents 
acceptor) 
1 
 
(100) [72] - (94) - 
2 
 
(91)[72] - (55) - 
3 
 
(3) - (24) (42) 
4 
 
(9) - (42) (46) [28] 
5 
 
(1) - (48) (68) 
6 
 
(17) (21) (33) (42) 
7 
 
(24) (12) (36) (50) 
8 
 
(<5) - (15) (12) 
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Entry Acceptor (Conversion) [Isolated yield]/ %  
  
1 equivalent 
acceptor 
1.2 
equivalents 
acceptor 
2 equivalents 
acceptor 
3x scale (2 
equivalents 
acceptor) 
9 
 
(<5) - (18) (14) 
10 
 
- (0) - - 
11 
 
(0) (0) - - 
12 
 
(0) - - - 
 
 On revisiting a previous substrate screen, it was noted that one attempt to 
extend methyl acrylate 296 gave a much higher conversion of 19%, compared to the 
3% consistently seen beforehand. This experiment had previously been discounted 
due to an inefficient seal and consequential loss of a significant proportion of the 
vinyl iodide. This suggested that an excess of acceptor may furnish increased 
reactivity. 
 In an attempt to improve the conversions for the vinyl silane acceptors 309 and 
310, 1.2 equivalents of acceptor were used (Table 21, Entries 6 and 7). For the 
methyl variant 309, a 5% increase in conversion was observed (although the ethyl 
variant 310 gave lower conversions) and hence two equivalents were tried. This gave 
vastly improved conversions of 33 and 36% for 309 and 310 respectively. On 
increasing the scale by three times, conversions further increased to 42% and 50%. 
The reason for this lies in the insolubility of silver(I) acetate. The reaction mixture is 
a suspension due to this and mass transfer is a key factor in the success of these 
reactions. It was been found that carrying out these reactions on a larger scale 
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significantly improved the level of stirring that was achieved, and consequently an 
increase in conversion was generally observed. In fact, the 100% conversion 
obtained for vinyl boronate 42 (Table 21, Entry 1) was only ever achieved on larger 
scales. 
 These conditions were then applied to other acceptors and these results can be 
seen in Table 21. Acceptors 296, 297 and 299, and 309-312 all showed significantly 
increased conversions, with the starkest improvement being that of methyl vinyl 
ketone 297 (Table 21, Entry 5), which went from 1% conversion with one 
equivalent of acceptor, to 68% with two equivalents on increased scale. Additionally, 
HM coupling was attempted using 1.2 equivalents of vinyl (tributyl)silane 248, with 
exclusive formation of the Stille product observed (Table 21, Entry 10). 
 The dramatic increase in yield on increasing the amount of acceptor to two 
equivalents raises even more mechanistic questions than did the peculiar reactivity of 
the vinyl boronates 42 and 305. In particular, the lesser effect observed with the 
vinyl silanes is intriguing. Methyl acrylate 296 and methyl vinyl ketone 297 showed 
the greatest improvement, with these substrates also being the least sterically 
hindered. It is possible that multiple acceptor molecules coordinate to palladium in 
this mechanism, speeding up the rate of reductive elimination. In the case of tert-
butyl acrylate 299 and the silanes 309 and 310, it could be that the steric bulk is 
slowing this process, leading to a smaller increase in conversion. 
 Attempts to isolate the dienes formed were met with limited success. The 
products were highly susceptible to polymerisation; particularly those formed from 
methyl acrylate 9, methyl vinyl ketone 297, and the vinyl silanes 309 and 310. 
Dienyl silanes 315 and 316 polymerised within 24 hours at room temperature, even 
under argon. The crude dienes could be stored, however, at -18 
o
C and use of BHT in 
reaction mixtures, work up solvents and eluents helped to relieve issues with 
polymerisation in some cases. 
 The volatility of the acrylates and methyl vinyl ketone 296, 297 and 297, 
allowed the excess acceptor to be easily removed from the crude mixture in vacuo. 
However, only the tert-butyl derivative 317 proved stable to silica gel 
chromatography and could be readily purified. The vinyl silanes 309 and 310, vinyl 
phosphonate 311 and vinyl sulfone 312 could not be removed from the crude 
reaction mixture in vacuo and to date a method to separate the vinyl acceptor and 
diene has not been found due to the similarity of the compounds. Excess acceptor 
180 
 
and the resulting dienes have consistently run as one spot on thin layer 
chromatography (TLC) in all systems attempted. Whilst only dienyl boronates 276 
and 318, and tert-butyl derivative 317 were successfully isolated, the other crude 
dienes were identified using 
1
H NMR and accurate mass. 
 Despite the greatly increased conversions seen for substrates 296, 297 and 299, 
and 309-312, the reaction times were still much longer than those for vinyl boronates 
42 and 305 (2-3 days for the prior substrates compared with 3-6 hours for the vinyl 
boronates). This suggests that the excess acceptor was key for the coupling, but the 
chelational assistance of the boronate ester group may be more important.  
 Triene formation was attempted on dienyl boronate 276, but no triene was 
observed. If we assume that the facilitation of the HM coupling with vinyl boronates 
42 and 305 is due to the formation of 7-membered chelate 308, then the diene would 
form a 9-membered chelate, which is less favourable.  
Section 2.1.3 Derivatisation of dienes 
In light of the instability of the dienes formed in Section 2.1.2 and the difficulty in 
separating them from the excess of acceptor used in the reaction mixture, it became 
desirable to try to functionalise them so that they could be more easily isolated. This 
was initially done via a series of 
1
H NMR experiments. Attention was focussed on 
(1E)-buta-1,3-dien-1-yltriethoxysilane 316, due its high susceptibility to 
polymerisation. 
 Compound 316 was combined with 2.5 equivalents of three different aryl 
nitroso compounds with deuterated chloroform (CDCl3) in an attempt to form the 
cycloadduct (Table 22, Equation 44). A further NMR experiment where the CDCl3 
was first passed through an alumina plug to remove traces of acid was also 
undertaken, as it had previously been found within the group that acid could have an 
effect on the reaction. In all cases peaks corresponding to the oxazine were observed. 
It was found that the more electron withdrawing nitroso dienophiles gave the best 
conversions (Table 22, Entries 1, 3 and 4). It appeared that two regioisomers were 
formed. Whilst the regioisomers were not isolated and characterised separately, it 
was presumed that the major regioisomer 321 was the one with least steric 
hinderance, as this had been observed for other dienyl systems within the group 
previously
194
 (Equation 44, Figure 26). For the methoxy and methyl carboxylate 
derivatives of nitrosobenzene 320b and 320c, the levels of each regioisomer 
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remained consistent (Table 22, Entries 2 and 3). However, in the case of 
nitrosobenzene, a slightly higher proportion of regioisomer 322 was observed after 3 
hours (1:0.22 and 0.19, compared with 1:0.14 and 0.13 for Entries 1 and 4, 
respectively). Whilst the difference is small, this could indicate that the oxazine 
formation is in fact reversible and that a conversion between the kinetic regioisomer 
322 and the thermodynamic, less sterically hindered regioisomer 321 may be 
occurring. (1E)-Buta-1,3-dien-1-yltrimethoxysilane 315 was also used to see the 
difference with the change in alkoxy group size. This methoxy analogue seemed to 
show a similar level reactivity to ethoxy analogue 316 after 5 hours, although there 
was not a corresponding 
1
H NMR to confirm the conversion after 18 hours. 
Additionally, the level of regioisomer 322 at this time is wass line with that seen for 
the ethoxy analogue 316. 
Table 22 Attempted functionalization of dienyl silanes 315 and 316, forming 
oxazine products. 
 
 
Entry R group R
1
 group 
Conversion (Reaction 
time)/ % 
Regioisomeric ratio 
321:322 
1 OEt H (320a) 100 (18 h) 1:0.14 
2 OEt OMe (320b) 34 (18 h) 1:0.17 
3 OEt 
COOEt 
(320c) 
100 (18 h) 1:0.12 
4 OEt H (320a) 
94 (18 h) (acid traces 
removed) 
1: 0.13 
5 OMe H (320a) 65 (5 h) 1:0.18 
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Figure 26 
1
H NMR of attempted nitrosocycloaddition onto dienyl silane 316 (Table 
22, Entry 1), showing the consumption of diene and the two supposed regioisomers 
321 and 322 
 A Diels-Alder cycloaddition was also attempted on (1E)-buta-1,3-dien-1-
yltriethoxysilane 316 using 4-phenyl-1,2,4-triazoline-3,5-dione 323. All of the diene 
was consumed but no product was visible from the 
1
H NMR (Figure 27, Equation 
45). However, a precipitate was formed. 
1
H NMR analysis of this did not indicate 
presence of the desired cycloadduct 324. 
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Figure 27 
1
H NMR spectrum of a) the attempted Diels-Alder cycloaddition, 
showing complete consumption of diene 316 and b) the precipitate formed during 
the reaction. 
 
Absence of dienyl peaks 
a) 
b) 
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 A sample of (1E)-buta-1,3-dien-1-yltriethoxysilane 316 was dissolved in 
CDCl3 and acetyl chloride 325 added in an attempt to desilylate the diene (Equation 
46). Figure 28 shows the result of treatment with acetyl chloride, the diene peaks 
shifted downfield and formation of ethyl acetate. However, butadiene 249 was not 
observed, suggesting that the result of this reaction was actually the reaction between 
an acyl and an ethoxy on the silicon group, supported by the formation of ethyl 
acetate. Only one equivalent of acetyl chloride was used, so the exact result of this 
reaction is unclear. 
 
 
 A sample of methyl (2E)-penta-2,4-dienoate 326 was treated with 33% 
ammonia solution in an attempt to make amide 327 (Equation 47). Unfortunately, 
no change was observed in either the proton or the carbon NMR. 
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Figure 28 
1
H NMR spectrum of a) crude (1E)-buta-1,3-dien-1-yltriethoxysilane 316 
and b) (1E)-buta-1,3-dien-1-yltriethoxysilane 316 following treatment with acetyl 
chloride 325 
 
a) 
b) 
Si(OEt) 3 
326 
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 With the nitroso Diels-Alder cycloaddition appearing a promising route, the 
focus moved to trapping out the dienes as cycloadducts. A one pot procedure to form 
dienyl boronate 276 and then effect the cycloaddition using nitrosobenzene was 
attempted (Equation 48). Vinyl boronate 42 was subjected to the optimised HM 
coupling protocol for boronate esters (one equivalent of acceptor) and after 6 hours, 
nitrosobenzene 320a was added and the reaction stirred overnight. 
1
H NMR analysis 
after 17.5 hours post addition indicated complete diene consumption and formation 
of 1-phenyl pyrrole 328, which was isolated in an 18% yield. 
 
 
 
 
 
 The isolated yield obtained was disappointing, considering the facile reactivity 
of the reaction. Unfortunately, large amounts of an azo-oxide 329 (as identified in 
the group previously)
194,195
 was formed during the course of the reaction and this was 
very difficult to isolate from the desired pyrrole.  
The reaction was attempted again, this time initially using 0.9 equivalents of 
nitrosobenzene and then adding small proportions of nitrosobenzene (0.3 equivalents 
after 16 hours and then a further 0.2 equivalents 2.5 hours later) as required to effect 
complete cycloaddition. This was much more successful, resulting in far less 
formation of azo oxide, and leading to the isolation of 328 in a 48% yield.
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 A one-pot procedure was also attempted on methyl vinyl ketone 297, this time 
attempting to employ ethyl vinyl ether 330 as an electron rich dienophile in an 
inverse electron demand Diels-Alder reaction (Equation 49). Unfortunately, it was 
found that only a 30% conversion was obtained after six hours, and that the diene 
that was formed did not undergo a cycloaddition with vinyl ether 330, even after 
heating the reaction mixture to reflux for two days. 
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 A sample of crude methyl dienyl ketone 332 was also used in an attempted 
cycloaddition with nitrosobenzene, following the literature procedure.
195
 Diene 332 
was dissolved in methanol and nitrosobenzene 320a added (Equation 50). The 
reaction was then stirred at room temperature. The reaction proved to be extremely 
facile, with 90% oxazine formation observed after 1 hour and 40 minutes. At this 
point an approximate regioisomeric ratio of 4:1 was observed for products presumed 
to be 333 and 334, respectively. 
 
Section 2.1.4 Capability of (E)-2-(buta-1,3-dienyl)-4,4,6-trimethyl-
1,3,2-dioxaborinane to act as a four-carbon building block for polyene 
synthesis 
Following the successful isolation of dienylboronate 276, its utility as a four-carbon, 
butadienyl dianion equivalent was examined, in a manner analogous to the use of the 
vinylboronates, such as 42, as two-carbon, vinyl dianion equivalent building blocks 
(as in Scheme 65, for example).
161,162,164,165,167,192  
Scheme 65 Use of 42 as a two-carbon, vinyl dianion equivalent building block 
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 Dienyl boronate 276 was successfully, and consistently, coupled with a 
number of aryl, heteroaryl and alkenyl halides 51 (Table 23, Equation 51). A 
consistent method of purification still remains elusive to date, however, it was found 
that used of silver(II) nitrate-impregnated silica proved useful in obtaining pure 
products. In some cases, the instability of the products meant that it was not possible 
to obtain optimum isolated yields. In many cases, alkenes were isolated with the 
TMB references. In some cases the products also could not be separated from the 
starting halide without giving an unacceptable isolated yield. In addition, the dienyl 
products were susceptible to polymerisation and, as before, BHT had to be used in 
work up solvents and eluents in order to successfully isolate the products. 
Table 23 Results of attempted SM couplings between diene 276 and a range of aryl 
halides. 
 
Entry R-X 
Reaction 
time/hours 
Crude yield 
(isolated yield)/% 
1 
 
4.5 76 (69) 
2 
 
22 32 (28) 
3 
 
23 33 (23) 
4 
 
25 23 (22) 
5 
 
6 91 (89) 
6 
 
22 74 (72) 
7 
 
25 70 (40) 
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Entry R-X 
Reaction 
time/hours 
Crude yield 
(isolated yield)/% 
8 
 
6 65 (64) 
9 
 
23 33 (24) 
10 
 
22 73 (68) 
11 
 
24 88 (88) 
12 
 
23 61 (46) 
13 
 
4 0, 58b (53) 
aYields determined by 1H NMR and GC on crude product 
after work up. b Ag2O base used. 
 
 Despite this, the ability of dienylboronate 276 to undergo coupling was 
demonstrated on both electron-donating and electron-withdrawing substrates. It was 
found that p-aryl iodides were coupled in good yields (Table 23, Entries 1, 5, 8 and 
10). In the case of p-iodoanisole 246 versus p-bromoanisole 337 (Table 23, Entries 
1 and 2), there was a significant drop in reactivity of the bromide compared to the 
iodide. There was also a significantly lower reactivity observed for the o-iodoanisole 
338 compared with p-iodoanisole 246 (Table 23, Entries 1 and 3). With the tolyl 
derivatives (Table 23, Entries 5, 6 and 7), the o-aryl halides did display a small drop 
in reactivity compared to the p-derivative, but there was no observed difference 
between the bromo- and iodo-derivatives and all three were coupled in good yields.  
Heterocyclic compounds were also coupled (Table 23, Entries 11 and 12), with 3-
iodopyridine giving an isolated yield of 88%. The coupling between iodoacrylate 
229 and diene 276 was attempted using both potassium tert-butoxide and silver(I) 
oxide to see if the silver was beneficial to the cross-coupling. The difference between 
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the two bases being apparent by 
1
H NMR of the two reaction mixtures; tert-butoxide 
resulted in no triene 348, whereas silver(I) oxide gave a 58% crude yield (Table 23, 
Entry 13).  
 It was considered desirable, due to the tendency for dienyl boronate 276 to 
polymerise on storage, for the trifluoroborate salt 349 of boronate 276 to be made, as 
a potentially air-stable and easier to use SM coupling partner. Ideally, in order to 
overcome the issues with polymerisation of boronate 276 on silica gel 
chromatography, the trifluoroborate 349 should be isolated directly from the crude 
boronate 276. Attempts to functionalise crude diene 276 included the Lloyd-Jones 
procedure,
196
 with KF and (+)-tartaric acid, as well as a procedure using KHF2. Use 
of KHF2 was unsuccessful on diene 276, and was attempted on the crude pinacol 
derivative 318 with just as little success. Crude diene 276 was dissolved in a mixture 
of 1:1 MeOH: MeCN, then a solution of KF in water was added dropwise at room 
temperature. Addition of (+)-tartaric acid with stirring, followed by dilution with 
MeCN, filtration to remove the salt and removal of the solvent gave crude 
trifluoroborate. Unfortunately, any unreacted vinyl boronate 42 left from the 
previous HM coupling was also converted to trifluoroborate and pure dienyl 
trifluoroborate 349 could not be isolated, even by recrystallization. The same 
procedure was attempted on a freshly purified sample of dienyl boronate 276 and 
trifluoroborate 349 was obtained in a quantitative yield (Equation 52). 
 
 
 
 A SM cross coupling was attempted on trifluoroborate 349 and para-
iodotoluene, using the conditions detailed in Table 23. Unfortunately, the 
temperature at which the reaction was undertaken appeared to cause decomposition 
of the trifluoroborate and no SM product was observed (Equation 53). 
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 Given the instability of some of the aryl dienes produced, it seemed 
appropriate to investigate methods to react them in situ to give more readily 
isolatable products. There was precedent for doing this, with the Thomson group 
successfully trapping out 2-naphthalenyl diene using a Diels-Alder cycloaddition 
(Scheme 66).
187 
Scheme 66 Successful Diels-Alder cycloaddition of an unsubstituted aryl diene by 
Thomson et al.
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 Here, the diene was made in situ via bromination of an allyl hydrazone, and 
then trapped out using either N-phenyl maleimide 351 or 4-phenyl-1,2,4-triazoline-
3,5-dione 323, successfully giving cycloadducts 352 and 353 in 56 and 77% isolated 
yields, respectively.
187 
 Using 1-naphthalenyl iodide 345, the SM coupling to make 1-naphthalenyl 
diene 354 was undertaken and the cycloaddition with N-phenyl maleimide 351 
attempted in a one-pot procedure. It was found that the presence of the dienophile 
from the start of the reaction slowed down the SM coupling. If dienophile 351 was 
added after reaction completion, no conversion to cycloadduct was observed. 
 Crude 1-naphthalenyl diene 345 and p-tolyl diene 354 were used in attempted 
cycloadditions with N-phenyl maleimide 351, 4-phenyl-1,2,4-triazoline-3,5-dione 
323 and maleic anhydride 356. In all cases, consumption of the diene was seen, but 
the corresponding cycloadduct could not be isolated.  
 A HM coupling was attempted on triene 348, using iodoacrylate 229, in an 
attempt to make the butadienyl diester. Unfortunately, no peaks corresponding to the 
desired product could be observed in the 
1
H NMR spectrum after 18 hours 
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(Equation 54). 
 
 
 
Section 2.1.5 Summary 
The potential for vinyl iodide 269 to act as a HM donor was evaluated, with 
optimised conditions providing access to key dienyl boronate 276. The reactivity of 
vinyl iodide has proven to be unusual, with poor reactivity for all substrates except 
for the vinyl boronates when using a 1:1 ratio of iodide to alkene acceptor, but in 
some cases displaying greatly increased reactivity when the ratio of alkene acceptor 
was increased to 3 equivalents. A chelation effect has been proposed to explain the 
facile reactivity of the vinyl boronates with vinyl iodide, a theory supported by the 
moderate reactivity of the vinyl siloxanes and the lack of reactivity of the 
coordinatively saturated vinyl BMIDA substrate. 
 
  
 
 
 Purification of the terminal dienes formed has proven consistently challenging, 
with products susceptible to polymerization and difficult to separate from the starting 
vinyl substrate. Some attempts have been made to trap out these dienes, or else 
functionalise them directly from a crude reaction mixture, with nitroso-
cycloadditions showing the most promise. 
 Dienyl boronate 269 has been used in a series of SM couplings to furnish a 
range of dienes and trienes. These products were again highly susceptible to 
polymerisation, but were more amenable to silica gel chromatography, with silica 
impregnated with silver(II) nitrate used to effect the best separation. 
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Section 2.2 Novel, mild Heck-Mizoroki cross-coupling 
conditions for the stereoselective construction of unstable 
polyenes 
Section 2.2.1 Optimisation for a room temperature HM coupling 
Throughout Section 1, a recurring theme was one of instability of the polyene 
intermediates to the temperatures employed in the key cross-coupling reactions. On 
commencing this project, HM couplings were performed at 50-55 °C and SM 
couplings were performed at 60 °C. Over time these were shown to cause 
degradation of the polyenyl intermediate, the aryl building block, or both (see 
Sections 1.2, 1.3 and 1.4). In Section 1.3, issues with stability were circumvented by 
running HM reactions at 30 °C, as completion was reached, but the SM:HM ratio 
was too poor at room temperature (Table 24, Equation 55). In order to access 
highly the unstable polyenic intermediates, a room temperature protocol for Heck-
Mizoroki cross-coupling would be desirable, as degradation of intermediates was 
observed even at room temperature (Section 1.3). 
Table 24 Temperature screen for the HM coupling of iodoacrylate 229 and vinyl 
boronate 42, showing HM vs competing SM ratios. 
 
Entry 
Catalyst loading/ 
mol% 
Temperature 
/ 
o
C 
Conversion after 24 h/ 
% 
HM: SM 
ratio 
1 5 50 100 
90:10 to 
97:3 
2 5 40 100 87:13 
3 10 40 100 80:20 
4 5 30 100 87:13 
5 10 30 100 85:15 
6 5 rt 100 72:28 
7 10 rt 100 68:32 
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The cause of this increase in SM product at room temperature is unclear and 
surprising, potentially suggesting that the HM is the thermodynamic preferred 
pathway, and therefore less favoured at room temperature.  
A ligand screen was undertaken in an attempt to optimise the HM:SM 
product ratio (Equation 56), with the results shown in Table 25.  
Table 25 Ligand screen for the HM coupling of iodoacrylate 229 and vinyl boronate 
42, showing HM vs competing SM ratios.
a
 
 
Entry Ligand 
Conversion after 3 
h/% 
HM: SM 
ratio 
1 No ligand 100 80:20 
2 Tri(o-tolyl)phosphine 100 68:32 
3 Triphenylphosphine 0 - 
4 Tris(o-methoxyphenyl)phosphine 100 89:11 
5 
Tris(4-
trifluoromethylphenyl)phosphine 
0 - 
6 Trifurylphosphine 100
b 
89:11 
a
Reaction undertaken using 10 mol% catalyst and 2 equivalents ligand wrt catalyst. 
b
Reaction complete after 1.5 hours 
The results were perhaps a little surprising, with the reaction proving to be 
either highly efficient (going to 100% conversion after 3 hours), or completely 
unreactive, with no conversion observed at all. It was observed that addition of an 
electron rich ligand facilitated HM coupling (Table 25, Entries 2, 4 and 6), whilst 
addition of electron deficient ligands resulted in no conversion (Table 25, Entries 3 
and 5). Tris(o-methoxyphenyl)phosphine and trifurylphosphine gave the best 
HM:SM ratio, with the smaller trifurylphosphine also giving a higher level of 
reactivity, with 100% conversion at the shorter time of 1.5 hours  (Table 25, Entries 
4 and 6). It was also noted that addition of no phosphine ligand gave a better ratio 
than the current phosphine of choice at 50 °C, tri(o-tolyl)phosphine. Initially, this 
observation was put down to steric effects, due to the comparative bulk of tri(o-
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tolyl)phosphine compared to the most successful trifurylphosphine. The reactivity of 
tris(o-methoxyphenyl)phosphine, however, discounted this. 
The optimal catalyst loading was then investigated, using trifurylphosphine 
as the ligand. The results are shown in Table 26, Equation 57. 
Table 26 Catalyst loading screen for the HM coupling of iodoacrylate 229 and vinyl 
boronate 42, showing HM vs competing SM ratios.
a
 
 
Entry 
Catalyst 
loading/ mol% 
Conversion 
after 3 h/% 
HM: SM 
ratio after 
3 h 
Conversion 
after 25 h/% 
HM: SM 
ratio after 
25 h 
1 10 100 89:11 100 87:13 
2 7.5 100 90:10 100 90:10 
3 5 100 91:9 100 89:11 
4 2.5 100 89:11 100 88:12 
5 1 100 88:12 100 89:11 
6 0.5 <1
 
- 31 77:23 
a
Reaction undertaken using 2 equivalents ligand wrt catalyst. 
It was found that the reaction could be performed at 1 mol%, achieving 100% 
conversion after 3 hours, with no reduction in the HM:SM ratio. These conditions 
showed a great deal of potential for their use in polyene construction via iterative 
cross coupling. Comparison of the in situ 
1
H NMR of the HM coupling between 
iodoacrylate and vinyl boronate using these conditions, and those originally 
employed within the group shows a cleaner spectrum for these milder conditions, 
indicating that the final polyenes may well be easier to purify (Figure 29).  
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Figure 29 
1
H NMR spectra for the HM coupling between iodoacrylate 229 and vinyl 
boronate 42 under a) the group’s original conditions and b) the newly optimised 
conditions. 
b) 
 
 
 
a) 
O B 
O 
O 
O 259 
O B 
O 
O 
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Section 2.2.2 Application of milder methodology 
Following on from the identification of optimised conditions for the model reaction 
between 229 and 42, the scope of this methodology needed to be evaluated. The aim 
was to apply the optimised conditions to polyenyl systems already reported by 
ourselves.
1,2 
In addition, application to the vinyl iodide methodology needed to be 
fully investigated, as this proved to be an unreactive system and the products were 
unstable.
4 
Preliminary work was moderately successful, where vinyl iodide 269 was 
shown to react moderately with vinyl boronate 42 with 10 mol% palladium(II) 
acetate and 20 mol% tris(o-methoxyphenyl)phosphine at room temperature, giving a 
48% estimated conversion after 24 hours to dienyl boronate 276 (Equation 58). 
 
Initially, there were some concerns that this reactivity would be reduced 
under the lower catalyst loading employed in the newly optimised conditions. A 
small substrate screen was undertaken using the new conditions, incorporating the 
cis-iodoacrylate 43 employed in the synthesis of viridenomycin and vinyl iodide 
269, along with 2 different aryl iodides 357 and 246 (Table 27, Equation 59). Cis-
iodoacrylate 43 proved highly reactive, comparable with trans-iodoacrylate 229 
(Table 27, Entry 2). Vinyl iodide 269 displayed similar reactivity to that observed 
using the conditions in Equation 58, an indication of the highly reactive nature of 
the palladium(II) acetate/trifurylphosphine system in this case, reaching 52% after 24 
hours (Table 27, Entry 5). Unfortunately, this conversion was considerably worse 
than that of the iodoacrylates, which reached 100% completion within 3 hours. Aryl 
iodides 357 and 246 proved unreactive at these temperatures, with no conversion 
observed for any of these substrates (Table 27, Entries 3-4). 
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Table 27 Attempted application of new conditions to the HM coupling of some 
alkenyl and aryl iodides. 
Entry Substrate Conversion after 3 h/% Conversion after 24 h/% 
1 
 
100 - 
2 
 
100 - 
3 
 
0 0 
4 
 
0 0, 7
a 
5 
 
31 52 
a
Conversion obtained at 40 °C 
Section 2.2.3 Summary 
In light of the instability of many of the longer chain polyenyl intermediates made 
during the course of this project, the HM cross-coupling conditions were reoptimised 
to operate at room temperature. Ligand screening was successful in achieving a 
comparable HM:SM ratio to the one observed at 50 °C, with the catalyst loading 
successfully dropped to 1 mol% from 5 mol%. The reaction time has also been 
greatly reduced from between 1 and 2 days to 3 hours. Aryl iodides are, however, 
unreactive under these conditions and there is still a need for more general, low 
temperature HM cross-coupling conditions. 
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3 Conclusions 
 
The aims of this project were to make progress in the synthesis of xanthomonadin 
208, utilising the group’s HM/IDB ICC methodology in the construction of polyene 
intermediates. After evaluating what was currently known in the literature, the 
biological action of these compounds was of considerable interest, and the project 
was widened to include both debrominated xanthomonadin and a number of 
truncated analogues in the expectation of shedding some light on the behaviour of 
the Xanthomonas pigments.  
 
The aim was to achieve a convergent and versatile synthetic route, with a 
number of different aryl building blocks accessed to accomplish this. Considerable 
challenges were encountered both in the synthesis of brominated styrenyl boronate 
pinacol ester 228 (where the unwanted production of geminal by-product 236 could 
be minimised, although not completely eliminated), and in the selection of a suitable 
cross-coupling reaction to connect a brominated styrenyl building block to the 
polyenyl section of the pigment. Some inroads were made here, with a SM coupling 
showing the most promise. 
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The group’s HM/IDB ICC methodology proved to be extremely versatile, 
providing access to three key polyenyl building blocks. The key issue with this part 
of the project was the stability of the polyenyl intermediates, especially the polyenyl 
iodides, which degraded rapidly, in many cases even in the dark and under argon. 
The HM methodology was reoptimised to operate at lower temperatures in order to 
minimise degradation of iodide coupling partners, with a room temperature version 
of the methodology showing promise. 
 
A number of pigments have been successfully made, with dehydro-tetraen-
yne xanthomonadin 235 and debrominated pentaenyl xanthomonadin 234 isolated 
and characterised. Pentaenyl xanthomonadin 233 was also isolated as a mixture with 
dehydro tetraen-yne xanthomonadin 235, due to the problematic nature of the final 
SM coupling with brominated styrenyl boronate pinacol ester 288. Debrominated 
xanthomonadin 210 has also been isolated as part of a crude mixture in trace 
amounts, with purification of the octaenes consistently proving difficult. Some 
evidence for the successful formation of xanthomonadin 208 in trace amounts has 
also been found, with the presence of the expected signals in a crude 
1
H NMR 
spectrum, and also some promising mass ion peaks in the mass spectrum. 
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The isolated truncated pigments fit well with the limited characterisation 
available in the literature for xanthomonadin 208, with the characteristic signals 
observed in the 
1
H NMR spectrum. Studying the behaviour of these pigments by 
NMR over time provided evidence of a major cis isomer of the pigments. This was 
further corroborated by the presence of a higher energy λmax for both truncated 
analogues in the UV-Vis spectrum. It also appeared that the pentaenyl 
xanthomonadin 233 was more stable than the other two analogues, perhaps 
suggesting a reason for the incorporation of the bromine into the polyene chain itself. 
Dehydro-tetraen-yne xanthomonadin 235 appeared more stable than debrominated 
pentaenyl xanthomonadin 234. 
The UV-Vis data was consistent with that obtained by Andrewes et al. for 
pigment mixtures containing xanthomonadin 208,
151
 possessing the same shape of 
curve and also displaying a λmax consistent with the lower conjugation of these two 
structures. In addition, it was shown that these two compounds fit with the expected 
λmax values as predicted by the Fieser-Kuhn rules.
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The above data provide strong evidence that we have successfully made 
compounds analogous to those isolated by Andrewes et al., and also support their 
characterisation.
133,151,154
 The data also provide a small insight into the behaviour of 
such sacrificial pigments and their behaviour towards both oxygen and light. It 
remains to be seen whether the truncated analogues can provide any photooxidative 
protection for bacteria that naturally cannot product such pigments for themselves. 
There have been opportunities throughout this project to work on 
optimisation of methodology. The optimisation of the HM methodology used in the 
HM/IDB ICC construction of key building blocks has already been discussed, but 
another sub-project was undertaken to establish the potential of vinyl iodide 269 as a 
HM coupling partner. Through considerable optimisation, this aim was achieved, 
although isolation of pure reaction products was not possible in many cases. This 
was due to the instability of the dienes to polymerisation and also to the similarity of 
the starting alkene to the diene, making them very difficult to separate by silica gel 
chromatography. This body of work not only showed that vinyl iodide 269 can be 
used to form a number of dienes, but also highlighted some key mechanistic 
questions due to the peculiar reactivity of non-coordinatively saturated vinyl 
boronates. These questions haven’t been definitively answered, but it appears that 
the coupling takes different routes depending on the nature of the substrate.  
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Vinyl iodide 269 was used to readily access key dienyl boronate 276, which 
was used in a series of SM couplings to access a range of dienes and trienes, 
providing a versatile method which could access all of these terminal polyenes where 
there had previously not been one robust way to do so. Isolation of these compounds 
was initially hampered by their instability to polymerisation, but use of BHT in all 
reaction, work up and chromatography solvents solved this problem. Use of silver(I) 
nitrate impregnated silica allowed for mixtures of these polyenes to be separated, 
although this did result in a decreased isolated yield. 
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4 Future work 
 
The potential to access these complex pigment molecules has been established 
through the work in this thesis. There are still a considerable number of challenges 
that need to be overcome in order for the natural pigments to be successfully made 
and isolated on a scale suitable for testing. Suitable purification conditions for the 
isolation of debrominated xanthomonadin 210 need to be identified. In order to 
access both xanthomonadin 208 and pentaenyl xanthomonadin 233, the cross-
coupling conditions onto a suitable aryl building block need to be optimised. The 
current model systems have their limitations in that the desired dienyl analogues 
have not been successfully isolated. Therefore, the isolation of these dienes needs to 
be achieved, or suitable alternative models identified. In particular, a lower 
temperature set of conditions need to be identify as the only conditions that currently 
give any desired product operate at 60 °C, at which temperature polyenyl iodide 
intermediates have already been shown to be unstable. In addition, dehydro-heptaen-
yne xanthomonadin 232 needs to be synthesised. The relatively simple synthesis of 
dehydro-tetraen-yne xanthomonadin 235 gives some indication that this analogue 
should be accessible, though it may suffer from the same instability shown by 
debrominated xanthomonadin 210 on purification.  
The behaviour of all of these target molecules under photooxidative 
conditions needs to be studied, and the nature of the degradation/polyene 
isomerisation should be studied in order to understand more about the mechanism of 
these structures. Work has commenced with Professor Conrad Mullineaux, Queen 
Mary College London, to investigate the ability for the the two isolated truncated 
analogues to protect bacteria against photooxidative damage. An ideal solution 
would be to find a way of quantifying the photoprotective activity of these 
compounds, in order to begin identifying the most important functional groups for 
activity. 
The next stage in the bacterial pigments project is to access some other 
pigments found in bacteria (see Section 1.1). Through making and testing these 
pigments, a better understanding of the structure-activity relationship will be 
obtained for these structures. Some work has already commenced towards this end, 
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with the vision being to access a range of aryl styrenyl boronate esters to be coupled 
to polyenyl intermediates of varying length. 
The optimised HM/IDB ICC methodology needs to be applied to the 
synthesis of our key polyenyl building blocks, to assess the possibility of operating 
these at room temperature. Following this, the methodology could be applied to the 
synthesis of the northern hemisphere of viridenomycin 18, the total synthesis of 
which is part way through completion (see Introduction). Scheme 67 shows the 
yields previously obtained for the synthesis of this key building block. The final HM 
has considerable room for improvement, and it could well be that the poor yield is 
due to the instability of the trienyl iodide to the reaction temperature. Further work 
needs be undertaken into the cause of HM vs SM selectivity, with the hope of better 
understanding the intriguing switch in reactivity on operating at a lower temperature. 
With the development of milder HM methodology, the HM coupling onto 
brominated styrenyl iodide 238 needs to be reinvestigated, as this could open up the 
potential of building xanthomonadin 208 utilising two tetraenyl intermediates, in an 
approach analogous to that of the synthesis of debrominated xanthomonadin 210. 
Scheme 67 Previously developed route to the northern hemisphere of viridenomycin 
18 
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The mechanisms involved in the cross-coupling of vinyl iodide with different 
alkenyl substrates needs to be further investigated, with DFT calculations currently 
being performed on the vinyl iodide-vinyl boronate system to evaluate the validity of 
the chelation theory. The cause of the greatly increased reactivity of some of the 
Michael acceptor substrates when 3 equivalents is used also needs to be investigated. 
There are still considerable issues with the isolation of the products from these 
couplings, and this needs to be addressed. Methods of functionalising these dienes 
have been briefly explored, but little progress has been made so far. 
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5 Experimental 
 
5.1 General experimental details 
All reactions were carried out in oven-dried glassware with magnetic stirring unless 
otherwise stated. All chemicals were purchased from commercial suppliers and used 
without further purification. Where petroleum ether is stated, this refers to petroleum 
ether bp 40-60 °C. Anhydrous acetonitrile was obtained by distillation of HPLC 
grade acetonitrile over calcium hydride. Anhydrous THF was obtained by distillation 
of HPLC grade THF over sodium metal, with a benzophenone indicator. Solvents 
were degassed, unless stated otherwise, by sparging with argon for 20 minutes. For 
all palladium cross-coupling reactions, cross-shaped stirrer bars were used for the 
most efficient stirring. Where reagents were added dropwise, these were added at a 
rate of 1 drop per second unless otherwise stated. Monitoring of reactions was 
achieved using any of TLC, 
1
H NMR and GC. TLC was performed using silica 
plates. The silica plates were polyester-backed silica TLC plates with 0.2 mm silica 
gel and fluorescent indicator. Spots were visualised using an ultraviolet (UV) lamp 
and KMnO4 dip, visualising in both long wave and short wave UV. Where a 
reference was used, naphthalene or 1,3,5-trimethoxybenzene were used as a 
reference for conversion calculations. HMR experiments were carried out on either a 
Bruker Avance-400 or a Varian VNMRS-700 spectrometer in deuterated chloroform 
(CDCl3-d), deuterated methanol (MeOD-d4), or deuterated dimethyl sulfoxide 
(DMSO-d6). Chemical shifts are reported in ppm relative to tetramethylsilane (TMS) 
reference. Experiments undertaken included 
1
H, 
11
B, 
19
F, 
13
C, COSY, PSYCHE, 
HSQC and HMBC NMR. NMR experiments were not boron-decoupled, but in all 
cases the coupling constant proved too small to be visible on the resulting spectra. 
GC data was obtained by removing 0.01 mL samples from the reaction mixture and 
diluting into 1 mL acetonitrile. GC experiments were run on a Hewlett Packard 5890 
Series II Gas Chromatograph fitted with a Hewlett Packard 6890 series injector, 
using a FactorFour™ capillary column VF-5 ms, 30 m, 0.25 mm, 0.25 μm. The 
experiment conditions were an initial temperature of 30 °C, held for 5 minutes, 
followed by a gradient of 20 °C/ minute to 150 °C, with a hold time of 11 minutes. 
Celite/silica filtration used Celite® S and technical grade silica gel: pore size 60 Å, 
230-400 mesh particle size, 40-63 μm particle size. The term ‘evaporated’ refers to 
208 
 
the removal of solvent in vacuo. Silica gel chromatography used technical grade 
silica gel: pore size 60 Å, 230-400 mesh particle size, 40-63 μm particle size. Where 
silver nitrate-impregnated silica gel was used, this was prepared according to Li and 
coworkers.
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 Alumina chromatography used activated, neutral, brockmann I 
standard grade aluminium oxide with ~150 mesh and 58 Å pore size. Electrospray 
ionisation (ESI) mass spectrometry was undertaken using a LTQ FT 
(ThermoFinnigan) high resolution, accurate mass LC ES MS/MS or a Thermo 
Scientific LTQ Orbitrap XL. Samples were made up as 1 mg per mL solutions in 
acetonitrile. GC/MS EI was undertaken using a Waters GCT Premier. Atmospheric 
solids analysis probe (ASAP) mass spectrometry was undertaken using LCT Premier 
XE (Waters) high resolution, accurate mass ultra performance liquid 
chromatography (UPLC) ASAP or a Thermo Scientific LTQ Orbitrap XL. Samples 
were either made up as 1 mg per mL solutions in acetonitrile or run as solids. Infra-
red (IR) spectroscopy was undertaken using a Perkin Elmer-1600 FTIR, using both 
liquid and solid samples. Melting point measurements were undertaken using a 
Gallenkamp melting point apparatus. Where products were susceptible to 
polymerisation, these were stored with approximately 20 ppm BHT under argon at 
either 4 
o
C or -18 
o
C.UV-Vis measurements were carried out on a Varian Cary 100 
Bio UV-Visible Spectrophotometer. Fluorescence measurements were carried out on 
a PerkinElmer LS 55 Fluorescence Spectrometer. Both UV-Vis and fluorescence 
measurements were carried out using quartz cuvettes, with samples dissolved in 
either spectrophotometric grade diethyl ether, or spectrophotometric grade 
chloroform. 
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5.2 Specific experimental procedures 
Methyl (2E)-3-iodoprop-2-enoate 229 
 
A solution of propiolic acid (5.00 g, 71.0 mmol) in aq. HI (57%, 25 mL) was heated 
under reflux for 0.5 hours, after which time the reaction was cooled to 0 
o
C. The 
resulting crystals were then filtered, washed with water (3 x 20 mL) and air-dried to 
afford 14.2 g of  (E)-3-iodoprenoic acid as an off-white solid. The stereochemistry as 
the (E)-isomer was confirmed by X-ray crystallography following slow evaporation 
from EtOAc.  (E)-3-Iodopropenoic acid (14.0 g, 70.7 mmol) was dissolved in MeOH 
(20 mL) and conc. H2SO4 (1 mL) was added. The reaction mixture heated under 
reflux for 24 hours, after which the solvent was removed in vacuo. The resulting 
crude product was dissolved in Et2O (100 mL), washed with H2O (50 mL), sat. 
NaHCO3 (2 x 50 mL), sat. Na2S2O5 (2 x 50 mL) and brine (50 mL). The organic 
extracts were then dried over MgSO4 and evaporated to yield methyl (2E)-3-
iodoprop-2-enoate as an off-white solid (12.9 g, 86% over two steps), mp  
48.5-51.3 
o
C. 
1
H NMR (400 MHz, CDCl3): δ 3.75 (3H, s, CH3), 6.88 (1H, d,  
J=14.8 Hz, H3), 7.89 (1H, d, J=14.8 Hz, H2). All spectroscopic data were consistent 
with those reported previously.
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1-Bromo-4-iodo-2-methoxybenzene 224 
 
4-Bromo-3-methoxyaniline (5.00 g, 24.8 mmol) was stirred in aqueous HCl (37%, 
250 mL) at 80 
°
C to ensure complete dissolution. This was then cooled to 0 
°
C and a 
cold solution of NaNO2 (2.22 g, 32.2 mmol) in H2O (125 mL) was added dropwise, 
keeping the temperature constant. The reaction mixture was stirred at 0 
°
C for 1 hour 
and a cold solution of KI (12.5 g, 74.3 mmol) was carefully added dropwise at 0 
°
C 
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over a period of 1 hour. The resulting dark brown solution was stirred and allowed to 
reach room temperature overnight. The reaction mixture was diluted with EtOAc 
(250 mL) and the layers separated. The aqueous layer was extracted using EtOAc  
(2 x 250 mL). The organic layers were combined and washed sequentially with sat. 
NaHCO3 (125 mL) and H2O (125 mL) until neutral pH. The organic layers were then 
washed with 5% Na2S2O5 (125 mL) and saturated brine (125 mL), dried over MgSO4 
and the solvent evaporated to afford a dark brown oil, from with the desired product 
spontaneously crystallised to give 1-bromo-4-iodo-2-methoxybenzene as a dark 
brown solid (7.8 g, 100 %), mp 53.1-55.6 
o
C.  
1
H NMR (400 MHz, CDCl3): δ 3.88 
(3H, s, OCH3), 7.14-7.18 (2H, m, H5,3), 7.22-7.25 (1H, m, H2). All spectroscopic 
data were consistent with those reported previously.
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 ((4-Bromo-3-methoxyphenyl)ethynyl)trimethylsilane 225 
 
 
 
1-Bromo-4-iodo-2-methoxybenzene (7.71 g, 24.8 mmol), Pd(PPh3)2Cl2 (0.173 g, 
0.242 mmol) and CuI (47 mg, 0.242 mmol) were added to a dry flask. After purging 
the flask with argon for 5 minutes, dry, degassed Et3N (139 mL) was added to the 
tube under argon, followed by TMS acetylene (4.0 mL, 29.8 mmol). The reaction 
was stirred at room temperature in the dark for 16 hours. The solvent was then 
evaporated and the residue was passed through a silica gel column, eluent 5% EtOAc 
in petroleum ether. Fractions containing the compound were evaporated to give 
desired product as an orange oil (7.11 g, 100%). 
1
H NMR (600 MHz, CDCl3): δ 0.25 
(9H, s, SiMe3), 3.89 (3H, s, OCH3), 6.92-6.98 (2H, m, H2, H6), 7.45 (1H, d,  
J=8.1 Hz, H5). 
29
Si NMR (139 MHz, CDCl3): δ -17.47 (s); 
13
C NMR (151 MHz, 
CDCl3): δ -0.2 (SiMe3), 56.2 (OMe), 95.0 (C8), 104.0 (C7), 112.5 (C4), 115.0 (C6), 
123.3 (C1), 125.4 (C2), 133.1 (C5), 155.4 (C3); IR (max, cm
-1
) 2157.0 (w, alkyne  
C-C), 2959.0 (m, arom. C-H), inter alia; LRMS (ASAP) 282.0 (M
+
-
79
Br, 50%), 
284.0 (M
+
-
81
Br, 58); HRMS (ASAP) [C12H15OSi
79
Br] calculated 282.0076, found 
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282.0083. 
1-Bromo-4-ethynyl-2-methoxybenzene 226 
 
 
((4-Bromo-3-methoxyphenyl)ethynyl)trimethylsilane (4.09 g, 14.5 mmol) was 
dissolved in THF (285 mL) and cooled to 0 
°
C under argon. TBAF (20.2 mL,  
20.2 mmol) was then added dropwise at 0 
°
C. The reaction was allowed to warm to 
room temperature, then stirred at this temperature for 1 hour. This mixture was then 
evaporated to give a black oil. The residue was redissolved in EtOAc (500 mL) and 
then passed through a Celite plug, washed with water (2 x 250 mL), then brine  
(250 mL), dried over MgSO4, filtered and evaporated to give a brown oil. The crude 
product was purified by silica gel chromatography, eluent 5% EtOAc in hexane. Pure 
fractions were evaporated to give desired product as an orange solid (2.1 g, 69%), 
mp 37.4-38.8 
o
C. 
1
H NMR (400 MHz, CDCl3): δ 3.12 (1H, s, H8), 3.89 (3H, s, 
OMe), 6.92-7.01 (2H, m, H3,6), 7.48 (1H, d, J=8.1 Hz, C5);
 13
C NMR (176 MHz, 
CDCl3): δ 56.2 (OMe), 77.9 (C8), 82.8 (C7), 112.9 (C1), 115.2 (C6), 122.3 (C2), 125.5 
(C3), 133.2 (C5), 155.6 (C4); IR (max, cm
-1
) 2051.4 (w, alkyne C-C), 2938.5 (w, 
alkene C-H), 3257.6 (s, alkyne C-H), inter alia; LRMS (ASAP) 210.0 (M
+
-
79
Br, 
54%), 212.0 (M
+
-
81
Br, 57); HRMS (ASAP) [C9H7O
79
Br] calculated 209.9680, found 
209.9689.
 
 [(Z)-7-Bromo-7-(4-bromo-3-methoxyphenyl)ethenyl] boronic acid 227 
 
To a well-stirring solution of BBr3 (0.19 mL, 1.92 mmol) in DCM (18 mL) was 
added 1-bromo-4-ethynyl-2-methoxybenzene  (0.402 g, 1.92 mmol) at -78 
°
C under a 
positive pressure of argon. The resulting purple solution was stirred at – 78 °C for  
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2 hours and warmed to 0 
°
C before adding NaHCO3 (0.323 g, 3.84 mmol) dissolved 
in H2O (13 mL). The resulting pale yellow solution was stirred for 25 minutes, then 
transferred to a separating funnel. The mixture was extracted with DCM (2 x 20 mL) 
and the organics washed with H2O (20 mL) and brine (20 mL), dried over MgSO4, 
filtered and evaporated to yield [(Z)-7-bromo-7-(4-bromo-3-methoxyphenyl)ethenyl] 
boronic acid as an unstable pale yellow solid (0.522 g, 81%), mp 115.3-118.1 °C.  
1
H NMR (400 MHz, CDCl3): δ 3.94 (3H, s, CH3), 6.47 (1H, s, H8), 7.03-7.19 (2H, 
m, H2,6), 7.45-7.60 (1H, m, H5); 
11
B NMR (128 MHz, CDCl3): δ 27.61. The 
compound was taken on to the next stage without any further purification or 
characterisation. All spectroscopic data were consistent with those reported 
previously.
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 (Z)-2-(2-Bromo-2-(4-bromo-3-methoxyphenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 228 
 
To a well-stirring solution of BBr3 (6.0 mL, 6.0 mmol, 1.0 M in DCM) in DCM (57 
mL) was added 1-bromo-4-ethynyl-2-methoxybenzene (1.25 g, 6.0 mmol) in DCM 
(10 mL) at -78 
°
C under a positive pressure of argon. The resulting purple solution 
was stirred at – 78 °C for 2 hours and warmed to 0 °C before adding sat. NaHCO3  
(19 mL). The resulting orange solution was stirred for 10 minutes, then transferred to 
a separating funnel. The mixture was extracted with DCM (2 x 114 mL) and the 
organics washed with H2O (114 mL) and brine (114 mL), dried over MgSO4, filtered 
and evaporated to yield a brown oil. This crude residue was then redissolved in 
DCM (63 mL) and MgSO4 (1.46 g, 12.1 mmol) and pinacol (0.716 g, 6 mmol) were 
added. The reaction mixture was stirred for 1 hour at room temperature, then the 
solution was filtered and evaporated to give desired product as a brown solid (1.88 g, 
75%), mp 74.8-77.0 °C.
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1
H NMR (700 MHz, CDCl3): δ 1.35 (12H, s, Bpin), 3.91 
(3H, s, OMe), 6.43 (1H, s, H1), 7.07-7.13 (2H, m, H4,8), 7.49 (1H, d, J=8.3 Hz, H7);  
11
B NMR (128 MHz, CDCl3): δ 29.18; 
13
C NMR (176 MHz, CDCl3): δ 25.0 (Bpin), 
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56.4 (OMe), 84.2 (C2), 111.3 (C4), 113.2 (C6), 120.9 (C8), 133.1 (C7), 138.9 (C3), 
141.8 (C1), 155.6 (C5);  IR (max, cm
-1
) KBr disk 2978 (m), 2942 (m), inter alia;
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LRMS (ASAP) 415.0 (M
+
-
10
B
79
Br, 11%), 416.0 (M
+
-
11
B
79
Br, 57), 417.0 (M
+
-
10
B
81/79
Br,  88), 418.0 (M
+
-
11
B
81/79
Br, 99), 419.0 (M
+
-
10
B
81
Br, 100), 420.0 (M
+
-
11
B
81
Br, 65); HRMS (ASAP) [C15H19
10
BO3Br2] calculated 414.9830, found 
414.9826. Structure confirmed by X-ray crystallography.
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1-[(Z)-7-Bromo-8-iodoethenyl]-3-methoxy-4-bromobenzene 238 
 
To a solution of [(Z)-7-bromo-7-(4-bromo-3-methoxyphenyl)ethenyl] boronic acid 
(0.972 g, 2.90 mmol) in MeCN (17 mL), protected from light, was added  
N-iodosuccinimide (0.780 g, 3.48 mmol) and the reaction mixture was stirred for  
3 hours at room temperature. The reaction mixture was diluted with EtOAc (60 mL) 
and washed with 5% Na2S2O5 (2 x 60 mL), H2O (2 x 60 mL) and brine (60 mL). The 
organic layer was dried over MgSO4, filtered and evaporated to yield 1.05 g of a 
crude orange oil. The crude product was purified by silica gel chromatography at  
0 
°
C, eluent 5% EtOAc in petroleum ether. Pure fractions were evaporated to yield  
1-[(Z)-7-bromo-8-iodoethenyl]-3-methoxy-4-bromobenzene as a pale yellow 
amorphous powder (0.947 g, 78%). 
1
H NMR (400 MHz, CDCl3) δ: 3.92 (3H, s, Me), 
6.98 (1H, dd, J = 8.3, 2.1 Hz, H2), 7.03 (d, J = 2.1 Hz, 1H, H6), 7.44 (1H, s, H8), 7.50 
(d, J=8.2 Hz, 1H, H5); 
13
C NMR (176 MH z, CDCl3) δ: 56.3 (Me), 83.7 (C8), 111.4 
(C6), 113.1 (C1), 120.9 (C2), 133.1 (C5), 136.5 (C4), 140.0 (C7), 155.7 (C3); IR (max, 
cm
-1
) 3044.4 (w, arom. C-H), 2939.5 (w, alkene C-H), 1585.7 (m, arom. C=C), 
1581.5 (m, arom. C=C), 1546.2 (m, arom. C=C); LCMS (ASAP) 416.8 (M
+
-
79
Br, 
55%), 418.8 (M
+
-
81/79
Br, 100), 420.8 (M
+
-
81
Br, 53); HRMS (ASAP) calculated 
[C9H7Br2IO]
 
417.8065, found 417.7909. 
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1-Bromo-4-(1-bromoethenyl)-2-methoxybenzene 236 
 
 
To a well-stirring solution of BBr3 (4.8 mL, 4.78 mmol, 1.0 M solution in DCM) in 
DCM (45 mL) at -78 
o
C was added a solution of 1-bromo-4-ethynyl-2-
methoxybenzene (1.0 g, 4.78 mmol) dropwise. The resulting deep pink solution was 
then stirred at -78 
°
C for 3 hours. The reaction mixture was then allowed to warm to 
0 
°
C and sat. NaHCO3 (15 mL), followed by Et2O (30 mL), were added dropwise at  
0 
°
C. The now pale yellow reaction mixture was then stirred at this temperature for  
2 hours. The reaction mixture was then transferred to a separating funnel and the 
layers separated. The aqueous layer was then washed with DCM (2 x 100 mL), then 
the organics was with H2O (100 mL) and then brine (100 mL). The organics were 
then dried over MgSO4, filtered and evaporated to yield 1.4 g of a pale yellow solid. 
The crude solid was then purified by silica gel chromatography, elution gradient 0% 
to 10% to 50% EtOAc in hexane. Pure fractions were evaporated to give 0.411 g of a 
pale yellow solid containing 41% desired product (0.173 g, 13%). 
1
H NMR  
(600 MHz, CDCl3): δ; 3.93 (3H, s, OMe), 5.80 (1H, d, J=2.1 Hz, H8), 6.12 (1H, d, 
J=2.1 Hz, H8), 7.02-7.12 (2H, m, H3,5), 7.50 (1H, d, J= 8.2 Hz, H6); 
13
C NMR 
(151 MHz, CDCl3): δ 56.4 (OMe), 111.2 (C3), 112.7 (C1), 118.4 (C8), 120.5 (C5), 
129.7 (C7) 132.92 (C6), 139.2 (C4) 156.5 (C2); IR (max, cm
-1
) : 2836 (m, C=C-H), 
2943 (m, C=C-H), 2970 (m, C=C-H) inter alia; LCMS (ASAP); 289.9 (M
+
-
79
Br, 
2%), 291.1 (M
+
-
81/79
Br, 5), 293.9 (M
+
-
81
Br, 3); HRMS (ASAP) calculated 
[C9H8O
79
Br2] 289.8959, found 289.8942. 
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2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 240 
 
Copper(I) chloride (16 mg, 0.158 mmol), xantphos (92  mg, 0.158 mmol), sodium 
tert-butoxide (31 mg, 0.32 mmol) and 4,4,5,5-tetramethyl-2-(tetramethyl-1,3,2-
dioxaborolan-2-yl)-1,3,2-dioxaborolane (1.33 g, 5.28 mmol) were added to a dry 
flask fitted with a Schlenk tap under argon. Dry THF (11 mL) was then added and 
the reaction stirred for 5 minutes. 1-bromo-4-ethynyl-2-methoxybenzene (1.11 g, 
5.28 mmol) was then added and the reaction stirred for 5 minutes, then dry MeOH 
(0.42 mL) was added. The reaction was stirred at room temperature overnight. The 
reaction mixture was diluted with EtOAc (110 mL) and washed with H2O (105 mL) 
and then brine (105 mL). The organics were dried over MgSO4, filtered and 
evaporated to yield 2.40 g of a dark yellow oil. The crude product was purified by 
silica gel chromatography, eluent 0-5% EtOAc in hexane. Pure fractions were 
evaporated to yield desired product as a yellow oil, which became a yellow solid on 
standing (1.40 g, 79%), mp 66.9-69.3 
o
C. 
1
H NMR (400 MHz, CDCl3) δ 1.31 (12H, 
s, Bpin), 3.90 (3H, s, Me), 6.16 (1H, d, J=18.4 Hz, H8), 6.91-7.06 (2H, m, H2,6), 7.33 
(1H, d, J=18.4 Hz, H7), 7.49 (1H, d, J=8.1 Hz, H5); 
11
B NMR (128 MHz, CDCl3) δ 
29.69; 
13
C NMR (101 MHz, CDCl3) δ 25.0 (Bpin), 56.2 (Me), 83.7 (C8), 110.1 (C7), 
112.5 (C4), 120.8 (C6), 133.5 (C1), 138.4 (C2), 148.6 (C5), 156.1 (C3); IR (max, cm
-1
) 
1548.4 (m, arom. C=C), 1619.8 (m, arom. C=C) inter alia; LRMS (ESI)  
339.1 ([M+H]-
79
Br, 47%), 341.1 ([M+H]-
81
Br, 50); HRMS (ESI) [C15H21
10
BO3
79
Br] 
calculated 338.0803, found 338.0814. 
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1-Bromo-4-[(1Z)-1-bromobuta-1,3-dien-1-yl]-2-methoxybenzene 244 
 
 
Pd(PPh3)2Cl2 (2 mg, 0.024 mmol) and 1-[(Z)-7-bromo-8-iodoethenyl]-3-methoxy-4-
bromobenzene (0.20 g, 0.481 mmol) were added to a dry flask, and the flask purged 
with argon for 5 minutes. Dry, degassed MeCN (5.0 mL) was added, followed 
tributyl(vinyl)tin (0.14 mL, 0.481 mmol). The reaction was then stirred at room 
temperature for 16 hours, then at 50 
°
C for 2 days. The reaction mixture was diluted 
with EtOAc containing ~ 3 ppm BHT (20 mL) and passed through a Celite/silica 
plug, then the solvent evaporated to give 0.408 g of a dark yellow oil. The crude 
product mixture was purified by silica gel chromatography, elution gradient 0-5% 
EtOAc in petroleum ether. Fractions containing product were evaporated to give 
0.185 g of a dark yellow oil as a mixture containing desired product (26 mg, 17%). 
1
H NMR (600 MHz, CDCl3) δ 3.92 (3H, s, OMe), 5.43 (1H, dd, J=9.6, 1.5 Hz, 
H10cis), 5.49-5.61 (1H, m, H10trans), 6.75-6.84 (2H, m, H8,9), 7.04-7.12 (3H, m, H3,5,6); 
LRMS (ASAP) 315.9 (M
+
-
79
Br, 2%), 317.9 (M
+
-
79/81
Br, 4), 319.9 (M
+
-
81
Br, 3); 
HRMS (ASAP) [C11H11Br2O] calculated 316.9177, found 316.9188. No further 
characterisation was performed. 
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 [(3Z)-4-Bromo-4-(4-bromo-3-methoxyphenyl)but-3-en-1-yn-1-yl]trimethylsilane 
251 
 
 
 
Pd(PPh3)2Cl2 (2 mg, 0.024 mmol), copper (I) iodide (1 mg, 0.048 mmol) and 1-[(Z)-
7-bromo-8-iodoethenyl]-3-methoxy-4-bromobenzene (0.2 g, 0.481 mmol) were 
added to a dry flask, and the flask sealed and purged with argon for 5 minutes. Dry, 
degassed Et3N (3.0 mL) was added, followed by ethynyl trimethylsilane (0.08 mL, 
0.577 mmol). The reaction was then stirred at room temperature for 3 days. The 
solvent was evaporated to give 0.353 g of a dark brown residue, which was subjected 
to silica gel chromatography, eluent 5% EtOAc in hexane. Fractions containing 
product were evaporated to give 0.202 g of a light brown solid which was a mixture 
containing desired product. 
1
H NMR (400 MHz, CDCl3) δ 0.19 (9H, s, SiMe3 (under 
TMS signal)), 3.91 (3H, s, OMe) 6.32 (1H, s, H8), 7.07 (1H, dd, J=8.3, 2.0 Hz, H6), 
7.16 (1H, d, J=2.0 Hz, H2), 7.49 (1H, d, J=8.2 Hz, H5); LRMS (ASAP) 385.9 (M
+
-
79
Br, 6%) 387.9 (M
+
-
79/81
Br, 14), 389.9 (M
+
-
81
Br, 10); HRMS (ASAP) calculated 
[C14H16
79
Br2OSi] 385.9337, found 385.9349. No further characterisation was 
performed (see main discussion). 
Methyl (2E)-5-(4-bromo-3-methoxyphenyl)pent-2-en-4-ynoate 252 
 
 
 
1-bromo-4-ethynyl-2-methoxybenzene (0.175 g, 0.833 mmol), methyl(2E)-3-
iodoprop-2-enoate (0.147 g, 0.694 mmol), bis(triphenylphosphine)palladium(II) 
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dichloride (49 mg, 0.007 mmol) and copper (I) iodide (1 mg, 0.007 mmol) were 
added to a flask, which was then purged with argon for 5 minutes. Dry, degassed 
Et3N (3.9 mL) was then added and the reaction stirred in the dark at room 
temperature for 3 days.  The solvent was then evaporated to give 0.347 g of a dark 
yellow solid. This residue was then purified using silica gel chromatography, eluent 
25% EtOAc in hexane. Pure fractions were evaporated to give desired product as a 
yellow solid (0.204 g, 89%), mp 85.8-86.8 
o
C. 
1
H NMR (700 MHz, CDCl3): δ 3.78 
(3H, s, H1), 3.90 (3H, s, H10), 6.32 (1H, d, J= 15.8 Hz, H3), 6.89-6.99 (3H, m, H4, H8, 
H13), 7.50 (1H, d, J= 8.0 Hz, H12); 
13
C NMR (176 MHz, CDCl3): δ 51.9 (C1), 56.3 
(C10), 86.8 (C5), 97.4 (C6), 113.6 (C11), 114.8 (C13), 122.3 (C9), 124.9 (C4), 125.4 
(C12), 130.0 (C3), 133.4 (C8), 155.7 (C7), 166.2 (C2); IR (max, cm
-1
) 1713.9 (s, C=O), 
2198.7 (s, alkyne), 2947.3 (w, alkene C-H) inter alia; LRMS (ASAP) 295.0 
([M+H]-
79
Br, 100%), 297.0 ([M+H]-
81
Br, 100); HRMS (ASAP) calculated 
[C13H12O3
79
Br] 294.9969, found 294.9970. Structure determined by X-ray 
crystallography. 
Silver(I) oxide 
A 1 M solution of NaOH in H2O (100 mL) was added slowly to a well-stirring 1 M 
solution of AgNO3 in H2O (100 mL) and the resulting flocculating solid suspension 
stirred for 5 minutes. The solid was filtered and dried to give desired product as a 
brown solid (15.4 g, 67%). 
Methyl (2E,4E)-5-(4-bromo-3-methoxyohenyl)penta-2,4-dienoate 253 
 
 
2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.256 g, 0.76 mmol), methyl (2E)-3-iodoprop-2-enoate (0.129 g, 
0.61 mmol), Pd(PPh3)2Cl2 (22 mg, 0.031 mmol) and silver oxide (0.174 g, 0.76 
mmol) were added to a dry flask and the flask sealed and purged with argon. Dry, 
degassed DME (4.6 mL) was then added and the reaction stirred at 60 °C for 2 days 
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17 hours. The reaction mixture was then diluted with EtOAc (50 mL) and passed 
through a short Celite/silica plug. The solvent was evaporated to give 0.340 g of a 
crude green/yellow solid. The crude residue was purified by silica gel 
chromatography, eluent 0-5% EtOAc in hexane to give 0.110 g of a bright yellow 
solid which rapidly polymerised, but from which the desired product could be 
identified (est. 41% I.Y. by 
1
H NMR). 
1
H NMR (400 MHz, CDCl3) δ: 3.69 (3H, s), 
3.86 (3H, s), 5.96 (1H, d, J=15.3 Hz), 6.85-6.93 (2H, m), 7.33 (1H, d, J=10.0 Hz), 
7.45-7.52 (1H, m), 7.55-7.50 (2H, m); LRMS (ASAP) 297.0 ([M+H] -
79
Br, 100%), 
299.0 ([M+H] -
79
Br, 99%) ; HRMS (ASAP) [C13H14O3Br] calculated 297.0126, 
found, 297.0128. No further characterisation was performed due to instability. 
Methyl (2E,4Z)-5-bromo-5-(4-bromo-3-methoxyohenyl)penta-2,4-dienoate 241 
 
 
2-[(Z)-2-Bromo-2-(4-bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (60 mg, 0.144 mmol), methyl (2E)-3-iodoprop-2-enoate (25 mg,  
0.12 mmol), Pd(PPh3)2Cl2 (4.2 mg, 0.006 mmol) and silver oxide (33 mg,  
0.144 mmol) were added to a dry flask and the flask sealed and purged with argon. 
Dry, degassed DME (1.1 mL) was then added and the reaction stirred at 60 °C for  
2 days 15 hours. The reaction mixture was then diluted with EtOAc (10 mL), passed 
through a short plug of Celite and the solvent evaporated to give 57 mg of a crude 
brown oil from which the desired product could be identified. 
1
H NMR (400 MHz, 
CDCl3) δ: 3.74 (3H, s), 3.90 (3H, s), 6.12 (1H, dd, J=15.4, 0.9 Hz), 7.03-7.12 (2H, 
m), 7.35 (1H, dd, J=8.1, 2.0 Hz), 7.46 (2H, d, J=8.0 Hz); LRMS (ASAP)  
374.9 ([M+H]-
79
Br, 36%), 376.9 ([M+H]-
79/81
Br, 68%), 378.9 ([M+H]-
81
Br, 36%). 
HRMS (ASAP) [C13H13O3Br2] calculated 374.9231, found 374.9247. No further 
characterisation was performed (see main discussion). 
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 (2E,4E)-5-(4,4,6-Trimethyl-[1,3,2-dioxaborinan-2-yl]-penta-2,4-dienoic acid methyl 
ester 259 
 
Method 1: To a dry Schlenk flask was added Pd(OAc)2 (36 mg, 0.160 mmol), 
 P(o-tol)3 (0.10 g, 0.330 mmol) and AgOAc (0.601 g, 3.60 mmol). The flask was 
purged with argon, and dry, degassed MeCN (10 mL) was added. 4,4,6-Trimethyl-2-
vinyl-1,3,2-dioxaborinane (0.655 mL, 3.80 mmol) was then added, followed by 
methyl (2E)-3-iodoprop-2-enoate (0.704 g, 3.32 mmol). The vessel was purged 
further with argon, and the reaction mixture was then heated to 50 °C with vigorous 
stirring for 2 days. The mixture was allowed to cool, then diluted with Et2O  
(280 mL) and passed through a short Celite/silica plug. The organic extracts were 
washed with 5% HCl (40 mL), H2O (80 mL) and brine (80 mL), dried over MgSO4 
and evaporated to yield 0.980 g of crude product as an orange oil. The crude product 
was purified by silica gel chromatography, eluent 10% EtOAc in hexane elution. 
Pure fractions were evaporated to yield (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-
dioxaborinan-2-yl]-penta-2,4-dienoic acid methyl ester as a yellow oil (0.404 g, 
51%). 
1
H NMR (400 MHz, CDCl3): δ 1.35-1.24 (9H, m, H9,10,11), 1.5-1.47 (1H, m, 
H7), 1.81 (1H, dd, J=14.0, 2.9 Hz, H7), 3.75 (3H, s, Me), 4.24 (1H, dqd, J=12.3, 6.2, 
2.9 Hz, H6), 5.99-5.86 (2H, m, H2,5), 6.97 (1H, ddd, J=17.3, 11.0, 0.7 Hz, H4),  
7.33-7.21 (1H, m, H3); 
11
B NMR (128 MHz, CDCl3): δ 25.52; 
13
C NMR (101 MHz, 
CDCl3): δ 23.58 (C9,10,11), 28.62 (C9,10,11), 31.65 (C9,10,11), 46.41 (C7), 52.12 (Me), 
65.52 (C6), 71.67 (C8), 123.17 (C2,5), 143.89 (C4), 146.54 (C3), 167.93 (C1); IR (max, 
cm
-1
) 2974.3 (w, C=C-H) 1719.5 (s, C=O) inter alia; LCMS (ESI) 237.1 (M
+
-
10
B, 
5%), 238.1 (M
+
-
11
B, 59); HRMS (ESI+) calculated [C12H19BO4+H]
+
 238.1470, 
found 238.1491.  
Method 2: To a dry flask was added methyl (2E)-3-iodoprop-2-enoate (2.82 g,  
13.3 mmol), Pd(OAc)2 (0.150 g, 0.67 mmol), P(o-tol)3 (0.408 g, 1.34 mmol) and 
AgOAc (2.41 g, 14.4 mmol).  The flask was purged with argon, and dry, degassed 
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MeCN (80 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.6 mL, 
15.2 mmol) was then added, the vessel was purged further with argon, and the 
reaction mixture was then heated to 50 °C with vigorous stirring for 23 hours. The 
mixture was allowed to cool, then diluted with Et2O (200 mL) and passed through a 
short Celite/silica plug. The organic extracts were washed with NH4Cl (200 mL), 
H2O (200 mL) and brine (200 mL), dried over MgSO4, filtered and evaporated to 
give crude product as a yellow oil (2.65g, 83%). The compound was taken on to the 
next stage without any further purification or characterisation. 
Method 3: To a dry flask was added methyl (2E)- 3-iodoprop-2-enoate (2.82 g,  
13.3 mmol), Pd(OAc)2 (0.150 g, 0.67 mmol), P(o-tol)3 (0.408 g, 1.34 mmol) and 
AgOAc (2.41 g, 14.4 mmol).  The flask was purged with argon, and dry, degassed 
MeCN (72 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.6 mL, 
15.2 mmol) was then added, the vessel was purged further with argon, and the 
reaction mixture was then heated to 30 °C with vigorous stirring for 19 hours. The 
mixture was allowed to cool, then diluted with Et2O (200 mL) and passed through a 
short Celite/silica plug. The solvent was evaporated to give crude product as a 
yellow oil (2.84g, 89%). The compound was taken on to the next stage without any 
further purification or characterisation. 
Method 4: To a dry flask was added methyl (2E)-3-iodoprop-2-enoate (1.0 g,  
4.72 mmol), Pd(OAc)2 (0.011 g, 0.0472 mmol), tri(2-furyl)phosphine (0.022 g,  
0.094 mmol) and AgOAc (0.851 g, 5.11 mmol). The flask was purged with argon, 
and dry, degassed MeCN (28 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.93 mL, 5.4 mmol) was then added, the vessel was purged further 
with argon, and the reaction mixture was stirred vigorously at room temperature for 
3 hours. The mixture was diluted with Et2O (71 mL) and passed through a short 
Celite/silica plug. The solvent was evaporated to give crude product as a pale yellow 
oil (1.0 g, 89%). The compound was taken on to the next stage without any further 
purification or characterisation. 
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Methyl (2E,4E)-5-iodopenta-2,4-dienoate 260 
 
Method 1: NaOMe (4.2 mL, 2.10 mmol, 0.5 M solution in MeOH) was added 
dropwise to a solution of (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-dioxaborinan-2-yl]-
penta-2,4-dienoic acid methyl ester (0.404 g, 1.70 mmol) in THF (6.0 mL) cooled to 
-78 °C for 1 hour 50 minutes. The reaction mixture was allowed to warm to room 
temperature whilst stirring. The mixture was diluted with Et2O (60 mL) and washed 
with 5% Na2S2O5 (2 x 20 mL), H2O (20 mL) and brine (20 mL). The organic extracts 
were dried over MgSO4, filtered and evaporated to yield a pale orange solid. The 
crude material was purified by silica gel chromatography, eluent 5% EtOAc in 
petroleum ether at 0 °C. Pure fractions were evaporated to yield methyl (2E,4E)-5-
iodopenta-2,4-dienoate as a white solid (0.337 g, 83%). 
1
H NMR (400 MHz, 
CDCl3): δ 3.75 (3H, s), 5.84-5.98 (1H, m), 6.89-6.98 (1H, m), 7.12-7.22 (2H, m); 
13
C NMR (101 MHz, CDCl3): δ 51.6, 89.6, 92.0, 121.0, 125.1, 136.4, 142.9. The 
compound was taken on to the next stage without any further characterisation.
  
Method 2: NaOMe (28 mL, 14.2 mmol, 0.5 M solution in MeOH) was added 
dropwise to a solution of (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-dioxaborinan-2-yl]-
penta-2,4-dienoic acid methyl ester (2.84 g, 11.9 mmol) in THF (44 mL) cooled to  
-78 °C under argon in the absence of light. The mixture was stirred at this 
temperature for 1 hour 5 minutes and iodine monochloride (12 mL, 12.1 mmol, of a 
1.0 M solution in DCM) was added dropwise. The mixture was stirred at -78 °C for 
2 hours, then allowed to warm to room temperature whilst stirring. The mixture was 
diluted with Et2O (356 mL) and washed with 5% Na2S2O5 (2 x 142 mL), water  
(142 mL) and brine (142 mL). The organic extracts were dried over MgSO4, filtered 
and evaporated to 3.2 g of a brown oil containing desired product (2.14 g, 76%). The 
compound was taken on to the next stage without any further purification or 
characterisation. 
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Methyl (2E,4E,6E)-7-(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-2,4,6-
trienoate 261 
 
Method 1: To a dry Schlenk flask was added Pd(OAc)2 (16 mg, 0.0710 mmol),  
P(o-tol)3 (43 mg, 0.142 mmol) and AgOAc (0.284 g, 1.70 mmol), followed by a 
solution of (2E,4E)-5-iodopenta-2,4-dienoate (0.337 g, 1.42 mmol) in dry, degassed 
MeCN (4.5 mL). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.24 mL, 1.42 mmol) 
was then added and the reaction mixture was then heated to 50 °C with vigorous 
stirring for 2 days. The mixture was allowed to cool, then diluted with Et2O (80 mL) 
and passed through a short Celite/silica plug. The organic extracts were washed with 
H2O (40 mL) and brine (40 mL), dried over MgSO4, filtered and evaporated to yield 
0.333 g of crude product as an orange oil. The crude product was purified by silica 
gel chromatography, eluent 10% EtOAc in hexane, to yield methyl (2E,4E,6E)-7-
(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-2,4,6-trienoate as a pale yellow 
solid (78 mg, 21%), mp 80.1-82.1°C. 
1
H NMR (400 MHz, CDCl3): δ 1.36-1.23 (9H, 
m, H11,12,13), 1.56-1.47 (1H, m, H9), 1.80 (1H, dd, J=13.9, 3.0 Hz, H9), 3.75 (3H, s, 
Me), 4.24 (1H, dqd, J=12.3, 6.2, 3.2 Hz, H8), 5.71 (1H, d, J=17.4 Hz, H7), 5.92 (1H, 
d, J=15.3 Hz, H2), 6.46-6.33 (1H, m, H4), 6.58 (1H, ddd, J=15.0, 10.7, 0.9 Hz, H5), 
6.97 (1H, dd, J=17.4, 10.7 Hz, H6), 7.35-7.27 (1H, m, H3); 
11
B NMR (128 MHz, 
CDCl3): δ 25.90; 
13
C NMR (101 MHz, CDCl3): δ 23.1 (C11,12,13), 28.1 (C11,12,13), 31.2 
(C11,12,13), 46.0 (C9), 51.6 (Me), 64.9 (C8), 71.0 (C10), 121.5 (C2,7), 131.7 (C4), 142.4 
(C5), 144.5 (C3), 145.2 (C6), 167.4 (C1); IR (max, cm
-1
) 2972.0 (w, C=C-H), 2949.7 
(w, C=C-H), 2924.1 (w, C=C-H) 1705.9 (C=O) inter alia; LCMS (ESI) 263.2 (M
+
-
10
B, 5%), 264.2 (M
+
-
11
B, 45); HRMS (ESI+) calculated [C14H21BO4+H]
+
 264.1620, 
found 264.1647.  
Method 2: To a dry flask was added Pd(OAc)2 (0.120 g, 0.525 mmol), P(o-tol)3 
(0.315 g, 1.50 mmol) and AgOAc (1.89 g, 11.3 mmol). The flask was purged with 
argon, and a solution of (2E,4E)-5-iodopenta-2,4-dienoate (2.50 g, 10.5 mmol) in 
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dry, degassed MeCN (63 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-
dioxaborinane (2.2 mL, 12.6 mmol) was then added, the vessel was purged further 
with argon, and the reaction mixture was then heated to 50 °C with vigorous stirring 
for 19.5 hours. The mixture was allowed to cool, then diluted with Et2O (180 mL) 
and passed through a short Celite/silica plug. The organic extracts were washed with 
NH4Cl (180 mL), H2O (180 mL) and brine (100 mL), dried over MgSO4, filtered, 
evaporated and dried on the high vacuum line for 2 days to give crude product as a 
brown oil (1.7 g, 48% from starting acrylate). The compound was taken on to the 
next stage without any further purification or characterisation. 
Method 3: To a dry flask was added Pd(OAc)2 (0.102 g, 0.460 mmol), P(o-tol)3 
(0.276 g, 0.911 mmol) and AgOAc (1.64 g, 9.81 mmol), followed by a solution of 
(2E,4E)-5-iodopenta-2,4-dienoate (2.14 g, 8.99 mmol) in dry, degassed MeCN  
(54 mL). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (1.8 mL, 10.3 mmol) was 
then added and the reaction mixture was then heated to 30 °C with vigorous stirring 
for 18.5 hours. The mixture was allowed to cool, then diluted with Et2O (136 mL) 
and passed through a short Celite/silica plug. The solvent was evaporated to yield  
3.8 g of a crude yellow solid containing desired product (2.28 g, 96%). The 
compound was taken on to the next stage without any further purification or 
characterisation. 
Methyl (2E,4E,6E)-7-iodohepta-2,4,6-trienoate 230 
 
NaOMe (21 mL, 10.3 mmol, 0.5 M solution in MeOH) was added dropwise to a 
solution of methyl (2E,4E,6E)-7-(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-
2,4,6-trienoate (2.28 g, 8.6 mmol) in THF (32 mL) cooled to -78 °C under argon in 
the absence of light. The mixture was stirred at this temperature for 40 minutes and 
iodine monochloride (8.8 mL, 8.77 mmol, 1.0 M solution in DCM) was added 
dropwise. The mixture was stirred at -78 °C for 2 hours, then allowed to warm to 
room temperature whilst stirring. The mixture was diluted with Et2O (258 mL) and 
washed with Na2S2O5 (2 x 103 mL), water (103 mL) and brine (103 mL). The 
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organic extracts were dried over MgSO4, filtered and evaporated to yield 4.9 g of a 
red solid, from which completion was assumed. 
1
H NMR (400 MHz, CDCl3): δ 3.74 
(3H,s), 5.98 (1H, d, J=15.3 Hz), 6.24-6.47 (2H, m), 6.61-6.71 (1H, m), 7.08-7.18 
(1H, m), 7.20-7.31 (1H, m). The compound was taken on to the next stage without 
any further purification or characterisation.
 
Methyl (2E,4E,6E,8E)-9-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)nona-2,4,6,8-
tetraenoate 262 
 
Method 1: To a dry flask was added Pd(OAc)2 (82 mg, 0.357 mmol), P(o-tol)3  
(0.214 g, 0.714 mmol) and AgOAc (1.29 g, 7.71 mmol), followed by a solution of 
methyl (2E, 4E, 6E)-7-iodohepta-2,4,6-trienoate (1.70 g, 6.44 mmol) in dry, degassed 
MeCN (43 mL), which had been previously degassed by a bubbling argon needle. 
4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (1.5 mL, 8.57 mmol) was then added 
and the reaction mixture was then heated to 50 °C with vigorous stirring for  
21 hours. The mixture was allowed to cool, then diluted with Et2O (150 mL) and 
passed through a short Celite/silica plug. The organic extracts were washed with 
H2O (150 mL) and brine (150 mL), dried over MgSO4, filtered and evaporated to 
yield 2.2 g of crude product as a brown oil. After drying the crude product on the 
high vacuum line for 2 days, 1.2 g of an orange solid was obtained. The compound 
was taken on to the next stage without any further purification or characterisation. 
Method 2: To a dry flask was added Pd(OAc)2 (98 mg, 0.44 mmol), P(o-tol)3  
(0.265 g, 0.875 mmol) and AgOAc (1.57 g, 9.42 mmol), followed by a solution of 
methyl (2E, 4E, 6E)-7-iodohepta-2,4,6-trienoate (2.28 g, 8.60 mmol) in dry, 
degassed MeCN (52 mL). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (1.4 mL, 
8.60 mmol) was then added and the reaction mixture was then heated to 30 °C with 
vigorous stirring for 15.5 hours. The mixture was allowed to cool, then diluted with 
Et2O (131 mL) and passed through a short Celite/silica plug. The solvent was 
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evaporated to yield 3.95 g of a crude viscous orange oil containing desired product 
(1.90 g, 76%). After drying the crude product on the high vacuum line for 2 days,  
1.2 g of an orange solid was obtained. The compound was taken on to the next stage 
without any further purification or characterisation. 
Method 3: To a dry flask was added Pd(OAc)2 (0.134 g, 0.440 mmol), P(o-tol)3 
(0.364 g, 1.20 mmol) and AgOAc (2.16 g, 13.0 mmol), followed by a solution of 
methyl (2E, 4E, 6E)-7-iodohepta-2,4,6-trienoate (3.14 g, 11.9 mmol) in dry, 
degassed MeCN (72 mL). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane  
(2.0 mL, 11.9 mmol) was then added and the reaction mixture was then heated to  
30 °C with vigorous stirring for 18 hours. The mixture was allowed to cool, then 
diluted with Et2O (180 mL) and passed through a short Celite/silica plug. The 
solvent was evaporated to yield 4.5 g of a crude viscous orange oil. The crude 
product was purified by silica gel chromatography, eluent 5% EtOAc in petroleum 
ether, to give desired product as a bright yellow solid (0.9 g, 23% from iodoacrylate). 
1
H NMR (700 MHz, CDCl3): δ 1.23-1.33 (9H, m, H13,14,15), 1.45-1.56 (1H, m, H11), 
1.79 (1H, dd, J=13.9, 2.9 Hz, H11), 3.74 (3H, s, Me), 4.22 (1H, dqd, J=11.5, 6.1,  
2.9 Hz, H10), 5.59-5.65 (1H, m, H9), 5.84-5.93 (1H, m, H2), 6.27-6.46 (3H, m, H4,6,7), 
6.54-6.63 (1H, m, H5), 6.91-7.00 (1H, m, H8), 7.28-7.37 (1H, m, H3); 
11
B NMR (128 
MHz, CDCl3): δ 25.92; 
13
C NMR (176 MHz, CDCl3): δ 23.1 (C13,14,15),  
28.1 (C13,14,15), 31.2 (C13,14,15), 45.9 (C11), 51.5 (Me), 64.8 (C10), 70.9 (C12),  
110.1 (C9), 120.6 (C2), 130.9 (C4,6,7), 133.6 (C4,6,7), 138.9 (C4,6,7), 140.6 (C5),  
144.4 (C3), 145.8 (C8), 167.4 (C1); LCMS (ASAP) 289.2 (M
+
-
10
B, 3%), 290.2 (M
+
-
11
B, 15); HRMS (ASAP) calculated [C16H24
10
BO4] 290.1804, found 290.1777. The 
compound was taken on to the next stage without any further purification or 
characterisation. 
Methyl (2E,4E,6E,8E)-9-iodonona-2,4,6,8-tetraenoate 263 
 
NaOMe (26 mL, 13.1 mmol, 0.5 M solution in MeOH) was added dropwise over 5 
minutes to a solution of a crude mixture containing methyl (2E,4E,6E,8E)-9-(4,4,6-
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trimethyl-1,3,2-dioxaborinan-2-yl)nona-2,4,6,8-tetraenoate (3.20 g, 10.9 mmol) in 
dry THF (41 mL) cooled to -78 °C under argon in the absence of light. The mixture 
was stirred at this temperature for 50 minutes and iodine monochloride (2.10 g,  
11.3 mmol) in dry DCM (11 mL) was added dropwise over 5 minutes. The mixture 
was stirred at -78 °C for 3 hours 40 minutes, then allowed to warm to room 
temperature. The mixture was diluted with Et2O (329 mL) and washed with Na2S2O5 
(2 x 132 mL), H2O (132 mL) and brine (132 mL). The organic extracts were dried 
over MgSO4, filtered and evaporated to yield 3.3 g of a dark brown solid. The crude 
product was purified by silica gel chromatography at 0 
o
C, eluent 0-5 % EtOAc in 
petroleum ether. Pure fractions were evaporated to yield desired product as an 
unstable yellow solid (0.754 g, 20% from starting iodoacrylate) 
1
H NMR (700 MHz, 
CDCl3): δ 3.75 (3H,s, OMe), 5.92 (1H, d, J=15.0 Hz, H2), 6.29 (1H, dd, J=8.7,  
6.1 Hz, H7), 6.38-6.45 (1H, m, H4), 6.47-6.55 (2H, m, H5,8), 7.07-7.14 (1H, m, H6),  
7.27-7.34 (2H, m, H3,9); 
13
C NMR (176 MHz, CDCl3) δ 51.7 (Me), 121.3 (C2),  
131.9 (C4), 132.1 (C7), 135.7 (C8), 139.8 (C5), 141.1 (C9), 144.2 (C3), 145.0 (C6), 
167.5 (C1); LRMS (ASAP) [M+H]= 291.0. HRMS (ASAP) [C10H12O2
127
I], 
calculated 290.9882, found 290.9896. 
Methyl (2E,4E,6E,8E,10E)-11-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)undeca-
2,4,6,8,10-pentaenoate 231 
 
To a dry flask was added Pd(OAc)2 (45 mg, 0.197 mmol), P(o-tol)3 (0.117 g, 
0.394 mmol) and AgOAc (0.713 g, 4.26 mmol), followed by a solution of methyl 
(2E,4E,6E,8E)-9-iodonona-2,4,6,8-tetraenoate (1.10 g, 3.79 mmol) in dry, degassed 
MeCN (24 mL). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.75 mL, 4.34 mmol) 
was then added and the reaction mixture was then heated to 50 °C with vigorous 
stirring for 21 hours. The mixture was allowed to cool, then diluted with Et2O  
(100 mL) and passed through a short Celite/silica plug. The organic extracts were 
washed with H2O (100 mL) and brine (100 mL), dried over MgSO4, filtered and 
evaporated to yield 1.2 g of crude product a deep red solid. A small portion (0.153 g) 
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was taken and purified by silica gel chromatography, eluent 10% EtOAc in 
petroleum ether 40-60 
o
C to verify presence of product. 
1
H NMR (400 MHz, 
CDCl3): δ 1.21-1.35 (9H, m), 1.41-1.51 (1H, m), 1.72-1.88 (1H, m), 3.74 (3H, s), 
4.23 (1H, dqd, J=12.2, 6.2, 2.9 Hz), 5.56-5.68 (1H, m), 5.88 (1H, d, J=15.3 Hz), 
6.25-6.50 (5H, m), 6.92-7.02 (1H, m), 7.32 (1H, ddd, J=13.0, 11.0, 3.7 Hz);  
11
B NMR (128 MHz, CDCl3) δ 23.80. The compound was taken on to the next stage 
without any further purification or characterisation. 
Methyl (2E,4E,6E,8E,10E)-11-iodoundeca-2,4,6,8,10-pentaenoate 264 
 
NaOMe (7.0 mL, 3.49 mmol, 0.5 M solution in MeOH) was added dropwise to a 
solution of (2E,4E,6E,8E,10E)-11-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)undeca-
2,4,6,8,10-pentaenoate (1.05 g, 3.33 mmol) in THF (12 mL) cooled to -78 °C under 
argon in the absence of light. The mixture was stirred at this temperature for 1 hour 
25 minutes and iodine monochloride (3.0 mL, 3.0 mmol, a 1.0 M solution in DCM) 
was added dropwise. The mixture was stirred at -78 °C for 1.5 hours, then allowed to 
warm to room temperature while stirring. The mixture was diluted with Et2O  
(150 mL) and washed with 5% Na2S2O5 (2 x 60 mL), H2O (60 mL) and brine 
(60 mL). The organic extracts were dried over MgSO4, filtered and evaporated to 
yield 0.70 g of a dark brown solid. 
1
H NMR (400 MHz, CDCl3): δ 3.75 (3H, s),  
5.72-5.84 (1H, m), 5.85-5.96 (1H, m), 6.16-6.47 (5H, m), 6.47-6.69 (1H, m),  
7.02-7.13 (1H, m), 7.28-7.37 (1H, m). The compound was taken on to the next stage 
without any further purification or characterisation. 
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Methyl (2E,4E,6E,8E,10E,12E)-13-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)trideca-
2,4,6,8,10,12-hexaenoate 265 
 
To a dry flask was added Pd(OAc)2 (26 mg, 0.110 mmol), P(o-tol)3 (68 mg,  
0.210 mmol) and AgOAc (0.414 g, 2.26 mmol), followed by a solution of methyl 
(2E,4E,6E,8E,10E)-11-iodoundeca-2,4,6,8,10-pentaenoate (0.70 g, 2.20 mmol) in 
dry, degassed THF(4 mL) and dry, degassed MeCN (13 mL), which had been 
previously degassed by a bubbling argon needle. 4,4,6-Trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.44 mL, 2.52 mmol) was then added and the reaction mixture was 
then heated to 50 °C with vigorous stirring for 20 hours. The mixture was allowed to 
cool, then diluted with Et2O (100 mL) and passed through a short Celite/silica plug. 
The organic extracts were washed with H2O (100 mL) and brine (100 mL), dried 
over MgSO4, filtered and evaporated to yield 0.661 g of crude product a neon orange 
solid. 
1
H NMR (400 MHz, CDCl3) δ 1.15-1.35 (9H, m), 1.50 (1H, dd, J=13.9,  
11.6 Hz), 1.79 (1H, dd, J=13.9, 2.9 Hz), 3.75 (3H, s), 4.22 (1H, dqd, J=11.7, 6.2,  
3.0 Hz), 6.22-6.48 (7H, m), 6.49-6.70 (1H, m), 7.01-7.18 (2H, m), 7.28-7.36 (2H, 
m). LRMS (ESI) M=342.1. The compound was taken on to the next stage without 
any further purification or characterisation. 
Methyl (2E,4E,6E,8E,10E,12E)-13-iodotrideca-2,4,6,8,10,12-hexaenoate 266 
 
NaOMe (4.6 mL, 2.31 mmol, 0.5 M solution in MeOH) was added dropwise to a 
solution of methyl (2E,4E,6E,8E,10E,12E)-13-(4,4,6-trimethyl-1,3,2-dioxaborinan-
2-yl)trideca-2,4,6,8,10,12-hexaenoate (0.661 g, 1.93 mmol) in THF (7.2 mL) cooled 
to -78 °C under argon in the absence of light. The mixture was stirred at this 
temperature for 50 minutes and iodine monochloride (2.0 mL, 1.99 mmol, 1.0 M 
solution in DCM) was added dropwise. The mixture was stirred at -78 °C for 1 hour 
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20 minutes, then allowed to warm to room temperature while stirring. The mixture 
was diluted with Et2O (100 mL) and washed with 5% Na2S2O5 (2 x 50 mL), H2O  
(50 mL) and brine (50 mL). The organic extracts were dried over MgSO4, filtered 
and evaporated to yield 0.523 g of a dark brown solid. The compound was taken on 
to the next stage without any further purification or characterisation (see main 
discussion). 
Methyl (2E,4E,6E,8E,10E,12E,14E)-15-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-
yl)pentadeca-2,4,6,8,10,12,14-heptaenoate 267 
 
To a dry flask was added Pd(OAc)2 (14 mg, 0.0610 mmol), P(o-tol)3 (37 mg,  
0.120 mmol) and AgOAc (0.223 g, 1.24 mmol), followed by a solution of methyl 
(2E,4E,6E,8E,10E,12E)-13-iodotrideca-2,4,6,8,10,12-hexaenoate (0.418 g,  
1.22 mmol) in dry, degassed THF (3.1 mL) and dry, degassed MeCN (7.7 mL). 
4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.24 mL, 1.37 mmol) was then added 
and the reaction mixture was then heated to 50 °C with vigorous stirring for  
17 hours. The mixture was allowed to cool, then diluted with Et2O (80 mL) and 
passed through a short Celite/silica plug. The organic extracts were washed with 
H2O (80 mL) and brine (80 mL), dried over MgSO4, filtered and evaporated to yield 
0.440 g of crude product a neon orange solid. The compound was taken on to the 
next stage without any further purification or characterisation (see main discussion). 
Methyl (2E,4E,6E,8E,10E,12E,14E)-15-iodopentadeca-2,4,6,8,10,12,14-heptaenoate 
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NaOMe (2.5 mL, 1.25 mmol, 0.5 M solution in MeOH) was added dropwise to a 
solution of methyl (2E,4E,6E,8E,10E,12E,14E)-15-(4,4,6-trimethyl-1,3,2-
dioxaborinan-2-yl)pentadeca-2,4,6,8,10,12,14-heptaenoate (0.440 g, 1.20 mmol) in 
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THF (4.4 mL) cooled to -78 °C under argon in the absence of light. The mixture was 
stirred at this temperature for 50 minutes and iodine monochloride (1.1 mL,  
1.08 mmol, 1.0 M solution in DCM) was added dropwise. The mixture was stirred at 
-78 °C for 1 hour 5 minutes, then allowed to warm to room temperature while 
stirring. The mixture was diluted with Et2O (80 mL) and washed with 5% Na2S2O5 
(2 x 40 mL), water (40 mL) and brine (40 mL). The organic extracts were dried over 
MgSO4, filtered and evaporated to yield 0.287 g of an orange solid. The compound 
was taken on to the next stage without any further purification or characterisation 
(see main discussion). 
Methyl (2E)-5-(trimethylsilyl)pent-2-en-4-ynoate 283 
 
 
 
(2E)-3-iodoprop-2-enoate (5.0 g, 23.5 mmol), Pd(PPh3)2Cl2 (0.160 g, 0.240 mmol) 
and copper (I) iodide (45 mg, 0.240 mmol) were added to a dry 3-neck flask and the 
vessel purged with argon for 5 minutes. Dry, degassed THF (60 mL) was added and 
then the solution was cooled to 0 °C.  Et3N (6.5 mL, 47.0 mmol) was added, 
followed by ethynyltrimethylsilane (3.3 mL, 23.5 mmol) and the flask was purged 
with argon for 2 minutes. The reaction mixture was stirred at room temperature for 
19 hours. The reaction mixture was diluted with Et2O (200 mL) and passed through a 
silica plug, then the solvent evaporated to give 5.44 g of a brown oil. The crude 
product was purified by silica gel chromatography, eluent 0-5% EtOAc in hexane. 
Pure fractions were evaporated to give desired product as a dark orange oil (4.21 g, 
98%). 
1
H NMR (400 MHz, CDCl3): δ 0.19 (9H, s, SiMe3), 3.73 (3H, s, OMe), 6.23 
(1H, d, J=15.9 Hz, H3), 6.72 (1H, d, J=15.9 Hz, H2); 
29
Si (139 MHz, CDCl3)  
δ -16.84; 13C NMR (101 MHz, CDCl3): δ -0.3 (SiMe3), 52.0 (OMe), 101.4 (C4),  
105.1 (C5), 125.6 (C2), 130.8 (C3), 166.3 (C1). Other spectroscopic data were 
consistent with those reported previously.
176
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(2E)-5-(Trimethylsilyl)pent-2-en-4-yn-1-ol 284 
 
 
A solution of methyl (2E)-5-(trimethylsilyl)pent-2-en-4-ynoate (1.0 g, 5.50 mmol) in 
dry DCM (28 mL) was cooled to -78 
o
C and DIBAL (11 mL, 11.0 mmol, 1.0 M 
solution in hexanes) was added dropwise under argon. The reaction mixture was 
stirred at this temperature for 4 hours. A solution of 1M HCl (15 mL) was added and 
the reaction allowed to reach room temperature. The organic layer was washed with 
sat. NaHCO3 (25 mL) to reach pH 7 and the aqueous washed with DCM  
(3 x 25 mL), then the organic extracts combined and washed with H2O (25 mL) and 
brine (25 mL), dried over MgSO4, filtered and evaporated to give desired product as 
a yellow oil (0.842 g, 95%). 
1
H NMR (400 MHz, CDCl3): δ 0.19 (9H, s, SiMe3), 
1.45 (1H, s, br, OH), 4.21 (2H, dd, J=5.1, 2.0 Hz, H1), 5.77 (1H, dt, J=16.0, 1.95 Hz, 
H3), 6.31 (1H, dt, J=16.0, 5.1 Hz, H2); 
29
Si NMR (139 MHz, CDCl3) δ -18.01;  
13
C NMR (101 MHz, CDCl3): δ 0.04 (SiMe3), 63.0 (C1), 95.5 (C5), 103.1 (C4),  
110.5 (C3), 143.1 (C2). Other spectroscopic data were consistent with those reported 
previously.
176
 
 (2E)-Pent-2-en-4-yn-1-ol  285 
 
 
(2E)-5-(Trimethylsilyl)pent-2-en-4-yn-1-ol (1.48 g, 9.50 mmol) was dissolved in 
MeOH (38 mL) and cooled to -10 
o
C under argon. Aqueous NaOH (9.5 mL of a  
2.5 M solution) was added slowly and the reaction stirred at this temperature for a 
further 2 hours. The reaction mixture was allowed to warm to room temperature and 
diluted with Et2O (40 mL). The aqueous layer was further washed with Et2O  
(40 mL), then the organics were washed with H2O (40 mL) and brine (40 mL), dried 
over MgSO4, filtered and evaporated to give desired product as a yellow oil (0.620 g, 
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79%). 
1
H NMR (400 MHz, CDCl3): δ 1.65 (1H, s, br, OH), 2.89 (1H, dq, J=2.2,  
0.7 Hz, H5), 4.14-4.28 (2H, m, H1), 5.74 (1H, dq, J=16.0, 2.1 Hz, H3), 6.35 (1H, dtd, 
J=16.0, 5.0, 0.7 Hz, H2). Other spectroscopic data were consistent with those 
reported previously.
176 
 (2E,4E)-5-(Tributylstannyl)penta-2,4-dien-1-ol 286 
 
Pd2dba3 (35 mg, 0.038 mmol), P(Cy)3BF4 (56 mg, 0.152 mmol) and N,N-
diisopropylethylamine (0.05 mL, 0.304 mmol) were added to dry, degassed DCM 
(76 mL) under a positive pressure of argon, then stirred for 10 minutes. A solution of 
(2E)-pent-2-en-4-yn-1-ol (0.620 g, 7.60 mmol) in DCM (20 mL) was added and the 
reaction cooled to 0 °C. Tributyltin hydride (2.43 mL, 9.12 mmol) in DCM (4 mL) 
was then added dropwise and the reaction stirred at 0 °C for 2 hours. The reaction 
was then allowed to warm to room temperature whilst stirring. The solvent was 
evaporated to give 3.50 g of a brown oil. The mixture was diluted with DCM (100 
mL) and passed through Celite, then the solvent removed to give 3.34 g of a brown 
oil which was taken straight into the next stage. 
1
H NMR (400 MHz, CDCl3): δ  
0.79-1.05 (15H, m, SnBu3), 1.14-1.36 (6H, m, SnBu3), 1.42-1.61 (6H, m, SnBu3), 
4.21 (2H, tdd, J=7.8, 4.4, 1.8 Hz, H1), 5.58-5.93 (1H, m, H2), 6.09-6.33 (2H, m, 
H3,4,5), 6.47-6.63 (1H, m, H3,4,5). Other spectroscopic data were consistent with those 
reported previously.
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 (2E,4E)-5-(Tributylstannyl)penta-2,4-dienal 287 
 
Activated MnO2 was placed in a dry flask and the flask purged with argon, then 
suspended in DCM (19 mL) and stirred while continuing to purge with argon. A 
solution of (2E,4E)-5-(tributylstannyl)penta-2,4-dien-1-ol in DCM (11 mL) was 
added slowly to the suspension and the reaction stirred at room temperature for  
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2 hours 15 minutes. The reaction mixture was passed through a plug of Celite, then 
the filter cake washed with DCM (56 mL), then EtOAc (94 mL). The solvent was 
evaporated to give 0.823 g of a crude brown oil, containing desired product (0.412 g, 
69% over the two steps). 
1
H NMR (400 MHz, CDCl3): δ 0.64-1.06 (15H, m, SnBu3), 
1.16-1.38 (6H, m, SnBu3), 1.44-1.64 (6H, m, SnBu3), 5.89-6.18 (1H, m, H2),  
6.70-6.87 (1H, m, H5), 6.93-7.07 (2H, m, H3,4), 9.57 (1H, d, J=8.0 Hz, H1). Other 
spectroscopic data were consistent with those reported previously.
174 
 (Dichloromethyl)boronic acid 289 
 
Dry DCM (0.75 mL, 11.8 mmol) was added to dry THF (21 mL) in a dry flask under 
argon and the solution cooled to -100 °C. n-BuLi (4.3 mL, 10.7 mmol, 2.5 M 
solution in hexanes) was added dropwise and the reaction stirred at -100 °C for  
30 minutes. Trimethyl borate (1.3 mL, 11.8 mmol) was added all in one portion and 
the reaction stirred for 35 minutes. 5M HCl (2.1 mL) was then added and the 
reaction mixture was allowed to warm to room temperature. Et2O (10 mL) was 
added and the layers separated. The aqueous was extracted with Et2O (2 x 10 mL). 
The organics were combined, dried over MgSO4, filtered and evaporated to a crude 
viscous pale yellow residue which became a solid on standing (1.54 g, 100 %).  
1H NMR (400 MHz, MeOD): δ 5.47; 11B NMR (128 MHz, MeOD): δ 22.6;  
13C NMR (101 MHz, MeOD): δ 68.9.  The compound was taken on to the next stage 
without any further purification or characterisation. 
 (Dichloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 290 
 
(Dichloromethyl) boronic acid (1.51 g, 11.8 mmol), MgSO4 (2.84 g, 23.6 mmol) and 
pinacol (1.39 g, 11.8 mmol) were placed in a flask and the flask purged with argon. 
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Dry THF (16 mL) was then added and the reaction stirred at room temperature for 3 
days. The reaction mixture was then filtered and the MgSO4 washed with DCM, then 
the solvent evaporated to give desired product as a pale yellow oil (2.15 g, 86%).  
1
H NMR (400 MHz, CDCl3): δ 1.31 (12H, s, pinacol ester), 5.33 (1H, S, tertiary 
carbon). 
11
B NMR (128 MHz, CDCl3): δ 29.0; LRMS (ASAP) 210.1 (M
+
-
10
B
35
Cl, 
3%), 211.0 (M
+
-
11
B
35
Cl, 8), 212.0 (M
+
-
10
B
35/37
Cl, 2), 213.0 (M
+
-
11
B
35/37
Cl, 6), 214.1 
(M
+
-
10
B
37
Cl, 5), 215.1 (M
+
-
11
B
37
Cl, 5); HRMS (ASAP) calculated [C7H14
10
BO2Cl2] 
210.0500, found 210.0491. The compound was taken on to the next stage without 
any further purification or characterisation. 
1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene 273 
 
 
 
2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (1.30 g, 3.85 mmol) was dissolved in dry THF (14 mL) and cooled to 
-78 
°
C under argon. NaOMe (9.2 mL, 4.62 mmol, 0.5 M in MeOH) was added 
dropwise and then reaction mixture stirred at -78 
o
C for 1 hour 15 minutes. Iodine 
monochloride (0.736 g, 3.95 mmol) in dry DCM (3.9 mL) was then added dropwise 
at this temperature and the reaction mixture stirred at -78 
°
C for a further 2 hours 10 
minutes. The reaction mixture was allowed to warm to room temperature and diluted 
with Et2O (116 mL), then washed with 5% Na2S2O5 (2 x 46 mL), H2O (46 mL) and 
brine (46 mL). The organics were dried over MgSO4 under argon, filtered and 
evaporated to give 1.30 g of a crude yellow solid containing desired product  
(0.863 g, 66%). 
1
H NMR (400 MHz, CDCl3): δ 3.90 (3H, s), 6.75-6.82 (2H, m), 6.88 
(1H, d, J=14.9 Hz), 7.37 (1H, d, J=14.9 Hz), 7.48 (1H, d, J=7.9 Hz). The compound 
was taken on to the next stage without any further purification or characterisation. 
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2-[(1E,3E)-4-(4-Bromo-3-methoxyphenyl)buta-1,3-dien-1-yl]-4,4,6-trimethyl-1,3,2-
dioxaborinane 270 
 
 
 
Method 1: 1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene (0.863 g, 2.55 mmol) 
was dissolved in dry, degassed MeCN (15 mL) and added to a dry, argon-purged 
flask containing Pd(OAc)2 (29 mg, 0.130 mmol), P(o-tol)3 (77 mg, 0.255 mmol) and 
AgOAc (0.458 g, 2.74 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane  
(0.50 mL, 2.92 mmol) was then added and the reaction mixture heated to 50 
°
C for 
18 hours. The reaction mixture was allowed to cool to room temperature, then 
diluted with Et2O containing ~3 ppm BHT (38 mL) and passed through a short 
Celite/silica plug. The solvent was evaporated to give 1.37 g of crude product as a 
viscous orange oil. The crude product was purified by silica gel chromatography, 
elution gradient 0-10 % EtOAc in petroleum ether. Pure fractions were evaporated to 
give desired product as a viscous yellow oil (0.725 g, 78%). 
1
H NMR (600 MHz, 
CDCl3): δ 1.23-1.33 (9H, m, H14,15,16), 1.46-1.53 (1H, m, H12), 1.80 (1H, ddd, 
J=14.0, 11.2, 2.9 Hz, H12), 3.92 (3H, s, OMe), 4.24 (1H, dqd, J=14.8, 6.1,  
3.1 Hz, H11), 5.64 (1H, d, J=17.4 Hz, H10), 6.59 (1H, d, 15.6 Hz, H7), 6.77-6.84 (1H, 
m, H8), 6.87-6.94 (2H, m, H2,6), 7.06 (1H, dd, J=17.3, 10.5 Hz, H9), 7.42-7.47 (1H, 
m, H5); 
11
B NMR (128 MHz, CDCl3): δ 25.56; 
13
C NMR (151 MHz, CDCl3): δ 23.1, 
28.1, 31.2 (C14,15,16), 46.0 (C12), 64.8 (C11), 70.8 (C13), 109.7 (C6), 111.3 (C4),  
120.3 (C2), 131.7 (C8), 133.3 (C5), 133.6 (C10), 134.9 (C7), 137.9 (C1), 146.3 (C9), 
155.9 (C3); LRMS (ASAP) 363.1 (M
+
-
10
B
79
Br, 7%), 364.1 (M
+
-
11
B
79
Br, 36), 365.1 
(M
+
-
10
B
81
Br, 100, includes [M+H]), 366.1 (M
+
-
11
B
81
Br, 51); HRMS (ASAP) 
[C17H23
10
BO3Br] calculated 364.0960, found 364.0958. 
Method 2: 1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene (1.40 g, 4.15 mmol) 
was dissolved in dry, degassed MeCN (24 mL) and added to a dry, argon-purged 
flask containing Pd(OAc)2 (46 mg, 0.208 mmol), P(o-tol)3 (0.123 g, 0.408 mmol) 
237 
 
and AgOAc (0.733 g, 4.38 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane 
(0.80 mL, 4.75 mmol) was then added and the reaction mixture heated to 30 
°
C for 
21.5 hours. The reaction mixture was allowed to cool to room temperature, then 
diluted with Et2O containing ~3 ppm BHT (61 mL) and passed through a short 
Celite/silica plug. The solvent was evaporated to give 1.67 g of crude product as a 
viscous orange oil. The crude product was purified by silica gel chromatography, 
elution gradient 0-10 % EtOAc in petroleum ether. Pure fractions were evaporated to 
give desired product as a viscous yellow oil (1.10 g, 73% over the two steps).  
1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene 274 
 
 
 
The crude mixture containing 2-[(1E,3E)-4-(4-bromo-3-methoxyphenyl)buta-1,3-
dien-1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane (0.725 g, 1.99 mmol) was dissolved 
in dry THF (7.3 mL) and cooled to -78 
o
C under argon. NaOMe (4.8 mL, 2.4 mmol, 
0.5 M in MeOH) was added dropwise and then reaction mixture stirred at -78 
°
C for 
55 minutes. Iodine monochloride (0.383 g, 2.054 mmol) in dry DCM (2.0 mL) was 
then added dropwise at this temperature and the reaction mixture stirred at -78 
o
C for 
a further 2 hours. The reaction mixture was allowed to warm to room temperature 
and diluted with Et2O (60 mL), then washed with 5% Na2S2O5 (2 x 24 mL), H2O  
(24 mL) and brine (24 mL). The organics were dried over MgSO4 under argon, 
filtered and evaporated to give a crude yellow solid containing desired product 
(0.708g, 98%). 
1
H NMR (400 MHz, CDCl3): δ 3.92 (3H, s), 6.47-6.49 (1H, m),  
6.51-6.53 (1H, m), 6.67 (1H, ddd, J=15.6, 10.6, 0.7 Hz), 6.85-6.91 (2H, m), 7.17 
(1H, ddd, J=14.4, 10.6, 0.7 Hz), 7.44-7.48 (1H, m). The compound was taken on to 
the next stage without any further purification or characterisation. 
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2-[(1E,3E,5E)-6-(4-Bromo-3-methoxyphenyl)hexa-1,3,5-trien-1-yl]-4,4,6-trimethyl-
1,3,2-dioxaborinane 270 
 
 
 
Method 1: 1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene  
(0.708 g, 1.95 mmol) was dissolved in dry, degassed MeCN (11.6 mL) and added to 
a dry, argon-purged flask containing Pd(OAc)2 (22 mg, 0.10 mmol), P(o-tol)3  
(59 mg, 0.190 mmol) and AgOAc acetate (0.348 g, 2.08 mmol). 4,4,6-Trimethyl-2-
vinyl-1,3,2-dioxaborinane (0.38 mL, 2.23 mmol) was then added and the reaction 
mixture heated to 50 
°
C for 2 days 17 hours. The reaction mixture was allowed to 
cool to room temperature then diluted with Et2O containing ~ 3 ppm BHT (29 mL) 
and passed through a short Celite/silica plug. The solvent was evaporated to give 
1.031 g of crude product as a brown oil. The crude product was purified by silica gel 
chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions 
were evaporated to yield desired product as a bright yellow oil (0.470 g, 62%). 
1
H 
NMR (600 MHz, CDCl3): δ 1.14-1.9 (1H, m, H16,17,18), 1.46-1.55 (1H, m, H14), 1.80 
(1H, dd, J=13.9, 2.9 Hz, H14), 3.92 (3H, s, OMe), 4.24 (1H, dqd, J=12.3, 6.2, 3.0 Hz, 
H13), 5.58 (1H, d, J=17.4 Hz, H12), 6.39-6.55 (3H, m, H8,9,10), 6.82 (1H, dd, J=15.5, 
10.0 Hz, H7), 6.82-6.92 (2H, m, H2,6), 7.00 (1H, dd, J=17.3, 9.9 Hz, H11), 7.45 (1H, 
d, J=8.1 Hz, H5); 
11
B NMR (128 MHz, CDCl3): δ 25.49; 
13
C NMR (151 MHz, 
CDCl3): δ 23.3, 28.3, 31.4 (C16,17,18), 46.2 (C14), 56.3 (OMe), 65.0 (C13), 71.0 (C15), 
109.5 (C6), 111.0 (C4), 120.3 (C2), 130.0 (C7), 132.7 (C8,9,10), 133.5 (C5),  
134.8 (C8,9,10), 136.2 (C8,9,10,12), 138.2 (C1), 146.5 (C11), 156.1 (C3); LRMS (ASAP) 
389.1 (M
+
-
10
B
79
Br, 12%), 390.1 (M
+
-
11
B
79
Br, 47), 391.1 (M
+
-
10
B
81
Br, 100, includes 
[M+H]), 392.1 (M
+
-
11
B
81
Br, 60);. HRMS (ASAP) [C19H24
10
BO3Br] calculated 
389.1038, found 389.1023.  
Method 2: 1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene (1.0 g, 
2.75 mmol) was dissolved in dry, degassed MeCN (16 mL) and added to a dry, 
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argon-purged flask containing Pd(OAc)2 (31 mg, 0.141 mmol), P(o-tol)3 (83 mg, 
0.268 mmol) and AgOAc (0.491 g, 2.93 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.53 mL, 3.14 mmol) was then added and the reaction mixture heated 
to 30 
°
C for 18 hours. The reaction mixture was allowed to cool to room temperature 
then diluted with Et2O containing ~ 3 ppm BHT (41 mL) and passed through a short 
Celite/silica plug. The solvent was evaporated to give 1.10 g of crude product as a 
viscous orange oil. The crude product was purified by silica gel chromatography, 
elution gradient 0-10% EtOAc in petroleum ether. Pure fractions were evaporated to 
yield desired product as a viscous yellow oil (0.600 g, 56%).  
1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 275 
 
 
The crude mixture containing 2-[(1E,3E,5E)-6-(4-bromo-3-methoxyphenyl)hexa-
1,3,5-trien-1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane (0.60 g, 1.54 mmol) was 
dissolved in dry THF (5.7 mL) and cooled to -78 
°
C under argon. NaOMe (3.7 mL, 
1.86 mmol, 0.5 M in MeOH) was added dropwise and then reaction mixture stirred 
at -78 
°
C for 40 minutes. Iodine monochloride (0.296 g, 1.59 mmol) in dry DCM  
(1.2 mL) was then added dropwise at this temperature and the reaction mixture 
stirred at -78 
°
C for a further 2 hours. The reaction mixture was allowed to warm to 
room temperature and diluted with Et2O (47 mL), then washed with 5% Na2S2O5  
(2 x 19 mL), H2O (19 mL) and brine (19 mL). The organics were dried over MgSO4 
under argon, filtered and evaporated to give a bright yellow solid containing desired 
product (est 0.506 g, 84%), which was found to rapidly decompose. 
1
H NMR  
(400 MHz, CDCl3): δ 3.93 (3H, s), 6.34 (1H, dd, J=7.4, 1.2 MHz), 6.56-6.63 (2H, 
m), 6.81 (1H, dd, J=9.9, 7.6 Hz), 6.86-6.94 (3H, m), 7.11 (1H, dd, J=14.3, 10.6 Hz), 
7.45-7.49 (1H, m). The compound was taken on to the next stage without any further 
purification or characterisation. 
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2-[(1E,3E,5E,7E)-8-(4-Bromo-3-methoxyphenyl)octa-1,3,5,7-tetraen-1-yl]-4,4,6-
trimethyl-1,3,2-dioxaborinane 272 
 
 
 
Method 1: 1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 
(0.233 g, 0.60 mmol) was dissolved in dry, degassed MeCN (3.7 mL) and added to a 
dry, argon-purged flask containing Pd(OAc)2 (7 mg, 0.031 mmol), P(o-tol)3 (18 mg, 
0.060 mmol) and AgOAc (0.109g, 0.645 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.12 mL, 0.690 mmol) was then added and the reaction mixture 
heated to 50 
°
C for 20 hours. The reaction mixture was allowed to cool to room 
temperature, then diluted with Et2O containing ~3 ppm BHT (25 mL) and passed 
through a short Celite/silica plug. The solvent was evaporated to give 0.296 g of 
crude product as a dark red viscous oil. The crude product was purified by silica gel 
chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions 
were evaporated to give desired product as a bright orange gum (0.146 g, 58%).  
Method 2: 1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 
(0.506 g, 1.30 mmol) was dissolved in dry, degassed MeCN (7.8 mL) and added to a 
dry, argon-purged flask containing Pd(OAc)2 (15 mg, 0.067 mmol), P(o-tol)3  
(39 mg, 0.127 mmol) and AgOAc (0.232 g, 1.39 mmol). 4,4,6-Trimethyl-2-vinyl-
1,3,2-dioxaborinane (0.25 mL, 1.49 mmol) was then added and the reaction mixture 
heated to 30 
o
C for 18.5 hours. The reaction mixture was allowed to cool to room 
temperature, then diluted with Et2O containing ~3 ppm BHT (19 mL) and passed 
through a short Celite/silica plug. The solvent was evaporated to give 0.704 g of 
crude product as a dark red viscous oil. The crude product was purified by silica gel 
chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions 
were evaporated to give desired product as a bright orange gum (0.289 g, 53%).  
1
H NMR (600 MHz, CDCl3): δ 1.24-1.6 (9H, m, H18,19,20), 1.46-1.54 (1H, m, H16), 
1.79 (1H, dd, J=13.8, 3.0 Hz, H16), 3.92 (3H, s, OMe), 4.24 (1H, dqd, J=12.3, 6.0, 
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2.9 Hz, H15), 5.55 (1H, d, J=17.3 Hz, H14), 6.03-6.18 (1H, m, H11), 6.39-6.44 (3H, m, 
H9,10,12), 6.48-6.52 (1H, m, H8), 6.84-6.94 (3H, m, H3,5,7), 6.95-7.04 (1H, m, H13), 
7.45 (1H, d, J=8.1 Hz, H6); 
11
B NMR (128 MHz, CDCl3): δ 25.37; 
13
C NMR (151 
MHz, CDCl3): δ 23.3, 28.3, 31.4 (C18,19,20), 46.2 (C16), 56.3 (OMe), 64.9 (C15), 71.0 
(C17), 109.6 (C5), 110.9 (C4), 120.2 (C1), 129.7 (C7), 130.0 (C14), 132.0 (C11), 133.5 
(C6), 134.1 (C9), 134.2 (C8), 135.1 (C10), 135.8 (C12), 138.3 (C3), 146.7 (C13), 156.1 
(C2); IR (max, cm
-1
) 1568.7 (m, alkene C=C), 1587.0 (m, alkene C=C), 1607.7 (m, 
alkene C=C), 2911.1 (m, C=CH), 2938.7 (m, C=CH), 2971.6 (m, C=CH) inter alia; 
LRMS (ASAP) 415.1 (M
+
-
10
B
79
Br, 16%), 416.1 (M
+
-
11
B
79
Br, 66), 417.1 (M
+
-
10
B
81
Br, 100, includes [M+H]), 418.1 (M
+
-
11
B
81
Br, 71);. HRMS (ESI) 
[C21H26
10
BO3Br] calculated 415.1195, found 415.1213.  
(3E)-4-Iodobuta-1,3-diene 277 
 
(E)-2-(Buta-1,3-dienyl)-4,4,6-trimethyl-1,3,2-dioxaborinane (2.77 g, 12.9 mmol) 
was dissolved in dry THF (48 mL) and cooled to -78 
°
C under argon. NaOMe  
(31 mL, 15.5 mmol, 0.5 M in MeOH) was added dropwise and then the reaction 
mixture stirred at -78 
°
C for 30 min. Iodine monochloride (2.47 g, 13.3 mmol) in dry 
DCM (13 mL) was then added dropwise at this temperature and the reaction mixture 
stirred at -78 
°
C for a further 2 hours. The reaction mixture was allowed to warm to 
room temperature and diluted with Et2O (400 mL), then washed with 5% Na2S2O5  
(2 x 160 mL), H2O (160 mL) and brine (160 mL). The organics were dried over 
MgSO4 under argon, filtered and evaporated to give 3.40 g of crude product as a 
dark brown oil. 
1
H NMR (400 MHz, CDCl3): δ 5.07 (1H, ddt, J=10.2, 1.4, 0.7 Hz, 
H1cis), 5.21 (1H, ddt, J=17.0, 1.5, 0.8 Hz, H1trans), 6.23 (1H, dddd, J=17.0, 10.7, 10.1, 
0.6 Hz, H2), 6.35 (1H, dq, J=14.4, 0.7 Hz, H4), 7.01 (1H, dd, J=14.4, 10.6 Hz, H3). 
The compound was taken on to the next stage without any further purification or 
characterisation. 
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2-[(1E,3E)-Hexa-1,3,5-trien-1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane 278 
 
(3E)-4-Iodobuta-1,3-diene (2.77 g, 12.9 mmol) was dissolved in dry, degassed 
MeCN (78 mL) and added to a dry, argon purged flask containing Pd(OAc)2  
(0.146 g, 0.650 mmol), P(o-tol)3 (0.395 g, 1.30 mmol) and AgOAc (2.60 g 15.6 
mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.5 mL, 14.7 mmol) was then 
added and the reaction mixture stirred at 50 
°
C for 20.5 hours. The reaction mixture 
was allowed to cool, diluted with 250 mL EtOAc containing ~3 ppm BHT and 
passed through a Celite/silica plug. The solvent was evaporated to give 5.90 g of a 
brown oil. The crude product was purified by silica gel chromatography, eluent 0-5% 
EtOAc in petroleum ether (eluents containing ~3 ppm BHT), to yield 1.50 g of a 
yellow oil containing desired product (est 0.462 g, 17% from vinyl boronate).  
1
H NMR (400 MHz, CDCl3): δ 1.24-1.32 (12H, m, H10,11,12), 1.42-1.56 (1H, m, H8), 
1.79 (1H, ddd, J=13.9, 3.0, 0.7Hz, H8), 4.17-4.28 (1H, m, H9), 5.14 (1H, dd, J=9.4, 
1.8 Hz, H1cis), 5.26 (1H, dd, J=16.1, 1.6 Hz, H1trans), 5.52 (1H, d, J=17.4 Hz, H6), 
6.22-6.43 (3H, m, H2,3,4), 6.88-6.99 (1H, m, H5); 
11
B NMR (128 MHz, CDCl3): δ 
25.81; 
13
C NMR (101 MHz, CDCl3): δ 23.3, 28.2, 31.4, 46.1, 64.9, 70.9, 118.7, 
133.9, 135.4, 135.6, 137.1, 146.6.; LRMS (ASAP) 206.1 ([M+H]- 
10
B, 5%) 207.1 
([M+H]- 
11
B, 18); HRMS (ASAP) [C12H20O2
10
B] calculated 206.1593, found 
206.1569.  
 (3E,5E)-6-Iodohexa-1,3,5-triene 279 
 
Crude mixture containing 2-[(1E,3E)-hexa-1,3,5-trien-1-yl]-4,4,6-trimethyl-1,3,2-
dioxaborinane (1.50 g, 8.86 mmol) was dissolved in dry THF (33 mL) and cooled to 
-78 
°
C under argon. NaOMe (21 mL, 10.7 mmol, 0.5 M in MeOH) was added 
dropwise and then the reaction mixture stirred at -78 
°
C for 40 minutes. Iodine 
monochloride (1.65 g, 7.97 mmol) in dry DCM (7.9 mL) was then added dropwise at 
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this temperature and the reaction mixture stirred at -78 
°
C for a further 2.5 hours. The 
reaction mixture was allowed to warm to room temperature and diluted with Et2O 
(280 mL), then washed with 5% Na2S2O5 (2 x 96 mL), H2O (96 mL) and brine  
(96 mL). The organics were dried over MgSO4 under argon, filtered and evaporated 
to give 0.941 g of crude product as a yellow oil containing desired product (0.282 g, 
11% from vinyl boronate). 
1
H NMR (400 MHz, CDCl3): δ 5.19-5.24 (1H, m),  
5.29-5.36 (1H, m), 6.08-6.38 (4H, m), 7.04 (1H, dd, J=14.4, 10.5 Hz). The 
compound was taken on to the next stage without any further purification or 
characterisation. 
Methyl (2E,4E,6E,8E)-11-(4-bromo-3-methoxyphenyl)undeca-2,4,6,8-tetraen-10-
ynoate 235 
 
 
Pd(PPh3)2Cl2 (1 mg, 0.002 mmol), copper (I) iodide (0.3 mg, 0.002 mmol), 1-bromo-
4-ethynyl-2-methoxybenzene (43 mg, 0.20 mmol) and methyl (2E,4E,6E,8E)-9-
iodonona-2,4,6,8-tetraenoate (50 mg, 0.170 mmol) were added to a dry flask and the 
vessel purged with argon. Dry, degassed Et3N (0.90 mL) was then added and the 
mixture was briefly degassed. The reaction mixture was then stirred at room 
temperature overnight. The solvent was removed to give a dark red residue, which 
was purified by silica gel chromatography at 0 
°
C, elution gradient 0-10% EtOAc in 
hexane. Pure fractions were evaporated to give desired product as a bright yellow 
amorphous solid (36 mg, 56%). 
1
H NMR (400 MHz, CDCl3): δ 3.76 (s, 3H, 
COOMe), 3.90 (s, 3H, aryl OMe), 5.91 (dd, J = 15.3, 6.1 Hz, 2H, H2,9), 6.29-6.54 (m, 
3H, H4,6,7), 6.60 (dd, J = 14.8, 10.5 Hz, 1H, H5), 6.75 (dd, J = 15.4, 10.4 Hz, 1H, H8), 
6.89-6.99 (m, 2H, H13,17), 7.28-7.39 (m, 1H, H16), 7.49 (dd, J = 11.4, 8.3 Hz, 1H, 
H13). 
13
C NMR (101 MHz, CDCl3): δ 51.6 (COOMe), 56.2 (aryl OMe), 90.0 (C11), 
93.7 (C10), 112.4 (C13), 113.1 (C9), 114.5 (C16), 121.2 (C2), 123.4 (C12), 124.9 (C15), 
131.7 (C7), 133.3 (C17), 134.1 (C6), 135.7 (C4), 139.9 (C5), 141.4 (C8), 144.1 (C3), 
155.6 (C14), 167.4 (C1). IR (max, cm
-1
) 1706.4 (C=O), 2184.6 (alkyne), 2956.1  
(C-H), inter alia.  LRMS (ASAP) 373.0 ([M+H]- 
79
Br, 100%) 375.0 ([M+H]- 
81
Br, 
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98); HRMS (ASAP) [C19H17O3Br] calculated 372.0361, found 372.0357; UV (Et2O 
5µM, nm) 370 (ε 148 400), 391 (ε 117 200); Fluorescence (Et2O 100 nM, nm) 439.5, 
467.5, 493.5.  
1-Bromo-4-[(1Z,3E,5E)-1-bromoocta-1,3,5,7-tetraen-1-yl]-2-methoxybenzene 280 
 
(3E,5E)-6-Iodohexa-1,3,5-triene (0.120 g, 0.583 mmol), (Z)-2-(2-bromo-2-(4-bromo-
3-methoxyphenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.243 g, 0.583 
mmol),  Pd(PPh3)4 (35 mg, 0.030 mmol) and Ag2O (0.161 g, 0.70 mmol) were added 
to a dry flask, then the flask purged with argon. Dry, degassed DME (5.3 mL) was 
then added and the reaction mixture heated to 60 
°
C for 20 hours. The reaction 
mixture was allowed to cool, diluted with Et2O containing ~3 ppm BHT (40 mL) and 
passed through a Celite/silica plug. The solvent was evaporated to give 0.634 g of a 
red oil.  The crude product was purified using silica gel chromatography, eluent  
0-5% EtOAc in hexane (eluents containing ~ 3 ppm BHT) to give 0.125 g of a wet 
orange solid containing desired product (59 mg, 28%). Partial 
1
H NMR (400 MHz, 
CDCl3) δ: 5.22 (1H, dd, J=7.3, 2.5 Hz), 5.33 (1H, d, J=15.1 Hz), inter alia; LRMS 
(ASAP) 368.9  ([M+H]- 
79
Br, 36%), 370.9 ([M+H]- 
79/81
Br, 68), 372.9 ([M+H]- 
81
Br, 
37); HRMS (ASAP) [C15H15OBr2], calculated 368.9490, found 368.9500. The 
compound was taken on to the next stage without any further purification or 
characterisation. 
1-Bromo-2-methoxy-4-[(1E,3E,5E)-octa-1,3,5,7-tetraen-1-yl]benzene 292 
 
 
2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.165 g, 0.490 mmol), (3E,5E)-6-iodohexa-1,3,5-triene (0.10 g, 
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0.490 mmol), Pd(PPh3)4 (29 mg, 0.0250 mmol) and Ag2O (0.135 g, 0.588 mmol) 
were added to a dry flask, then the flask purged with argon. Dry, degassed DME  
(4.4 mL) was then added and the reaction mixture heated to 60 
°
C for 22.5 hours. 
The reaction mixture was allowed to cool, diluted with Et2O containing ~3 ppm BHT 
(30 mL) and passed through a Celite/silica plug. The solvent was evaporated to give 
0.440 g of a red oil.  The crude product was purified using silica gel 
chromatography, eluent 0-5% EtOAc in hexane (eluents containing ~3 ppm BHT) to 
give 0.172 g of a wet orange solid that was rapidly polymerised, but from which the 
desired product could be identified. Partial 
1
H NMR (400 MHz, CDCl3) δ: 5.13 (1H, 
d, J=8.4 Hz), 5.26 (1H, dd, J=16.7, 1.6 Hz), inter alia; LRMS (ASAP) 289.0   
([M-H]- 
79
Br, 33%), 291.0 ([M-H]- 
81
Br, 31).; HRMS (ASAP) [C15H14OBr], 
calculated 289.0228, found 289.0319. No further characterisation was performed due 
to instability. 
Methyl (2E,4E,6E,8E,10Z)-11-bromo-11-(4-bromo-3-methoxyphenyl)undeca-
2,4,6,8,10-pentaenoate 233 
 
 
2-[(Z)-2-Bromo-2-(4-bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.10 g, 0.240 mmol), methyl (2E,4E,6E,8E)-9-iodonona-2,4,6,8-
tetraenoate (58 mg, 0.20 mmol), Pd(PPh3)4 (12 mg, 0.010 mmol) and Ag2O (55 mg, 
0.240 mmol) were added to a dry flask and the flask purged with argon. Dry, 
degassed DME (1.8 mL) was then added and the reaction stirred at 60 °C for  
16 hours. The reaction mixture was then diluted with EtOAc (10 mL) and passed 
through a short plug of Celite/silica. The solvent was evaporated to give 0.106 g of a 
crude brown oil. The crude product was purified by silica gel chromatography at  
0 
o
C, elution gradient 0-10% EtOAc in hexane, to give 31 mg of an orange solid 
from which the desired product could be identified. 
1
H NMR (700 MHz, CDCl3): δ 
3.75 (3H, s), 3.89 (3H, s), 5.91 (2H, dd, J=15.4, 10.4 Hz), 6.35-6.50 (3H, m),  
6.56-6.67 (2H, m), 6.70-6.77 (1H, m), 6.84-7.01 (2H, m), 7.29-7.34 (1H, m), 7.44-
7.51 (1H, m); LRMS (ASAP) 452.0  (M
+
- 
79
Br, 7%), 454.0 (M
+
- 
79/81
Br, 15), 456.0 
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(M
+
- 
81
Br, 11);  HRMS (ASAP) [C19H18O3Br2] calculated 451.9623, found 
451.9631. 
Methyl (2E,4E,6E,8E,10E,12E,14E,16Z)-17-bromo-17-(4-bromo-3-
methoxyphenyl)heptadeca-2,4,6,8,10,12,14,16-octaenoate 208 
 
 
1-Bromo-4-[(1Z,3E,5E)-1-bromoocta-1,3,5,7-tetraen-1-yl]-2-methoxybenzene  
(59 mg, 0.160 mmol) was dissolved in dry, degassed THF (0.50 mL) and dry, 
degassed MeCN (1.3 mL), then added to a dry, argon purged flask containing methyl 
(2E,4E,6E,8E)-9-iodonona-2,4,6,8-tetraenoate (63 mg, 0.220 mmol), Pd(OAc)2  
(2 mg, 0.0101 mmol), P(o-tol)3 (6 mg, 0.0220 mmol) and AgOAc (38 mg,  
0.230 mmol). The reaction mixture was degassed for 5 minutes and then heated to 50 
°
C for 24 hours. The reaction mixture was allowed to cool, then diluted with Et2O 
containing ~3 ppm BHT (25mL) and passed through a Celite/silica plug. The solvent 
was evaporated to yield 96 mg of a bright red gum. The crude product was purified 
by silica gel chromatography at 0 
°
C, eluent 0-10% EtOAc in hexane (eluents 
containing ~ 3ppm BHT) to give 25 mg of a yellow solid, which contained small 
amounts of desired product (see main discussion). 
Methyl (2E,4E,6E,8E,10E)-11-(4-bromo-3-methoxyphenyl)undeca-2,4,6,8,10-
pentaenoate 234 
 
 
Method 1: 2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (26 mg, 0.0760 mmol), methyl (2E, 4E, 6E,8E)-9-iodonona-2,4,6,8-
tetraenoate (18 mg, 0.0610 mmol), Pd(PPh3)4 (7 mg, 0.0061 mmol) and Ag2O  
(17 mg, 0.0760 mmol) were added to a dry flask and the flask purged with argon. 
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Dry, degassed DME (0.46 mL) was then added and the reaction stirred at 40 °C for 
17 hours. The reaction mixture was then diluted with EtOAc containing ~ 3ppm 
BHT (6.0 mL) and passed through a short plug of Celite/silica. The solvent was 
evaporated to give 55 mg of a green residue. The crude product was purified by 
silica gel chromatography at 0 
°
C, eluent benzene, to give desired product as a bright 
yellow solid (10 mg, 42%), mp 207.3-208.9 °C. 
1
H NMR (700 MHz, CDCl3): δ 3.75 
(3H, s, ester OMe), 3.92 (3H, s, aryl OMe), 5.89 (1H, d, J=15.2 Hz, H2), 6.37 (2H, 
ddd, J=15.1, 11.2, 4.3 Hz, H4,6), 6.41-6.52 (3H, m, H7,8,9), 6.55 (1H, d, J=15.5 Hz, 
H11), 6.62 (1H, dd, J=14.7, 11.2 Hz, H5), 6.80-6.85 (1H, m, H10), 6.87-6.93 (2H, m, 
H13,17), 7.29-7.35 (1H, m, H3), 7.47 (1H, d, J=8.1 Hz, H16); 
13
C NMR (176 MHz, 
CDCl3): δ 51.7 (ester OMe), 56.3 (aryl OMe), 109.6 (C17), 111.3 (C15), 120.3 (C13), 
120.5 (C2), 129.7 (C10), 130.5 (C4,6), 132.6 (C4,6), 133.1 (C11), 133.5 (C16),  
133.7 (C7,8,9), 135.4 (C7,8,9), 137.2 (C7,8,9), 138.0 (C12), 140.8 (C5), 144.7 (C3), 156.2 
(C14), 167.7 (C1); IR (max, cm
-1
)  inter alia 1703.9 (m, C=O),  2912.8 (w, C-H 
alkene), 2924.4 (w, C-H alkene), 2938.4 (w, C-H alkene),  2952.3 (w, C-H alkene); 
LRMS (ASAP) 375.1  ([M+H]- 
79
Br, 92%), 377.1 ([M+H]- 
81
Br, 95); HRMS 
(ASAP) [C19H19O3Br] calculated 374.0499, found 374.050. UV (CHCl3 5µM, nm) 
397 (ε 67 000), 417 (ε 56 000). Fluorescence (CHCl3 100 nM, nm) 498, 527, 566, 
594. 
Method 2:  2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (26 mg, 0.0760 mmol), methyl (2E, 4E, 6E,8E)-9-iodonona-2,4,6,8-
tetraenoate (18 mg, 0.0610 mmol), Pd(OAc)2 (1 mg, 0.0061 mmol), PPh3 (5 mg, 
0.0183 mmol) and Ag2CO3 (34 mg, 0.122 mmol) were added to a dry flask and the 
flask purged with argon. Dry, degassed MeCN (0.46 mL) was then added and the 
reaction stirred at room temperature for 17 hours. The reaction mixture was then 
diluted with EtOAc containing ~ 3ppm BHT (6.0 mL) and passed through a short 
plug of Celite/silica. The solvent was evaporated to give 82 mg of a green residue. 
The crude product was purified by silica gel chromatography at 0 
o
C, eluent benzene, 
to give desired product as a bright yellow solid (est. 19 mg, 81%).  
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Methyl (2E,4E,6E,8E,10E,12E,14E,16E)-17-(4-bromo-3-methoxyphenyl)heptadeca-
2,4,6,8,10,12,14,16-octaenoate 210 
 
 
2-[(1E,3E,5E,7E)-8-(4-Bromo-3-methoxyphenyl)octa-1,3,5,7-tetraen-1-yl]-4,4,6-
trimethyl-1,3,2-dioxaborinane (27 mg, 0.0650 mmol), methyl (2E,4E,6E,8E)-9-
iodonona-2,4,6,8-tetraenoate (16 mg, 0.0550 mmol), Pd(PPh3)4 (7 mg, 0.0250 mmol) 
and Ag2O (15 mg, 0.065 mmol) were added to a dry flask and purged with argon. 
Dry, degassed DME (0.50 mL) was added and the reaction heated to 40 
°
C for  
26 hours. The reaction mixture was allowed to cool to room temperature and then 
diluted with Et2O containing ~ 3 ppm BHT (10 mL) and passed through a Celite 
plug. The organics were evaporated to give 25 mg of an orange residue. The crude 
product was dissolved in CDCl3, and then cooled to 0 
°
C. Petroleum ether was added 
until precipitation of a red solid was achieved. The solid was collected on a sinter 
funnel and washed with cold petroleum ether, then the solid collected by dissolving 
in CHCl3 and then removing the solvent in vacuo to give 7 mg of a red solid 
containing desired product (0.5 mg, 2 %).  
1
H NMR (700 MHz, CDCl3): δ 3.74 (3H, 
s), 3.95 (3H, s), 5.91-5.99 (3H, m), 6.24-6.47 (12H, m), 6.85-6.92 (2H, m), 7.43-7.50 
(2H, m); LRMS (ASAP) 453.1  ([M+H]- 
79
Br, 23%), 455.1 ([M+H]- 
81
Br, 22); 
HRMS (ASAP) [C25H26O3Br] calculated 453.1065, found 453.1058. 
Methyl (2Z)-3-iodoprop-2-enoate 43 
 
Sodium iodide (14.4 g, 96 mmol) and methyl propiolate (5.3 mL, 59.6 mmol) were 
added to a flask and acetic acid (22 mL) added. The reaction mixture was then 
heated to 115 °C for 1 hour. The mixture was poured onto H2O (100 mL) whilst stil 
hot, then extracted with Et2O (3 x 100 mL) and washed with sat. NaHCO3  
(4 x 50 mL), 5% Na2S2O5 (50 mL) and brine (50 mL). The organic extracts were 
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then dried over MgSO4, filtered and evaporated to give desired product as a yellow 
oil (12.1 g, 96%).  
1
H NMR (400 MHz, CDCl3) δ 3.77 (3H, s, OMe), 6.90 (1H, d, 
J=8.9 Hz, H3), 7.46 (1H, d, J=8.9 Hz, H2); 
13
C NMR (101 MHz, CDCl3) δ  
51.8 (OMe), 95.2 (C3), 129.7 (C2), 165.1 (C1).  All spectroscopic data were 
consistent with those reported previously.
199 
(E)-2-(Buta-1,3-dienyl)-4,4,6-trimethyl-1,3,2-dioxaborinane 276 
 
Method 1: To a dry Schlenk flask under argon was added a solution of vinyl iodide 
(0.19 mL, 2.50 mmol) in dry MeCN (4.5 mL). To the solution was added Pd(OAc)2 
(0.280 g, 1.25 mmol). The reaction was degassed using the freeze-pump-thaw 
method (2 x cycles). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (1.8 mL,  
10.3 mmol) was then added and the mixture further degassed (2 x cycles). The 
reaction was then heated to 55 C with vigorous stirring. After 2 days, the reaction 
was cooled to room temperature, diluted with Et2O (80 mL), filtered through Celite 
and then washed with 5% HCl (2 x 20 mL), H2O (40 mL) and brine (40 mL). The 
organics were dried over MgSO4, filtered and evaporated to yield crude product 
(1.21 g) as a brown oil which partially crystallised on standing. The crude product 
was purified by silica chromatography, eluent 15% EtOAc in hexane, to yield an 
impure yellow oil. The crude product was further purified by silica chromatography, 
eluent 5% EtOAc in petroleum ether, to yield desired product as a yellow oil  
(0.325 g, 78%). 
Method 2: To a dry flask were added Pd(OAc)2  (0.146 g, 0.650 mmol), P(o-tol)3 
(0.395 g, 1.30 mmol) and AgOAc (2.60 g 15.6 mmol). Dry, degassed MeCN  
(24 mL) was added together with vinyl iodide (0.96 mL, 13.0 mmol) and 4,4,6-
trimethyl-2-vinyl-1,3,2-dioxaborinane (2.2 mL, 13.0 mmol). The reaction mixture 
was heated at 50 °C for 48 hours with vigorous stirring. The reaction mixture was 
allowed to cool, then diluted with Et2O (250 mL) and passed through a short 
Celite/silica plug. The organic extracts were evaporated to yield 2.60 g of crude 
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product as an orange oil. The crude product was purified by silica chromatography, 
elution gradient 0-4% EtOAc in petroleum ether. Pure fractions were evaporated to 
yield (E)-2-(buta-1,3-dienyl)-4,4,6-trimethyl-1,3,2-dioxaborinane as a pale yellow 
oil (1.71 g, 73%). 
1
H NMR (400 MHz, CDCl3): δ 1.33-1.26 (9H, m, H8,9,10), 1.50 
(1H, dd, J=13.9, 11.7 Hz, H6), 1.81-1.76 (1H, m, H6), 4.22 (1H, dqd, J=12.2, 6.3, 2.7 
Hz, H5), 5.18 (1H, dd, J=9.8, 1.7 Hz, H1a), 5.32 (1H, dd, J=17.1, 1.7 Hz, H1b), 5.51 
(1H, d, J=17.5, H4), 6.39 (1H, dt, J=17.1, 10.2 Hz, H2), 6.91 (1H, dd, J=17.6, 10.5 
Hz, H3); 
11
B NMR (128 MHz, CDCl3): δ 26.19; 
13
C NMR (101 MHz, CDCl3): δ  
23.1 (C8,9,10), 28.0 (C8,9,10), 31.2 (C8,9,10), 46.0 (C6), 64.71 (C5), 70.7 (C7), 119.5 (C1), 
139.1 (C2), 147.2 (C3, C4); IR (max, cm
-1
)  2973.5 (m, C=C-H), 1591 (m, C=C), inter 
alia; LCMS (ASAP) 180.1 (M
+
- 
10
B, 9%) 181.1 (M
+
- 
11
B, 33); HRMS (ASAP) 
calculated [C10H17
10
BO2+H] 180.1428, found 180.1431. 
Method 3: To an oven dried round bottomed flask were added Pd(OAc)2 (0.146 g, 
0.650 mmol), P(o-tol)3 (0.395 g, 1.30 mmol) and AgOAc (2.60 g 15.6 mmol). MeCN 
(24 mL), previously degassed by a bubbling argon needle, was added together with 
vinyl iodide (1.154 mL, 15.6 mmol) and 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane 
(2.2 mL, 13.0 mmol). The reaction mixture was heated at 50 °C for 2 days 17 hours 
with vigorous stirring. The reaction mixture was allowed to cool, then diluted with 
Et2O containing ~ 3 ppm BHT (250 mL) and passed through a short Celite/silica 
plug. The organic extracts were evaporated to yield 3.1 g of crude product as an 
orange oil (2.77 g, 99%).  
2-[(1E)-Buta-1,3,-dienyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 318 
 
To a dry Schlenk flask was added Pd(OAc)2 (29 mg, 0.125 mmol), P(o-tol)3 (76  mg, 
0.250 mmol) and AgOAc (0.50 g, 3.0 mmol), followed by dry, degassed MeCN  
(4.5 mL). Vinylboronic acid pinacol ester (0.42 mL, 2.50 mmol) was then added, 
followed by vinyl iodide (0.19 mL, 2.50 mmol). The reaction mixture was then 
heated to 55 °C with vigorous stirring for 2 days. The mixture was allowed to cool, 
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then diluted with Et2O (280 mL) and passed through a short Celite/silica plug. The 
organic extracts were washed with 5% HCl (40 mL), H2O (80 mL) and brine  
(80 mL), dried over MgSO4 and evaporated to yield 0.980 g of crude product as an 
orange oil. The crude product was purified by silica gel chromatography, eluent 10% 
EtOAc in hexane. Pure fractions were evaporated to yield 2-[(1E)-buta-1,3,-dienyl-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane as a an orange oil (0.318 g, 72%). 
1
H NMR 
(400 MHz, CDCl3): δ 1.30 (12H, s, Bpin), 5.28 (1H, ddt, J=10.0, 1.5, 0.7, H1a), 5.40 
(1H, ddt, J=17.1, 1.6, 0.8 Hz, H1b), 5.60 (1H, dq, J=17.7, 0.7 Hz, H4), 6.44 (1H, 
dddd, J=16.9, 10.5, 9.9, 0.8 Hz, H2), 7.03 (1H, dd, J=17.8, 10.4 Hz, H3); 
11
B NMR 
(128 MHz, CDCl3): δ 29.84. All spectroscopic data were consistent with those 
reported previously.
200
  
General conditions used for chain extension using vinyl iodide 
 
Method 1: Pd(OAc)2 (0.0975 mmol), P(o-tol)3 (0.195 mmol) and AgOAc  
(2.34 mmol) were added to a dry flask under argon in the absence of light. Degassed 
MeCN (6.0 mL) was added, followed by alkene (3.90 mmol) and then vinyl iodide 
(1.95 mmol) under a positive pressure of argon. The flask was then purged with 
argon for 2 minutes, and then stirred at 50 °C for between 17 hours and 3 days. 
Conversion was determined by 1H NMR. The reaction mixture was diluted with 
EtOAc containing ~ 3 ppm BHT (60 mL) and passed through a short Celite/silica 
plug. This was then evaporated to give crude product which was then analysed by  
1H NMR. Where purification was undertaken, this was achieved through silica gel 
chromatography. 
Method 2: Pd(OAc)2 (0.0325 mmol), P(o-tol)3 (0.0650 mmol) and AgOAc  
(0.780 mmol) were added to a dry flask under argon in the absence of light. 
Degassed MeCN (2.0 mL) was added, followed by TMB (0.65 mL, 0.65 mmol, 1 M 
solution in MeCN), BHT (0.01 mL, 10-20 ppm,1x10
-3
 M solution in MeCN), alkene  
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(1.30 mmol) and then vinyl iodide (0.650 mmol) under a positive pressure of argon. 
The flask was then purged with argon for 2 minutes, and then stirred at 50 °C for 
between 17 hours and 3 days. Conversion was determined by 
1
H NMR. The reaction 
mixture was diluted with EtOAc containing ~ 3 ppm BHT (20 mL) and passed 
through a short Celite/silica plug. This was then evaporated to give crude product 
which was then analysed by 
1
H NMR. Where purification was undertaken, this was 
achieved through silica gel chromatography. 
Method 3: Pd(OAc)2 (0.0325 mmol), P(o-tol)3 (0.0650 mmol) and AgOAc  
(0.780 mmol) were added to a dry flask under argon in the absence of light. 
Degassed MeCN (2.0 mL) was added, followed by TMB (0.65 mL, 0.65 mmol, 1 M 
solution in MeCN), BHT (0.01 mL, 10-20 ppm,1x10
-3
 M solution in MeCN), alkene 
(0.780 mmol) and then vinyl iodide (0.650 mmol) under a positive pressure of argon. 
The flask was then purged with argon for 2 minutes, and then stirred at 50 °C for 
between 17 hours and 3 days. Conversion was determined by 
1
H NMR. The reaction 
mixture was diluted with EtOAc containing ~ 3 ppm BHT (20 mL) and passed 
through a short Celite/silica plug. This was then evaporated to give crude product 
which was then analysed by 
1
H NMR. Where purification was undertaken, this was 
achieved through silica gel chromatography. 
Method 4: Pd(OAc)2 (0.0325 mmol), P(o-tol)3 (0.0650 mmol) and AgOAc  
(0.780 mmol) were added to a dry flask under argon in the absence of light. 
Degassed MeCN (2.0 mL) was added, followed by alkene (0.650 mmol) and then 
vinyl iodide (0.650 mmol) under a positive pressure of argon. The flask was then 
purged with argon for 2 minutes, and then stirred at 50 °C for between 17 hours and 
3 days. Conversion was determined by 
1
H NMR.  
Method 5: Pd(OAc)2 (0.0325 mmol), P(o-tol)3 (0.0650 mmol) and AgOAc  
(0.780 mmol) were added to dry Radleys Carousel reaction tubes under argon. 
MeCN (2.0 mL), previously degassed by the freeze-pump-thaw method (4 cycles), 
was added, the tubes were purged with argon, and vinyl iodide (0.650 mmol), 
followed by the alkene (0.650 mmol) were added. The tubes were heated to 50 °C 
with vigorous stirring for 2 days. Conversion was determined by 
1
H NMR. 
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Methyl (2E)-penta-2,4-dienoate 326 
 
 
After a 3 day reaction time, desired product was obtained as a crude orange oil, 42% 
conversion. 
1
H NMR (400 MHz, CDCl3): δ 3.76 (3H, s), 5.50 (1H, ddt, J=10.0, 1.4, 
0.7 Hz), 5.61 (1H, ddt, J=16.9, 1.5, 0.8 Hz), 5.92 (1H, dq, J=15.4, 0.7 Hz), 6.46 (1H, 
dddd, J=16.9, 10.9, 10.0, 0.7 Hz), 7.22-7.32 (1H, m, plus CDCl3); LCMS (EI) 112.1; 
HRMS (EI) calculated [C6H7O2+H] 112.0516, found 112.0519. All spectroscopic 
data were consistent with those reported previously.
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Tert-butyl (2E)-penta-2,4-dienoate 317 
 
 
After a 2 day reaction time, desired product obtained as a pale yellow oil (84 mg, 
28%). 
1
H NMR (700 MHz, CDCl3): δ 1.49 (9H, s, t-Bu), 5.44 (1H, ddd, J=10.0, 1.5, 
0.8 Hz, H5cis), 5.57 (1H, ddt, J=17.0, 1.6, 0.8 Hz, H5trans), 5.84 (1H, dd, J=15.4,  
0.8 Hz, H2), 6.43 (1H, dddd, J=16.9, 10.9, 10.0, 0.8 Hz, H3), 7.16 (1H, ddt, J=15.4, 
11.0, 0.8 Hz, H4); 
13
C NMR (176 MHz, CDCl3): δ 28.1 (t-Bu), 124.2 (C2), 124.7 
(C5), 134.8 (C3), 143.5 (C4), 166.1 (C1); IR (max, cm
-1
) : 3008.3 (m, C=C-H), 2980.6 
(m, C=C-H), 2935.5 (m, C=C-H), 1707.6 (m, C=C) inter alia; LCMS (ESI) 326.2; 
HRMS (ASAP) calculated [C18H32O4 (2M)+NH4] 326.2326, found 326.2326. 
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 (3E)-Hexa-3,5-dien-2-one 332 
 
 
After a 3 day reaction time, desired product was obtained as a crude dark orange oil, 
68% conversion. 
1
H NMR (400 MHz, CDCl3): δ 2.29 (3H,s), 5.48-5.57 (1H, m), 
5.61-5.71 (1H, m), 6.16 (1H, d, J=15.7 Hz), 6.47 (1H, dddd, J=16.9, 10.8, 9.9,  
0.7 Hz), 7.10 (1H, ddt, J=15.8, 10.8, 0.8 Hz); LCMS (EI) 96.1; HRMS (EI) 
calculated [C6H8O] 96.0577, found 96.0575. All spectroscopic data were consistent 
with those reported previously.
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 (1E)-Buta-1,3-dien-1-yltrimethoxysilane 315 
 
After a 3 day reaction time, desired product was obtained as a crude yellow oil, 42 % 
conversion. 
1
H NMR (700 MHz, CDCl3): δ 3.58 (9H, s, plus starting acceptor), 5.25 
(1H, ddt, J=10.0, 1.5, 0.7 Hz), 5.36 (1H, ddt, J=17.0, 1.5, 0.7 Hz), 5.55 (1H, dq, 
J=18.6, 0.7 Hz), 6.38 (1H, dtd, J=17.0, 10.0, 0.8 Hz), 6.82 (1H, ddt, J=18.6, 10.2,  
0.8 Hz); LCMS (EI) 174.1; HRMS (EI) calculated [C7H14O3Si] 174.0703, found 
174.0707. 
(1E)-Buta-1,3-dien-1-yltriethoxysilane 316 
 
After a 3 day reaction time, desired product was obtained as a crude orange oil, 50% 
conversion. 
1
H NMR (700 MHz, CDCl3): δ 1.23 (9H, t, J=7.0 Hz, plus starting 
acceptor), 3.83 (6H, q, J=7.0Hz, plus starting acceptor), 5.23 (1H, ddt, J=10.0, 1.5, 
0.7 Hz), 5.33 (1H, ddt, J=17.0, 1.5, 0.7 Hz), 5.58 (1H, dq, J=18.5, 0.7 Hz), 6.37 (1H, 
dtd, J=17.0, 10.1, 0.9 Hz), 6.81 (1H, ddt, J=18.6, 10.2, 0.8 Hz); LCMS (EI) 216.1; 
HRMS (EI) calculated [C10H20O3Si] 216.1175, found 216.1177. 
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Dimethyl [(1E)-buta-1,3-dien-1-yl)]phosphonate 359 
 
After a 3 day reaction time, desired product was obtained as a crude dark orange oil, 
12% conversion. 
1
H NMR (600 MHz, CDCl3): δ 2.04 (6H, s), 5.44-5.49 (1H, m), 
5.52-5.60 (1H, m), 5.64-5.68 (1H, m), 6.41 (1H, dtd, J=17.0, 10.3, 1.9 Hz), 7.04-7.13 
(1H, m); LRMS (ASAP) 163.1; HRMS (ASAP) calculated [C6H11O3P+H] 163.0515, 
found 163.0519. 
 (3E)-4-Methanesulfonylbuta-1,3-diene 360 
 
After a 3 day reaction time, desired product was obtained as a crude dark orange oil, 
14% conversion. 
1
H NMR (600 MHz, CDCl3): δ 2.94 (3H, s), 5.61-5.65 (m, 1H), 
5.72 (1H, dt, J=16.8, 0.9 Hz), 6.11 (1H, underneath signal for starting acceptor), 6.43 
(1H, underneath signal for starting acceptor), 7.13-7.20 (m, 1H); LCMS (EI) 132.0; 
HRMS (EI) calculated [C5H8O2S] 132.0247, found 132.0245. All spectroscopic data 
were consistent with those reported previously.
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N-Phenyl pyrrole 328
 
 
 
Pd(OAc)2 (48 mg, 0.195 mmol), P(o-tol)3 (0.119 g, 0.390 mmol) and AgOAc  
(0.780 g, 4.68 mmol) were added to a dry flask under argon in the absence of light. 
Dry, degassed MeCN (6.0 mL) was added, followed by vinyl iodide (0.29 mL,  
3.90 mmol) and then 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (0.67 mL, 1.95 
mmol) under a positive pressure of argon. The flask was purged with argon for  
5 minutes and stirred at 50 °C for 6 hours. Nitrosobenzene (0.379 g, 3.51 mmol) was 
then added and the reaction stirred at the same temperature overnight. A further  
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0.3 equivalents of nitrosobenzene was added (0.126 g, 1.17 mmol) and the reaction 
stirred for a further 2.5 hours. 0.2 equivalents of nitrosobenzene was then added  
(84 mg, 0.78 mmol) and the reaction stirred overnight. The reaction was allowed to 
cool, then diluted with DCM (120 mL) and passed through a short Celite/silica plug. 
Concentration in vacuo gave 1.1 g of a dark brown oil. The crude product was 
purified by silica gel chromatography, elution gradient 2-10% toluene in hexane to 
give desired product as a white solid (0.267 g, 48%), mp 60.8-62.2 oC; 1H NMR 
(400 MHz, CDCl3) δ 6.35 (2H, t, J=2.2 Hz), 7.10 (2H, t, 2.2 Hz), 7.21-7.29 (1H, m), 
7.36-7.46 (4H, m). Other spectroscopic data are consistent with those reported 
previously.195 
1
H NMR reaction scale cycloadditions of dienyl silanes 
The dienyl silane (0.139 mmol) and the nitrosobenzene (2.5 equivalents) were added 
to a vial and dissolved in 1.0 mL CDCl3. Where necessary the CDCl3 was passed 
through a short plug of alumina before dissolution. The solution was transferred to a 
pre-cooled NMR tube and 
1
H NMR experiments performed at 30 minutes, and then 
at the time specified in the table. 
General conditions used for SM couplings on dienyl boronate 
 
 
To a completely cooled, oven dried round bottomed flask was added (E)-2-(buta-1,3-
dienyl)-4,4,6-trimethyl-1,3,2-dioxaborinane (0.183 g, 1.01 mmol), followed by BHT 
(0.01 mL, 10-20 ppm, 1x10-3 M solution in THF), TMB (0.68 mL, 0.675 mmol, 1 M 
solution in THF), aryl or vinyl halide (0.675 mmol), t-BuOK (91 mg, 0.810 mmol) 
and Pd(PPh3)4 (39 mg, 0.0338 mmol). After purging with argon for 2 minutes, 
degassed THF (6.0 mL) was added, and the reaction mixture further degassed for  
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2 minutes. The reaction mixture was heated to 60 °C. After the reaction was 
complete, the mixture was allowed to cool, diluted with EtOAc containing ~ 3 ppm 
BHT  
(80 mL) and passed through a short Celite/silica gel plug and the organic extracts 
were evaporated to yield crude product. A small portion of the crude product was 
used for GC and 1H NMR analysis to determine crude yield. The crude product was 
purified by silica gel chromatography to yield the desired polyene. 
1-[(1E)-Buta-1,3-dien-1-yl]-4-methoxybenzene 361 
 
 
 
After a 4.5 hour reaction time, product obtained as a colourless oil (84 mg, 78%) 
following silica gel chromatography on silver nitrate impregnated silica, eluent 5% 
EtOAc in hexane. 1H NMR (400 MHz, CDCl3): δ 3.81 (3H, s, Me), 5.11 (1H, ddt,  
J= 10.7, 1.5, 0.7 Hz, H10cis), 5.28 (1H, ddt, J=16.9, 1.6, 0.8 Hz, H10trans), 6.44-6.54 
(2H, m, H7,8), 6.67 (1H, ddt, J=15.5, 10.5, 0.8 Hz, H9), 6.83-6.87 (2H, m, H2,6),  
7.32-7.38 (2H, m, H3,5). 13C NMR: (176 MHz, CDCl3) δ 55.7 (C11), 114.4 (C2,6), 
116.8 (C10), 127.67 (C3,5,8), 130.3 (C1), 132.7 (C8), 137.7 (C7), 159.6 (C4). All 
spectroscopic data were consistent with those reported previously.187  
1-[(1E)-Buta-1,3-dien-1-yl]-2-methoxybenzene 362 
 
 
After a 25 hour reaction time, product obtained as a colourless oil containing 0.87:1 
reference:product (25 mg, 23%), following silica gel chromatography on silver 
nitrate impregnated silica, eluent 5% EtOAc in hexane. 1H NMR (700 MHz, CDCl3): 
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δ 3.86 (3H, s, OMe), 5.15 (1H, ddt, J=10.0, 1.5, 0.7 Hz, H10cis), 5.31 (1H, ddt, 
J=16.9, 1.6, 0.8 Hz, H10trans), 6.55 (1H, dtd, J=17.0, 10.2, 0.7 Hz, H9), 6.79-6.85 (1H, 
m, H8), 6.87 (1H, dd, J=8.3, 1.1 Hz, H7), 6.90-6.95 (2H, m, H3,4), 7.22 (1H, ddd, 
J=8.2, 7.3, 1.7 Hz, H6), 7.48 (1H, dd, J=7.6, 1.7 Hz, H5). 
13C NMR (176 MHz, 
CDCl3): δ 55.4 (OMe), 85.9 (C2), 110.9 (C7), 116.9 (C10), 120.6 (C3), 126.5 (C5), 
127.6 (C4), 128.6 (C6), 130.2 (C8), 137.9 (C9), 156.8 (C1). All spectroscopic data 
were consistent with those reported previously.
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1-[(1E)-Buta-1,3-dien-1-yl]-4-methylbenzene 355 
 
 
 
After a 6 hour reaction time, product obtained as a yellow oil (87 mg, 89%), 
following silica gel chromatography, eluent 1% EtOAc in hexane. 1H NMR  
(700 MHz, CDCl3): δ 2.34 (3H, s, Me), 5.15 (1H, ddt, J= 10.0, 1.6, 0.8 Hz, H10cis), 
5.32 (1H, ddt, J= 17.1, 1.8, 0.9 Hz, H10trans), 6.47-6.59 (2H, m, H7,8), 6.75 (1H, m, 
H9), 7.14 (2H, d, J= 7.9 Hz, H3,5), 7.31-7.33 (2H, m, H2,6). 
13C NMR (176 MHz, 
CDCl3): δ 21.1(C11), 117.0 (C10), 126.3 (C2,6), 128.7 (C9), 129.3 (C3,5), 132.8 (C1), 
134.3 (C8), 137.3 (C7), 137.5 (C4); IR (max, cm
-1) 1581 (m, aromatic C-C), 1630 (m, 
alkene C-C), 1641 (m, alkene C-C), 1659 (m, alkene C-C), inter alia. All 
spectroscopic data were consistent with those reported previously.187 
1-[(1E)-Buta-1,3-dien-1-yl]-2-methylbenzene 363 
 
 
After a 25 hour reaction time, product obtained as a colourless oil (39 mg, 40%), 
following silica gel chromatography on silver nitrate impregnated silica, eluent 1% 
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EtOAc in hexane. 1H NMR (700 MHz, CDCl3): δ 2.81 (3H, s, Me), 5.18 (1H, ddd, 
J=10.0, 1.6, 0.8 Hz, H10cis), 5.34 (1H, ddd, J= 17.0, 1.7, 0.8 Hz, H10trans), 6.56 (1H, 
dt, J= 16.9, 10.1 Hz, H9), 6.70 (1H, ddd, J= 15.5, 10.3, 0.8 Hz, H8), 6.80 (1H, d,  
J= 15.5 Hz, H7), 7.14-7.20 (3H, m, H3,4,5), 7.47-7.52 (1H, m, H6).
 13C NMR  
(151 MHz, CDCl3): δ 19.8 (C11), 117.4 (C10), 125.2 (C6), 126.1 (C3), 127.5(C5), 
130.4 (C4), 130.5 (C7), 130.7 (C8), 135.6 (C2), 136.0 (C1), 137.5 (C9). All 
spectroscopic data were consistent with those reported previously.
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1-[(1E)-Buta-1,3-dien-1-yl]-4-nitrobenzene 364 
 
 
 
After a 6 hour reaction, product obtained as a yellow solid (78 mg, 66%), following 
silica gel chromatography on silver nitrate impregnated silica, eluent 1% EtOAc in 
hexane, mp 66.0-69.9 °C. 1H NMR (400 MHz, CDCl3): δ 5.35 (1H, d, J= 10.0 Hz, 
H10cis), 5.48 (1H, d, J= 16.9 Hz, H10trans), 6.52 (1H, dt, J= 16.9, 10.3 Hz, H9), 6.60 
(1H, d, J= 15.7 Hz, H7), 6.93 (1H, dd, J= 15.7, 10.5 Hz, H8), 7.50 (2H, d, J= 8.7 Hz, 
H2,6), 8.16 (2H, d, J= 14.0 Hz, H3,5). 13C NMR (176 MHz, CDCl3): δ 120.9 (C10), 
124.1 (C3,5), 126.8 (C2,6), 130.4 (C7), 134.0 (C8), 136.4 (C9), 143.6 (C4), 146.8 (C1). 
All spectroscopic data were consistent with those reported previously.
204
 
 (E)-Methyl-2-(buta-1,3-dienyl) benzoate 365 
 
 
After a 23 hour reaction time, product obtained as a colourless oil containing 
1:1:0.33 reference:unreacted aryl:product (29 mg, 24%), following silica gel 
chromatography on silver nitrate impregnated silica, eluent 1% EtOAc in hexane.  
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1H NMR (700 MHz, CDCl3): δ 3.90 (3H, s, CO2Me), 5.21 (1H, ddt, J=10.0, 1.5,  
0.8 Hz, H10 cis proton), 5.36 (1H, ddt, J=16.8, 1.5, 0.8 Hz, H10 trans proton), 6.58 
(1H, dtd, J=16.9, 10.3, 0.8 Hz, H9) 6.71 (1H, ddt, J=15.6, 10.5, 0.9 Hz, H7), 7.28 
(1H, td, J=7.6, 1.2 Hz, H5), 7.40 (1H, m, H8), 7.46 (1H, tdd, J=7.9, 1.5, 0.7 Hz, H3), 
7.59-7.69 (1H, m, H4), 7.84-7.89 (1H, m, H6).
13C NMR (151 MHz, CDCl3): δ 52.1 
(Me), 118.4 (C10), 126.7 (C4), 127.1 (C5), 130.5 (C6), 131.1 (C8), 131.9 (C3), 132.3 
(C7), 137.4 (C9), 166.9 (CO2Me), 167.8 (C1); IR (max, cm
-1) 1678 (w, C=C stretch), 
1659 (w, C=C stretch), 1649 (w, C=C stretch), 1641 (w, C=C stretch), inter alia; 
LRMS (ASAP) 188.1; HRMS (ASAP) calculated [C12H12O2], 189.0916, found 
189.0923. 
2-[(1E)-Buta-1,3-dien-1-yl]-naphthalene 354 
 
 
 
Product obtained as a colourless oil (82 mg, 68%), following silica gel 
chromatography on silver nitrate impregnated silica, eluent 1% EtOAc in hexane.  
1H NMR (400 MHz, CDCl3): δ 5.25 (1H, ddt, J= 9.9, 1.4, 0.7 Hz, H14cis), 5.40 (1H, 
ddt, J= 16.8, 1.6, 0.8 Hz, H14trans), 6.67 (1H, ddt, J= 16.9, 10.31 Hz, H13), 6.86 (1H, 
ddt, J= 15.3, 10.6, 0.9 Hz, H12), 7.36 (1H, d, J= 15.3 Hz, H11), 7.45-7.55 (3H, m, 
H3,5,9), 7.68 (1H, dt, J= 7.3, 1.0 Hz, H10), 7.76-7.83 (1H, m, H7), 7.84-7.89 (1H, m, 
H8), 8.15 (1H, dq, J=8.1, 0.9 Hz, H4). 
13C NMR (151 MHz, CDCl3): δ 117.9 (C14), 
123.4 (C10), 123.6 (C4), 125.6 (C3), 125.7 (C5), 126.0 (C9), 128.0 (C7), 128.6 (C8), 
129.6 (C11), 131.2 (C1), 132.5 (C12), 133.7 (C6), 134.5 (C2), 137.4 (C13). All 
spectroscopic data were consistent with those reported previously.
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3-[(1E)-Buta-1,3-dien-1-yl]-pyridine 356 
 
 
After a 24 hour reaction time, product obtained as a yellow oil containing 1.03 borate 
byproduct:product (78 mg, 88%), following silica gel chromatography, eluent  
10-50% EtOAc in hexane. 1H NMR (600 MHz, CDCl3): δ 5.20-5.28 (1H, m, H10 cis 
proton), 5.39 (1H, dd, J=17.0, 1.4 Hz, H10 cis proton), 6.45-6.56 (2H, m, H7,9), 6.83 
(1H, dd, J=15.7 Hz, 10.5 Hz, H8), 7.18-7.25 (1H, m, H6), 7.66-7.77 (1H, m, H5), 8.45 
(1H, d, J=4.8 Hz, H2), 8.61 (1H, s, H4). 
13C NMR (176 MHz, CDCl3): δ 119.1 (C10), 
123.5 (C6), 128.9 (C7), 131.6 (C8), 132.6 (C3.5), 136.6 (C9), 148.4 (C2), 148.5 (C4). 
IR (max, cm
-1) 2968 (w, alkene C-H), 1678 (m, C=C stretch), 1659 (m, C=C stretch), 
1641 (m, C=C stretch), inter alia; LRMS (ASAP) 131.1; HRMS (ASAP) calculated 
[C9H10N], 132.0813, found 132.0817. All spectroscopic data were consistent with 
those reported previously.
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2-[(1E)-Buta-1,3-dien-1-yl]-thiophene 367 
 
 
After a 23 hour reaction, product obtained as a colourless oil (42 mg, 46%), 
following silica gel chromatography on silver nitrate impregnated silica, eluent 1% 
EtOAc in hexane. 1H NMR (400 MHz, CDCl3): δ 5.15 (1H, ddt, J= 10.1, 1.5, 0.7 Hz, 
H9cis), 5.31 (1H, ddt, J= 16.9, 1.6, 0.7 Hz, H9trans), 6.44 (1H, dt, J=16.8, 10.0 Hz, H7), 
6.57-6.75 (2H, m, H6,8), 6.94-6.99 (2H, m, H4,5), 7.14-7.19 (1H, m, C3). 
13C NMR 
(176 MHz, CDCl3): δ 117.6 (C9), 124.6 (C3), 125.8 (C6), 127.7 (C4,5), 129.5 (C8), 
136.8 (C7), 142.6 (C2). All spectroscopic data were consistent with those reported 
previously.206 
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Methyl (3E, 5E)-octa-3,5,7-trienoate 348 
 
 
After a 4 hour reaction time, product obtained as a colourless oil (49 mg, 53%), silica 
gel chromatography on silver nitrate impregnated silica, eluent 0-10% ethyl acetate 
in hexane. 1H NMR (400 MHz, CDCl3): δ 3.75 (3H, s, Me), 5.32 (1H, dd, J= 9.9,  
1.3 Hz, H8cis), 5.42 (1H, dd, J= 16.7, 1.3 Hz, H8trans), 5.91 (1H, d, J= 15.3 Hz, H3), 
6.30-6.36 (1H, m, H7), 6.39-6.46 (1H, m, H5) 6.56 (1H, ddt, J= 14.8, 10.7, 0.7 Hz, 
H6), 7.31 (1H, ddd, J= 15.3, 11.3, 0.7 Hz, C4). 
13C NMR (176 MHz, CDCl3): δ  
51.4 (C1), 120.9 (C3), 121.5 (C8), 130.2 (C7), 136.0 (C5), 140.8 (C6), 144.2 (C4), 
167.2 (C2); IR (max, cm
-1) 1631 (w, alkene C-C), 1641 (w, alkene C-C), 1659 (w, 
alkene C-C), 1678 (w, alkene C-C), 1727 (s, ester C=O) inter alia; LRMS (ASAP) 
138.068; HRMS (ASAP) calculated [C8H10O2], 139.0752, found 139.0759. 
Procedure for making silica impregnated with 10% silver(I) nitrate 
A solution of silver nitrate (11.0 g) in distilled H2O (60 mL) was added to silica  
(100 g) and ground for 5 minutes using a mortar and pestle. This was then dried in 
an oven at 150 
°
C overnight and stored in a beaker wrapped in aluminium in a 
dessicator over P2O5. 
Potassium (1E)-buta-1,3-dien-1-yltrifluoroboranuide 349 
 
 
(E)-2-(Buta-1,3-dienyl)-4,4,6-trimethyl-1,3,2-dioxaborinane (0.10 g, 0.560 mmol) 
was dissolved in MeOH (1.1 mL), then MeCN (1.1 mL) was added. KF (0.130 g, 
2.21 mmol) in H2O (0.4 mL) was added dropwise at room temperature, followed by 
(+)-tartaric acid (0.170 g, 1.13 mmol) in THF (1.7 mL) dropwise. The resulting 
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white suspension was stirred for 1 minute, then sonicated for 1 minute, then stirred 
for 5 minutes. MeCN (1.7 mL) was then added, the reaction was stirred for  
2 minutes, then MeCN (0.5 mL) was added and the reaction stirred for a further  
2 minutes. The suspension was filtered, the white solid was washed with MeCN  
(3 x 3.0 mL) and the filtrate concentrated in vacuo to give desired product as a white 
(90 mg, 100%), mp  126.6 
o
C (decomp); 
1
H NMR (400 MHz, acetone-d6): δ 4.74 
(1H, dd, J=9.1, 2.5 Hz, H4cis), 4.89 (1H, dd, J=16.3, 2.2 Hz, C4trans), 5.63-5.73 (1H, 
m, H2), 6.18-6.34 (2H, m, H1,3);
 11
B NMR (128 MHz, acetone-d6): δ 2.69 (q,  
J=56.0 Hz); 
19
F NMR (376 MHz, acetone-d6): δ -142.03 (dd, J=105.8, 48.7 Hz);  
13
C NMR (151 MH, acetone-d6): δ 112.0 (C4), 136.1 (C2,3), 143.0 (C1); IR (max,  
cm
-1
): 3186.4 (w, alkene C-H), 1591.9 (m, C=C), inter alia; LRMS (ESI -ve) [M-K] 
120.0; HRMS (ESI -ve) calculated [C4H5
10
BF3], 120.0478, found 120.0481. 
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5.3 Screen conditions 
5.3.1 Screens detailed in Section 1.2 
Conditions used in SM screen on boronic acid 
 
 
 
 
 
[(Z)-7-Bromo-7-(4-bromo-3-methoxyphenyl)ethenyl] boronic acid (20 mg,  
0.0911 mmol), methyl (2E)-3-iodoprop-2-enoate (13mg, 0.0608 mmol), Pd(PPh3)4  
(4 mg, 0.00306 mmol) and base (0.0729 mmol) were added to dry reaction tubes 
under argon. Degassed THF (0.53 mL) was then added, the tubes were further 
purged with argon for 2 minutes, and the tubes were heated to 60 
°
C with vigorous 
stirring for 4 days. A further 0.5 mL THF was added, and the reaction was analysed 
by 
1
H NMR. 
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Conditions used in SM screen on styrenyl iodide 
 
1-[(Z)-7-Bromo-8-iodoethenyl]-3-methoxy-4-bromobenzene (50 mg, 0.120 mmol), 
Pd(PPh3)4 (7 mg, 0.006 mmol) and base (0.144 mmol) were added to dry reaction 
tubes under argon. Dry, degassed DME (1.1 mL) was then added, followed by 4,4,6-
trimethyl-2-vinyl-1,3,2-dioxaborinane (0.03 mL, 0.144 mmol), the tubes were further 
purged with argon for 2 minutes, and the tubes were heated to 60 
°
C with vigorous 
stirring for 3 days. The reactions were then analysed by 
1
H NMR. 
Conditions used in SM screen on 4-iodoanisole 
 
Entries 1 and 2: 4-iodoanisole (0.309 g, 1.32 mmol), catalyst (0.066 mmol) and base 
(1.58 mmol) were added to a dry flask, and the flask purged with argon. 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.23 mL, 1.32 mmol) was added, followed 
by dry, degassed DME (12 mL), then the flask was purged with argon for a further  
2 minutes. The reaction mixture was then stirred at 60 
°
C for 16.5 and 19 hours, 
respectively. The reactions were then analysed by 
1
H NMR. 
Entries 3 and 4: 4-iodoanisole (0.140 g, 0.60 mmol), catalyst (0.030 mmol) and base 
(0.720 mmol) were added to a dry flask, and the flask purged with argon. 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.12 mL, 0.720 mmol) was added, followed 
by dry, degassed DME (5.3 mL), then the flask was purged with argon for a further 2 
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minutes. The reaction mixture was then stirred at 60 
°
C for 3 days. The reactions 
were then analysed by 
1
H NMR. 
Conditions used in screen on styrenyl Bpin 
 
Conditions were analogous to those above. 
Conditions used in screen on brominated styrenyl Bpin 
 
Conditions were analogous to those above. 
5.3.2 Screens detailed in Section 1.3 
Conditions used in temperature screen on tetraenyl iodide 
 
Tetraenyl iodide (50 mg) was dissolved in 5.0 mL degassed MeCN-d6, and 0.50 mL 
of this solution added to 5 pre-cooled NMR tubes. 0.20 mL of a 1 M solution of 
TMB in degassed MeCN-d6 was added, the tubes were degassed, and each tube was 
heated to the stipulated temperature for 2 hours before analysing the mixture by 
1
H 
NMR. 
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Conditions used for HM temperature screen 
 
Methyl (2E)-3-iodoprop-2-enoate (0.141 g, 0.665 mmol), Pd(OAc)2 (8 mg,  
0.0340 mmol), P(o-tol)3 (20 mg, 0.0670 mmol) and AgOAc (0.120 g, 0.721 mmol) 
were added to dry flasks under argon in the absence of light. Dry, degassed MeCN 
(4.0 mL) was added to each flask, followed by 4,4,6-trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.13 mL, 0.760 mmol) under a positive pressure of argon. The flasks 
were then purged with argon for 2 minutes, and then heated to the stipulated 
temperature with vigorous stirring, with conversion monitored at 3 hours and 24 
hours by 
1
H NMR. The HM:SM ratio was also determined by 
1
H NMR. 
5.3.3 Screens detailed in Section 2.1 
General conditions used for base and ligand screen  
 
Pd(OAc)2 (0.0650 mmol) monodentate ligand (0.130 mmol) or bidentate ligand 
(0.0650 mmol) and base (0.780 mmol) were added to reaction tubes under argon. 
MeCN (4.5 mL), previously degassed by the freeze-pump-thaw method (4 x cycles) 
was added to each tube together with vinyl iodide (0.650 mmol) and 4,4,6-trimethyl-
2-vinyl-1,3,2-dioxaborinane (0.780 mmol). The reaction tubes were then evacuated 
and filled with argon, and the reaction tubes stirred at 50 °C for 3 days. An internal 
reference compound of naphthalene (0.0650 mmol) was used. Reaction products and 
conversions were identified by 
1
H NMR. 
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General conditions used for boronate equivalents screen  
 
Pd(OAc)2  (0.0650 mmol), P(o-tol)3  (0.130 mmol) and AgOAc (0.780 mmol) were 
added to reaction tubes under argon. MeCN (4.5 mL), previously degassed by the 
freeze-pump-thaw method (4 x cycles) was added to each tube together with vinyl 
iodide (0.650 mmol) and 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane. The reaction 
tubes were then evacuated and filled with argon, and the reaction tubes stirred at  
50 °C for 36 hours. Reaction products and conversions were identified by 
1
H NMR 
General conditions used for catalyst screen  
 
To oven dried reaction tubes under argon were added catalyst (0.0325 mmol),  
P(o-tol)3 (20 mg, 0.0650 mmol), AgOAc (0.130 g, 0.780 mmol) and naphthalene  
(9 mg, 0.0650 mmol). Degassed MeCN (2.0 mL) was added to each tube together 
with vinyl iodide (0.10 g, 0.650 mmol) and 4,4,6-trimethyl-2-vinyl-1,3,2-
dioxaborinane (0.10 g, 0.650 mmol). The reaction tubes were then heated to 50 °C 
for 17 hours with vigorous stirring, after which a portion was taken and analysed by 
GC and 
1
H NMR. Reaction products and conversions were identified relative to 
naphthalene internal standard. 
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General conditions used for silver(I) acetate equivalent screen  
 
To oven dried reaction tubes under argon were added Pd(OAc)2 (7 mg,  
0.0325 mmol), P(o-tol)3 (20 mg, 0.0650 mmol), AgOAc and naphthalene (9 mg, 
0.0650 mmol). Degassed MeCN (2.0 mL) was added to each tube together with 
vinyl iodide (0.10 g, 0.650 mmol) and 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane 
(0.10 g, 0.650 mmol). The reaction tubes were then heated to 50 °C for 22 hours 
with vigorous stirring, after which a portion was taken and analysed by GC and  
1
H NMR. Reaction products and conversions were identified relative to naphthalene 
internal standard. 
General conditions used for initial SM couplings  
 
To an oven dried reaction tube were added (E)-2-(buta-1,3-dienyl)-4,4,6-trimethyl-
1,3,2-dioxaborinane (0.146 g, 0.810 mmol), aryl or vinyl halide (0.675 mmol), 
t-BuOK (91 mg, 0.80 mmol), Pd(PPh3)4 (39 mg, 0.0338 mmol) and naphthalene  
(9 mg, 0.0675 mmol). The reaction tube was then purged with argon and evacuated 
(x2). Degassed THF (6.0 mL) was added under argon and the reaction mixture 
heated to 67 °C for 24 hours. The reaction mixture was allowed to cool, then diluted 
with Et2O (30 mL) and passed through a short Celite/silica plug. The organic extracts 
were washed with H2O (40 mL) and brine (40 mL), dried over MgSO4, filtered and 
evaporated to yield crude product. The crude product was purified by silica 
chromatography to yield desired polyene. 
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5.3.4 Screens detailed in Section 2.2 
Conditions for the temperature screen are detailed in Section 5.3.2. 
Conditions used for HM ligand screen 
 
Methyl (2E)-3-iodoprop-2-enoate (0.141 g, 0.665 mmol), Pd(OAc)2 (15 mg,  
0.0670 mmol), ligand  (0.134 mmol) and AgOAc (0.120 g, 0.721 mmol) were added 
to dry flasks under argon in the absence of light. Degassed MeCN (4.0 mL) was 
added to each flask, followed by 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane  
(0.13 mL, 0.760 mmol) under a positive pressure of argon. The flasks were then 
purged with argon for 2 minutes, and then stirred vigorously at room temperature, 
with conversion monitored at 1.5 hours, 3 hours and 24 hours by 
1
H NMR. The 
HM:SM ratio was also determined by 
1
H NMR. 
Conditions used for catalyst loading screen 
 
Methyl (2E)-3-iodoprop-2-enoate (0.141 g, 0.665 mmol), Pd(OAc)2,  
tri(2-furyl)phosphine (2 equivalents wrt catalyst) and AgOAc (0.120 g, 0.721 mmol) 
were added to dry round-bottomed flasks under argon in the absence of light. 
Degassed MeCN (4.0 mL) was added to each flask, followed by 4,4,6-trimethyl-2-
vinyl-1,3,2-dioxaborinane (0.13 mL, 0.760 mmol) under a positive pressure of 
argon. The flasks were then purged with argon for 2 minutes, then stirred vigorously 
at room temperature, with conversion monitored at 3 hours and 24 hours by  
1
H NMR. The HM:SM ratio was also determined by 
1
H NMR. 
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Conditions for substrate scope 
Iodide (0.665 mmol), Pd(OAc)2 (2 mg, 0.00665 mmol), tri(2-furyl)phosphine (3 mg, 
0.0133 mmol)) and AgOAc (0.120 g, 0.721 mmol) were added to dry flasks under 
argon in the absence of light. Degassed MeCN (4.0 mL) was added to each flask, 
followed by 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (0.13 mL, 0.760 mmol) 
under a positive pressure of argon. The flasks were then purged with argon for  
2 minutes, then stirred vigorously at room temperature, with conversion monitored at 
3 hours and 24 hours by 
1
H NMR.  
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Appendix 
(Z)-2-(2-bromo-2-(4-bromo-3-methoxyphenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 61 (13srv085)
168
 
 
 
 
 
Table 1. Crystal data and structure refinement for 61 
  
Empirical formula  C15H19BO3Br2  
Formula weight  417.93  
Temperature/K  120  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  15.3222(8)  
b/Å  8.5128(5)  
c/Å  13.2436(7)  
α/°  90  
β/°  103.701(8)  
γ/°  90  
Volume/Å
3
  1678.27(17)  
Z  4  
ρcalcmg/mm
3
  1.654  
m/mm
-1
  4.836  
F(000)  832.0  
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Crystal size/mm
3
  0.52 × 0.48 × 0.14  
2Θ range for data collection  2.736 to 64°  
Index ranges  
-22 ≤ h ≤ 22, -12 ≤ k ≤ 12, -19 ≤ l 
≤ 19  
Reflections collected  25514  
Independent reflections  5829[R(int) = 0.0294]  
Data/restraints/parameters  5829/0/200  
Goodness-of-fit on F
2
  1.017  
Final R indexes [I>=2σ (I)]  R1 = 0.0242, wR2 = 0.0515  
Final R indexes [all data]  R1 = 0.0407, wR2 = 0.0568  
Largest diff. peak/hole / e Å
-3
  0.56/-0.45  
 
Table 2.  Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for 61. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
 
Atom x y Z U(eq) 
Br1 1868.3(2) 6888.8(2) 1324.3(2) 27.02(5) 
Br2 5565.0(2) 8084.5(2) 5785.5(2) 23.92(4) 
O1 2242.8(7) 4485.7(13) -640.7(8) 21.4(2) 
O2 1851.0(7) 2485.0(13) 314.0(8) 22.4(2) 
O3 5951.8(7) 5991.5(13) 4166.9(8) 21.4(2) 
C1 1453.9(10) 3751.5(19) 
-
1316.6(12) 
21.5(3) 
C2 1406.7(10) 2138.8(18) -763.9(12) 20.4(3) 
C3 667.8(12) 4835(2) 
-
1301.3(14) 
32.2(4) 
C4 1605.4(13) 3630(2) 
-
2402.1(13) 
32.5(4) 
C5 464.0(12) 1569(2) -795.4(15) 33.3(4) 
C6 1950.5(12) 851(2) - 29.2(4) 
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1115.4(13) 
C7 6280.8(11) 4918.2(19) 3512.9(13) 23.7(3) 
C8 3043.7(10) 4390.1(18) 1307.1(11) 20.8(3) 
C9 2945.9(9) 5689.9(17) 1828.8(11) 17.6(3) 
C10 3558.6(9) 6308.0(17) 2781.7(11) 16.6(3) 
C11 4464.5(10) 5849.7(16) 3001.1(11) 16.9(3) 
C12 5062.2(9) 6358.1(16) 3898.7(11) 16.7(3) 
C13 4748.8(10) 7344.1(17) 4579.0(11) 18.1(3) 
C14 3862(1) 7815.2(16) 4368.4(12) 19.6(3) 
C15 3266.6(10) 7306.1(17) 3469.0(12) 19.3(3) 
B 2370.6(11) 3781(2) 308.3(13) 19.0(3) 
 
Table 3. Anisotropic Displacement Parameters (Å
2
×10
3
) for 61. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+...+2hka×b×U12] 
 
Atom U11 U22 U33 U23 U13 U12 
Br1 18.15(7) 26.67(8) 31.88(9) -6.61(6) -2.78(6) 5.03(6) 
Br2 23.96(8) 24.48(8) 21.30(7) -7.25(6) 1.30(6) -2.81(6) 
O1 19.4(5) 24.2(5) 19.8(5) -0.4(4) 2.9(4) -4.2(4) 
O2 24.7(6) 25.7(5) 15.3(5) -0.6(4) 2.0(4) -4.6(4) 
O3 16.0(5) 24.4(5) 22.9(5) -5.4(4) 2.7(4) 2.5(4) 
C1 20.3(7) 26.2(7) 16.9(6) -1.0(6) 2.1(5) -2.5(6) 
C2 18.9(7) 25.7(7) 16.0(6) -2.3(5) 2.7(5) -4.6(6) 
C3 27.0(9) 36.1(9) 29.6(9) 2.0(7) -0.8(7) 6.5(7) 
C4 39.8(10) 39.9(10) 18.6(7) 0.5(7) 8.4(7) -5.3(8) 
C5 24.6(8) 41.3(10) 33.9(9) -1.8(8) 6.9(7) -12.4(7) 
C6 31.3(9) 26.8(8) 27.3(8) -6.8(6) 2.7(7) 0.5(7) 
C7 20.3(7) 27.9(8) 23.0(7) -2.6(6) 5.6(6) 5.4(6) 
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C8 19.2(7) 21.8(7) 20.1(7) -1.8(6) 1.8(6) 0.4(6) 
C9 14.4(6) 19.0(6) 19.4(6) 1.7(5) 4.2(5) -0.4(5) 
C10 16.3(6) 15.1(6) 18.5(6) 0.0(5) 4.4(5) -1.8(5) 
C11 17.6(6) 16.0(6) 17.7(6) -1.9(5) 5.5(5) 0.3(5) 
C12 15.5(6) 14.9(6) 19.8(6) 0.9(5) 4.6(5) -0.4(5) 
C13 21.1(7) 15.8(6) 17.0(6) -1.8(5) 4.1(5) -3.6(5) 
C14 20.9(7) 17.1(7) 22.4(7) -3.8(5) 8.4(6) -0.5(5) 
C15 17.9(7) 17.5(6) 23.4(7) -1.7(5) 6.7(6) 0.0(5) 
B 17.5(7) 21.1(8) 18.7(7) -2.9(6) 4.7(6) 1.3(6) 
 
 
 
 
 
 
 
 
 
Table 4. Bond Lengths for 61. 
 
Atom Atom Length/Å   Atom Atom Length/Å 
Br1 C9 1.9213(14)   C2 C5 1.515(2) 
Br2 C13 1.8888(14)   C2 C6 1.516(2) 
O1 C1 1.4631(18)   C8 C9 1.332(2) 
O1 B 1.364(2)   C8 B 1.561(2) 
O2 C2 1.4587(18)   C9 C10 1.480(2) 
O2 B 1.362(2)   C10 C11 1.404(2) 
O3 C7 1.4303(18)   C10 C15 1.394(2) 
O3 C12 1.3611(17)   C11 C12 1.387(2) 
C1 C2 1.566(2)   C12 C13 1.397(2) 
C1 C3 1.521(2)   C13 C14 1.380(2) 
C1 C4 1.513(2)   C14 C15 1.387(2) 
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Table 5. Bond Angles for 61. 
 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
B O1 C1 107.06(12)   C8 C9 C10 127.68(13) 
B O2 C2 107.24(12)   C10 C9 Br1 115.28(10) 
C12 O3 C7 117.60(11)   C11 C10 C9 118.30(13) 
O1 C1 C2 102.21(11)   C15 C10 C9 122.45(13) 
O1 C1 C3 105.96(13)   C15 C10 C11 119.25(13) 
O1 C1 C4 108.67(13)   C12 C11 C10 120.68(13) 
C3 C1 C2 113.64(13)   O3 C12 C11 124.70(13) 
C4 C1 C2 114.74(14)   O3 C12 C13 116.45(13) 
C4 C1 C3 110.76(14)   C11 C12 C13 118.83(13) 
O2 C2 C1 102.58(11)   C12 C13 Br2 119.09(11) 
O2 C2 C5 108.22(13)   C14 C13 Br2 119.79(11) 
O2 C2 C6 106.48(12)   C14 C13 C12 121.09(13) 
C5 C2 C1 114.65(14)   C13 C14 C15 119.90(13) 
C5 C2 C6 110.49(14)   C14 C15 C10 120.23(14) 
C6 C2 C1 113.66(13)   O1 B C8 123.83(14) 
C9 C8 B 125.64(14)   O2 B O1 113.87(13) 
C8 C9 Br1 117.00(11)   O2 B C8 122.29(14) 
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Table 6. Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for 61. 
 
Atom x y z U(eq) 
H3A 576 4885 -595 41(3) 
H3B 124 4428 -1775 41(3) 
H3C 797 5889 -1525 41(3) 
H4A 1635 4686 -2686 43(4) 
H4B 1108 3047 -2847 43(4) 
H4C 2171 3077 -2376 43(4) 
H5A 494 545 -451 44(3) 
H5B 127 1469 -1520 44(3) 
H5C 162 2326 -435 44(3) 
H6A 2564 1225 -1067 42(3) 
H6B 1672 567 -1837 42(3) 
H6C 1967 -73 -669 42(3) 
H7A 6204 5376 2818 28(3) 
H7B 5944 3931 3463 28(3) 
H7C 6920 4712 3809 28(3) 
H8 3569 3781 1565 25 
H11 4670 5184 2530 20 
H14 3660 8487 4838 23 
H15 2658 7639 3321 23 
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15srv238  
 
Table 1 Crystal data and structure refinement for 15srv238.  
Identification code  15srv238 
Empirical formula  C13H11O3Br 
Formula weight  295.13 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  7.5029(6) 
b/Å  7.7331(6) 
c/Å  11.6022(9) 
α/°  96.926(3) 
β/°  103.697(3) 
γ/°  110.372(3) 
Volume/Å
3
  597.69(8) 
Z  2 
ρcalcg/cm
3
  1.640 
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μ/mm-1  3.431 
F(000)  296.0 
Crystal size/mm
3
  0.24 × 0.22 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.76 to 58 
Index ranges  -10 ≤ h ≤ 10, -10 ≤ k ≤ 10, -15 ≤ l ≤ 15 
Reflections collected  11320 
Independent reflections  3174 [Rint = 0.0511, Rsigma = 0.0585] 
Data/restraints/parameters  3174/0/156 
Goodness-of-fit on F
2
  1.029 
Final R indexes [I>=2σ (I)]  R1 = 0.0311, wR2 = 0.0623 
Final R indexes [all data]  R1 = 0.0441, wR2 = 0.0660 
Largest diff. peak/hole / e Å
-3
  0.49/-0.42 
 
  
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for 15srv238. Ueq is defined as 1/3 of of the trace 
of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Br1 2868.3(3) 6482.9(3) 842.56(19) 19.53(8) 
O1 2460(2) 2503(2) 320.1(13) 18.9(3) 
O2 1613(2) -5173(2) 6709.0(13) 19.2(3) 
O3 2801(2) -2469(2) 8132.2(13) 22.0(3) 
C1 2692(3) 2452(3) 3526.4(19) 16.1(4) 
C2 2564(3) 1804(3) 2318.4(19) 15.8(4) 
C3 2591(3) 2992(3) 1505.1(18) 14.1(4) 
C4 2760(3) 4838(3) 1930.8(18) 13.4(4) 
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C5 2880(3) 5477(3) 3117.2(19) 16.5(4) 
C6 2845(3) 4289(3) 3922.3(19) 16.9(4) 
C7 2695(3) 1269(3) 4391.0(19) 18.2(4) 
C8 2729(3) 399(3) 5176(2) 19.5(5) 
C9 2829(3) -548(3) 6155(2) 19.1(5) 
C10 1992(3) -2416(3) 6020.8(19) 16.4(4) 
C11 2198(3) -3291(3) 7084.3(19) 15.0(4) 
C12 1738(4) -6207(3) 7663(2) 22.2(5) 
C13 2560(3) 718(3) -98(2) 18.6(5) 
  
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for 15srv238. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
Br1 25.51(13) 12.63(11) 22.06(12) 9.16(8) 8.27(9) 6.84(9) 
O1 30.6(9) 14.2(7) 15.8(8) 4.7(6) 9.6(7) 11.2(7) 
O2 29.8(9) 12.9(7) 16.6(8) 5.9(6) 7.2(7) 9.2(7) 
O3 29.6(9) 16.3(8) 16.0(8) 3.5(6) 4.7(7) 5.6(7) 
C1 13.9(10) 16.6(10) 18.9(11) 7.9(8) 6.0(9) 5.4(9) 
C2 18.0(11) 11.2(10) 20.5(11) 5.8(8) 8.3(9) 6.0(8) 
C3 14(1) 12.8(10) 15(1) 4.0(8) 4.7(8) 4.2(8) 
C4 13.2(10) 10.4(9) 16.9(10) 5.6(7) 5.2(8) 3.7(8) 
C5 16.9(11) 12(1) 21.1(11) 3.5(8) 6.0(9) 6.0(8) 
C6 16.9(11) 18.7(11) 15.7(10) 4.3(8) 5.5(9) 6.9(9) 
C7 18.7(11) 17.4(11) 19.5(11) 4.7(8) 7.0(9) 7.1(9) 
C8 22.4(12) 14.9(10) 21.5(12) 5.5(8) 8.9(10) 5.5(9) 
C9 21.5(12) 19.0(11) 16.9(11) 5.4(8) 6.2(9) 7.2(9) 
C10 20.4(11) 15.6(10) 13.1(10) 3.4(8) 4.5(9) 7.0(9) 
C11 13.3(10) 14.4(10) 17.5(11) 4.9(8) 4.5(9) 5.2(8) 
C12 32.3(13) 16.8(11) 22.1(12) 11.7(9) 10.5(10) 10.8(10) 
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C13 23.2(12) 12.6(10) 20.9(11) 2.3(8) 7.8(9) 7.7(9) 
 
Table 4 Bond Lengths for 15srv238. 
Atom Atom Length/Å   Atom Atom Length/Å 
Br1 C4 1.8928(19)   C2 C3 1.392(3) 
O1 C3 1.352(2)   C3 C4 1.404(3) 
O1 C13 1.440(2)   C4 C5 1.376(3) 
O2 C11 1.346(2)   C5 C6 1.385(3) 
O2 C12 1.446(2)   C7 C8 1.197(3) 
O3 C11 1.200(2)   C8 C9 1.426(3) 
C1 C2 1.399(3)   C9 C10 1.331(3) 
C1 C6 1.395(3)   C10 C11 1.479(3) 
C1 C7 1.437(3)         
  
Table 5 Bond Angles for 15srv238. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C3 O1 C13 117.77(15)   C5 C4 C3 121.57(18) 
C11 O2 C12 115.66(16)   C4 C5 C6 119.83(19) 
C2 C1 C7 121.46(19)   C5 C6 C1 119.82(19) 
C6 C1 C2 120.21(18)   C8 C7 C1 175.2(2) 
C6 C1 C7 118.32(19)   C7 C8 C9 177.0(2) 
C3 C2 C1 120.14(18)   C10 C9 C8 124.2(2) 
O1 C3 C2 124.85(18)   C9 C10 C11 120.8(2) 
O1 C3 C4 116.73(17)   O2 C11 C10 109.96(17) 
C2 C3 C4 118.42(18)   O3 C11 O2 124.16(18) 
C3 C4 Br1 118.70(15)   O3 C11 C10 125.87(19) 
C5 C4 Br1 119.72(15)           
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Table 6 Selected Torsion Angles for 15srv238. 
A B C D Angle/˚   A B C D Angle/˚ 
C2 C3 O1 C13 -8.5(3)   C9 C10 C11 O2 -166.9(2) 
C4 C3 O1 C13 171.70(18)   C9 C10 C11 O3 12.8(3) 
C7 C8 C9 C10 -180(100)   C10 C11 O2 C12 -179.96(17) 
C8 C9 C10 C11 178.9(2)   C12 O2 C11 O3 0.3(3) 
 
  
Table 7 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for 15srv238. 
Atom x y z U(eq) 
H2 2458 552 2052 19 
H5 2987 6730 3384 20 
H6 2924 4724 4742 20 
H9 3539 201 6955 23 
H10 1254 -3196 5232 20 
H12A 1276 -7557 7300 33 
H12B 899 -6023 8159 33 
H12C 3124 -5742 8178 33 
H13A 2506 563 -958 28 
H13B 1431 -314 -4 28 
H13C 3810 689 382 28 
 
 
 
